Arnold Ganser
#108,486
Most Influential Person Now
Researcher
Arnold Ganser's AcademicInfluence.com Rankings
Arnold Ganserengineering Degrees
Engineering
#3060
World Rank
#4081
Historical Rank
Electrical Engineering
#616
World Rank
#677
Historical Rank
Arnold Gansercomputer-science Degrees
Computer Science
#4029
World Rank
#4237
Historical Rank
Data Science
#40
World Rank
#40
Historical Rank
Computational Linguistics
#311
World Rank
#316
Historical Rank
Machine Learning
#670
World Rank
#680
Historical Rank
Download Badge
Engineering Computer Science
Arnold Ganser's Degrees
- PhD Computer Science Stanford University
- Masters Electrical Engineering University of California, Berkeley
Similar Degrees You Can Earn
Why Is Arnold Ganser Influential?
(Suggest an Edit or Addition)Arnold Ganser's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Genomic Classification and Prognosis in Acute Myeloid Leukemia. (2016) (2608)
- Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial (2004) (2288)
- Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia. (2008) (1608)
- Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation (2017) (1382)
- Retinoic acid and arsenic trioxide for acute promyelocytic leukemia. (2013) (1143)
- Intracoronary Bone Marrow Cell Transfer After Myocardial Infarction: Eighteen Months’ Follow-Up Data From the Randomized, Controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) Trial (2006) (1046)
- Monitoring of Bone Marrow Cell Homing Into the Infarcted Human Myocardium (2005) (969)
- Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma. (2010) (779)
- TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome. (2012) (539)
- Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study. (2009) (446)
- Cdkn1a deletion improves stem cell function and lifespan of mice with dysfunctional telomeres without accelerating cancer formation (2006) (429)
- Naturally Occurring Human Urinary Peptides for Use in Diagnosis of Chronic Kidney Disease* (2010) (425)
- Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults (1988) (417)
- A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with del5q. (2011) (413)
- RUNX1 mutations in acute myeloid leukemia: results from a comprehensive genetic and clinical analysis from the AML study group. (2011) (406)
- The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML. (2011) (389)
- Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes. (2012) (388)
- Adult patients with acute lymphoblastic leukemia and molecular failure display a poor prognosis and are candidates for stem cell transplantation and targeted therapies. (2012) (388)
- Monitoring of minimal residual disease in NPM1-mutated acute myeloid leukemia: a study from the German-Austrian acute myeloid leukemia study group. (2011) (364)
- Prognostic impact, concurrent genetic mutations, and gene expression features of AML with CEBPA mutations in a cohort of 1182 cytogenetically normal AML patients: further evidence for CEBPA double mutant AML as a distinctive disease entity. (2011) (356)
- Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells. (2007) (356)
- Differential impact of allelic ratio and insertion site in FLT3-ITD-positive AML with respect to allogeneic transplantation. (2014) (343)
- Intracoronary bone marrow cell transfer after myocardial infarction: 5-year follow-up from the randomized-controlled BOOST trial. (2009) (336)
- Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL). (2006) (330)
- Individual patient data-based meta-analysis of patients aged 16 to 60 years with core binding factor acute myeloid leukemia: a survey of the German Acute Myeloid Leukemia Intergroup. (2004) (327)
- Incidence and prognostic influence of DNMT3A mutations in acute myeloid leukemia. (2011) (282)
- Prognostic significance of ASXL1 mutations in patients with myelodysplastic syndromes. (2011) (270)
- Specific inhibition of bcr-abl gene expression by small interfering RNA. (2003) (266)
- Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non-High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial. (2017) (265)
- How I treat the acquired von Willebrand syndrome. (2011) (259)
- Tumor suppressor genes in normal and malignant hematopoiesis (2002) (256)
- Insertion of FLT3 internal tandem duplication in the tyrosine kinase domain-1 is associated with resistance to chemotherapy and inferior outcome. (2009) (256)
- Impact of IDH1 R132 mutations and an IDH1 single nucleotide polymorphism in cytogenetically normal acute myeloid leukemia: SNP rs11554137 is an adverse prognostic factor. (2010) (247)
- High EVI1 expression predicts outcome in younger adult patients with acute myeloid leukemia and is associated with distinct cytogenetic abnormalities. (2010) (243)
- High meningioma 1 (MN1) expression as a predictor for poor outcome in acute myeloid leukemia with normal cytogenetics. (2006) (241)
- Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel. (2017) (234)
- A Randomized , Double-Blind , Placebo-Controlled , Phase III Study of Filgrastim in Remission Induction and Consolidation Therapy for Adults With De Novo Acute Myeloid Leukemia (1997) (234)
- Recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes--a phase-I/II trial. (1988) (232)
- Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults. (1988) (225)
- How I treat refractory and early relapsed acute myeloid leukemia. (2015) (224)
- Effects of recombinant human interleukin-3 in patients with myelodysplastic syndromes. (1990) (215)
- Treatment of Adult ALL according to protocols of the German Multicenter Study Group for Adult ALL (GMALL). (2000) (213)
- Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemia. (2010) (210)
- Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission. (2004) (205)
- Midostaurin added to chemotherapy and continued single-agent maintenance therapy in acute myeloid leukemia with FLT3-ITD. (2019) (205)
- Bone marrow cells are a rich source of growth factors and cytokines: implications for cell therapy trials after myocardial infarction. (2008) (201)
- Precision oncology for acute myeloid leukemia using a knowledge bank approach (2017) (200)
- Lentivirus-mediated antagomir expression for specific inhibition of miRNA function (2007) (199)
- A multicenter phase II trial of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapy (2012) (198)
- Effects of recombinant human interleukin-3 in patients with normal hematopoiesis and in patients with bone marrow failure (1990) (196)
- Mutant IDH1 promotes leukemogenesis in vivo and can be specifically targeted in human AML. (2013) (195)
- G-CSF as immune regulator in T cells expressing the G-CSF receptor: implications for transplantation and autoimmune diseases. (2003) (195)
- RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico-pathologic and genetic features (2016) (193)
- Prognostic impact of WT1 mutations in cytogenetically normal acute myeloid leukemia: a study of the German-Austrian AML Study Group. (2009) (188)
- Prognostic impact of IDH2 mutations in cytogenetically normal acute myeloid leukemia. (2010) (187)
- IDH1 mutations in patients with myelodysplastic syndromes are associated with an unfavorable prognosis (2010) (186)
- The Human C3a Receptor Is Expressed on Neutrophils and Monocytes, but Not on B or T Lymphocytes (1997) (185)
- Measurable residual disease monitoring by NGS before allogeneic hematopoietic cell transplantation in AML. (2018) (184)
- Aberrant splicing of U12-type introns is the hallmark of ZRSR2 mutant myelodysplastic syndrome (2014) (184)
- CMV serostatus still has an important prognostic impact in de novo acute leukemia patients after allogeneic stem cell transplantation: a report from the Acute Leukemia Working Party of EBMT. (2013) (181)
- Defective in vitro growth of the hemopoietic progenitor cells in the acquired immunodeficiency syndrome. (1987) (180)
- Allogeneic hematopoietic stem-cell transplantation for chronic lymphocytic leukemia with 17p deletion: a retrospective European Group for Blood and Marrow Transplantation analysis. (2008) (177)
- Axl, a prognostic and therapeutic target in acute myeloid leukemia mediates paracrine crosstalk of leukemia cells with bone marrow stroma. (2013) (176)
- Human γδ T cells are quickly reconstituted after stem-cell transplantation and show adaptive clonal expansion in response to viral infection (2017) (176)
- Deferasirox in iron-overloaded patients with transfusion-dependent myelodysplastic syndromes: Results from the large 1-year EPIC study. (2010) (175)
- Proteins induced by telomere dysfunction and DNA damage represent biomarkers of human aging and disease (2008) (169)
- Proteomics applied to the clinical follow-up of patients after allogeneic hematopoietic stem cell transplantation. (2004) (168)
- Immunosuppressive therapy for patients with myelodysplastic syndrome: a prospective randomized multicenter phase III trial comparing antithymocyte globulin plus cyclosporine with best supportive care--SAKK 33/99. (2011) (167)
- Clinical impact of DNMT3A mutations in younger adult patients with acute myeloid leukemia: results of the AML Study Group (AMLSG). (2013) (164)
- Effect of recombinant interferons alpha and gamma on human bone marrow-derived megakaryocytic progenitor cells. (1987) (163)
- Clonal evolution in relapsed NPM1-mutated acute myeloid leukemia. (2013) (162)
- Mutations in the cohesin complex in acute myeloid leukemia: clinical and prognostic implications. (2014) (159)
- Secondary genetic lesions in acute myeloid leukemia with inv(16) or t(16;16): a study of the German-Austrian AML Study Group (AMLSG). (2013) (156)
- Peripheral blood tyrosinase messenger RNA detection and survival in malignant melanoma. (1996) (153)
- Monosomal karyotype in adult acute myeloid leukemia: prognostic impact and outcome after different treatment strategies. (2012) (151)
- Diagnostic workup of patients with acquired von Willebrand syndrome: a retrospective single‐centre cohort study (2008) (148)
- Matched unrelated or matched sibling donors result in comparable survival after allogeneic stem-cell transplantation in elderly patients with acute myeloid leukemia: a report from the cooperative German Transplant Study Group. (2008) (147)
- Proteomic patterns predict acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. (2007) (144)
- TIF1γ, a novel member of the transcriptional intermediary factor 1 family (1999) (144)
- Myeloid-derived growth factor (C19orf10) mediates cardiac repair following myocardial infarction (2015) (144)
- MN1 overexpression induces acute myeloid leukemia in mice and predicts ATRA resistance in patients with AML. (2007) (144)
- The value of allogeneic and autologous hematopoietic stem cell transplantation in prognostically favorable acute myeloid leukemia with double mutant CEBPA. (2013) (142)
- Proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditions (2017) (141)
- Detection of chimeric BCR-ABL genes on bone marrow samples and blood smears in chronic myeloid and acute lymphoblastic leukemia by in situ hybridization. (1994) (139)
- A prospective, randomised, phase II study of horse antithymocyte globulin vs rabbit antithymocyte globulin as immune-modulating therapy in patients with low-risk myelodysplastic syndromes (2004) (137)
- Enhanced sensitivity to inhibition of SHP2, STAT5, and Gab2 expression in chronic myeloid leukemia (CML). (2006) (133)
- Acute Myeloid Leukemia (AML): different treatment strategies versus a common standard arm--combined prospective analysis by the German AML Intergroup. (2012) (133)
- Alloantigen‐specific de novo‐induced Foxp3+ Treg revert in vivo and do not protect from experimental GVHD (2009) (132)
- Monosomy 7 and activating RAS mutations accompany malignant transformation in patients with congenital neutropenia. (1995) (131)
- Circulating endothelial cells as a marker of endothelial damage in allogeneic hematopoietic stem cell transplantation. (2004) (129)
- Prognostic impact of minimal residual disease in CBFB-MYH11-positive acute myeloid leukemia. (2010) (128)
- Prethymic phenotype and genotype of pre-T (CD7+/ER-)-cell leukemia and its clinical significance within adult acute lymphoblastic leukemia. (1989) (126)
- Concomitant granulocyte colony-stimulating factor and induction chemoradiotherapy in adult acute lymphoblastic leukemia: a randomized phase III trial. (1995) (126)
- Gene-expression profiling identifies distinct subclasses of core binding factor acute myeloid leukemia. (2005) (126)
- Increased lipoprotein (a) levels as an independent risk factor for venous thromboembolism. (2000) (126)
- Effects of recombinant human interleukin-3 in aplastic anemia. (1990) (123)
- Single nucleotide polymorphism in the mutational hotspot of WT1 predicts a favorable outcome in patients with cytogenetically normal acute myeloid leukemia. (2010) (123)
- Prognostic value of minimal residual disease quantification by real-time reverse transcriptase polymerase chain reaction in patients with core binding factor leukemias. (2003) (120)
- Rituximab consolidation after high-dose chemotherapy and autologous blood stem cell transplantation in follicular and mantle cell lymphoma: a prospective, multicenter phase II study. (2004) (116)
- Next‐generation sequencing for minimal residual disease monitoring in acute myeloid leukemia patients with FLT3‐ITD or NPM1 mutations (2012) (116)
- Survival, prognostic factors and rates of leukemic transformation in 381 untreated patients with MDS and del(5q): A multicenter study (2012) (114)
- Comprehensive analysis of mammalian miRNA* species and their role in myeloid cells. (2011) (110)
- A Randomized, Double-Blind, Placebo-Controlled, Phase III Study of Filgrastim in Remission Induction and Consolidation Therapy for Adults With De Novo Acute Myeloid Leukemia (1997) (105)
- IFN-γ Production by Allogeneic Foxp3+ Regulatory T Cells Is Essential for Preventing Experimental Graft-versus-Host Disease (2012) (105)
- Integrative prognostic risk score in acute myeloid leukemia with normal karyotype. (2011) (105)
- Marrow fibrosis predicts early fatal marrow failure in patients with myelodysplastic syndromes (2008) (101)
- Improving acute promyelocytic leukemia (APL) outcome in developing countries through networking, results of the International Consortium on APL. (2013) (100)
- Enforced expression of miR-125b affects myelopoiesis by targeting multiple signaling pathways. (2011) (99)
- Epidemiological, genetic, and clinical characterization by age of newly diagnosed acute myeloid leukemia based on an academic population-based registry study (AMLSG BiO) (2017) (98)
- Prognostic significance of FLT3 internal tandem duplication, nucleophosmin 1, and CEBPA gene mutations for acute myeloid leukemia patients with normal karyotype and younger than 60 years: a systematic review and meta-analysis (2014) (97)
- Cell of origin in AML: susceptibility to MN1-induced transformation is regulated by the MEIS1/AbdB-like HOX protein complex. (2011) (96)
- Modulation of Gene Expression by Lentiviral-Mediated Delivery of Small Interfering RNA (2003) (96)
- Clonal evolution patterns in acute myeloid leukemia with NPM1 mutation (2019) (95)
- Reappearance of effector T cells is associated with recovery from COVID-19 (2020) (93)
- Interleukin 10 (IL-10): an immunosuppressive factor and independent predictor in patients with metastatic renal cell carcinoma (1999) (92)
- Virus-associated hemophagocytic syndrome as a major contributor to death in patients with 2009 influenza A (H1N1) infection (2011) (91)
- Pan-mutant-IDH1 inhibitor BAY1436032 is highly effective against human IDH1 mutant acute myeloid leukemia in vivo (2017) (91)
- Elevated pretreatment serum levels of soluble vascular cell adhesion molecule 1 and lactate dehydrogenase as predictors of survival in cutaneous metastatic malignant melanoma. (1998) (89)
- Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemia (2016) (88)
- A phase I/II study of sunitinib and intensive chemotherapy in patients over 60 years of age with acute myeloid leukaemia and activating FLT3 mutations (2015) (88)
- Gene-expression profiles and their association with drug resistance in adult acute myeloid leukemia. (2005) (87)
- SF3B1 mutations in myelodysplastic syndromes: clinical associations and prognostic implications (2012) (87)
- Autoimmunity resulting from cytokine treatment predicts long-term survival in patients with metastatic renal cell cancer. (1999) (86)
- Deregulated expression of EVI1 defines a poor prognostic subset of MLL-rearranged acute myeloid leukemias: a study of the German-Austrian Acute Myeloid Leukemia Study Group and the Dutch-Belgian-Swiss HOVON/SAKK Cooperative Group. (2013) (85)
- Consensus conference on European preparedness for haematological and other medical management of mass radiation accidents (2006) (85)
- Elevated serum levels of S100 and survival in metastatic malignant melanoma. (1997) (85)
- Impact of NPM1/FLT3-ITD genotypes defined by the2017 European LeukemiaNet in patients with acute myeloid leukemia. (2019) (84)
- Intracoronary autologous bone marrow cell transfer after myocardial infarction: the BOOST-2 randomised placebo-controlled clinical trial (2017) (84)
- First Global Consensus for Evidence-Based Management of the Hematopoietic Syndrome Resulting From Exposure to Ionizing Radiation (2011) (83)
- Efficient gene transfer into the CNS by lentiviral vectors purified by anion exchange chromatography (2002) (82)
- Treatment of Relapsed Acute Myeloid Leukemia (2020) (82)
- Prophylaxis and treatment of chemo- and radiotherapy-induced oral mucositis – are there new strategies? (1999) (81)
- Prevalence and prognostic value of IDH1 and IDH2 mutations in childhood AML: a study of the AML–BFM and DCOG study groups (2011) (81)
- Prognostic factors in adult patients up to 60 years old with acute myeloid leukemia and translocations of chromosome band 11q23: individual patient data-based meta-analysis of the German Acute Myeloid Leukemia Intergroup. (2009) (81)
- Quantitative determination of lentiviral vector particle numbers by real-time PCR. (2001) (81)
- Increased lipoprotein (a) levels as an independent risk factor for venous thromboembolism (2000) (81)
- TIF1gamma, a novel member of the transcriptional intermediary factor 1 family. (1999) (81)
- Rare occurrence of DNMT3A mutations in myelodysplastic syndromes (2011) (80)
- Sequential in vivo treatment with two recombinant human hematopoietic growth factors (interleukin-3 and granulocyte-macrophage colony-stimulating factor) as a new therapeutic modality to stimulate hematopoiesis: results of a phase I study. (1992) (80)
- Prothrombotic immune thrombocytopenia after COVID-19 vaccine (2021) (80)
- Impact of Molecular Genetics on Outcome in Myelofibrosis Patients after Allogeneic Stem Cell Transplantation. (2017) (80)
- Genomic landscape and clonal evolution of acute myeloid leukemia with t(8;21): an international study on 331 patients. (2019) (77)
- Monitoring of BCR-ABL expression using real-time RT-PCR in CML after bone marrow or peripheral blood stem cell transplantation (1999) (77)
- Decitabine improves progression-free survival in older high-risk MDS patients with multiple autosomal monosomies: results of a subgroup analysis of the randomized phase III study 06011 of the EORTC Leukemia Cooperative Group and German MDS Study Group (2015) (77)
- Impact of salvage regimens on response and overall survival in acute myeloid leukemia with induction failure (2017) (76)
- A randomized, double-blind, placebo-controlled, phase III study of filgrastim in remission induction and consolidation therapy for adults with de novo acute myeloid leukemia. The International Acute Myeloid Leukemia Study Group. (1997) (75)
- Post-Transplant Cyclophosphamide versus Antithymocyte Globulin in HLA-Mismatched unrelated Donors transplantation. (2019) (75)
- Achievement of complete remission predicts outcome of allogeneic haematopoietic stem cell transplantation in patients with chronic myelomonocytic leukaemia. A study of the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation (2015) (75)
- Safety and toxicity of amphotericin B in glucose 5% or intralipid 20% in neutropenic patients with pneumonia or fever of unknown origin: randomised study (1998) (74)
- Clonal Hematopoiesis of Indeterminate Potential. (2016) (74)
- Real‐time RT‐PCR for the detection and quantification of AML1/MTG8 fusion transcripts in t(8;21)‐positive AML patients (1999) (73)
- ASXL1 mutations in younger adult patients with acute myeloid leukemia: a study by the German-Austrian Acute Myeloid Leukemia Study Group (2015) (73)
- A phase II open-label study of cetuximab in unresectable hepatocellular carcinoma: Final results (2007) (73)
- Acute undifferentiated leukemia: implications for cellular origin and clonality suggested by analysis of surface markers and immunoglobulin gene rearrangement. (1986) (72)
- Recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes--a phase I/II trial. (1988) (72)
- Biologic effects of recombinant human interleukin-3 in vivo. (1991) (72)
- Circulating endothelial cells are an early predictor in renal cell carcinoma for tumor response to sunitinib (2010) (72)
- Effects of recombinant human interleukin-3 on human hematopoietic progenitor and precursor cells in vivo. (1990) (71)
- High-resolution genomic profiling of adult and pediatric core-binding factor acute myeloid leukemia reveals new recurrent genomic alterations. (2010) (71)
- Iron chelation therapy with deferasirox in patients with aplastic anemia: a subgroup analysis of 116 patients from the EPIC trial. (2010) (71)
- Lentiviral gene transfer into peripheral blood-derived CD34+ NOD/SCID-repopulating cells. (2002) (71)
- Adding dasatinib to intensive treatment in core-binding factor acute myeloid leukemia—results of the AMLSG 11-08 trial (2018) (70)
- Human regulatory T cells in allogeneic stem cell transplantation. (2011) (69)
- Stem cell transplantation in severe congenital neutropenia: an analysis from the European Society for Blood and Marrow Transplantation. (2015) (69)
- Aberrant methylation and impaired expression of the p15INK4b cell cycle regulatory gene in chronic myelomonocytic leukemia (CMML) (2003) (68)
- Interactions among HCLS1, HAX1 and LEF-1 proteins are essential for G-CSF–triggered granulopoiesis (2012) (68)
- The oncogenic fusion protein RUNX1-CBFA2T1 supports proliferation and inhibits senescence in t(8;21)-positive leukaemic cells (2004) (68)
- Effect of topical oral G-CSF on oral mucositis: a randomised placebo-controlled trial (1998) (68)
- Literature Review and Global Consensus on Management of Acute Radiation Syndrome Affecting Nonhematopoietic Organ Systems (2011) (68)
- A patient-oriented approach to treatment of myelodysplastic syndromes. (1998) (67)
- Stable RNA interference (RNAi) as an option for anti-bcr-abl therapy (2005) (65)
- SETBP1 mutation analysis in 944 patients with MDS and AML (2013) (65)
- Phase I and pharmacokinetic study of TZT-1027, a novel synthetic dolastatin 10 derivative, administered as a 1-hour intravenous infusion every 3 weeks in patients with advanced refractory cancer. (2004) (65)
- Comparative genomic hybridization in the investigation of myeloid leukemias (1995) (64)
- Detection of karyotypic aberrations in acute myeloblastic leukaemia: a prospective comparison between PCR/FISH and standard cytogenetics in 140 patients with de novo AML (1998) (63)
- Comparison of nested competitive RT-PCR and real-time RT-PCR for the detection and quantification of AML1/MTG8 fusion transcripts in t(8;21) positive acute myelogenous leukemia (2000) (63)
- Prothrombotic immune thrombocytopenia after COVID-19 vaccination (2021) (63)
- Bendamustine plus rituximab (B-R) versus CHOP plus rituximab (CHOP-R) as first-line treatment in patients with indolent lymphomas: Nine-year updated results from the StiL NHL1 study. (2017) (63)
- Clinical course of myelodysplastic syndromes. (1992) (62)
- Impact of different post-remission strategies on quality of life in patients with acute myeloid leukemia (2008) (62)
- Aggravation of vincristine-induced neurotoxicity by itraconazole in the treatment of adult ALL (1995) (61)
- Marrow fibrosis and its relevance during imatinib treatment of chronic myeloid leukemia (2007) (61)
- Measurable Residual Disease Monitoring in Acute Myeloid Leukemia with t(8;21)(q22;q22.1): Results of the AML Study Group. (2019) (61)
- Acute leukemias of ambiguous lineage in adults: molecular and clinical characterization (2013) (61)
- Diagnostic value of procalcitonin serum levels in comparison with C-reactive protein in allogeneic stem cell transplantation. (2002) (60)
- Recovery and composition of microparticles after snap-freezing depends on thawing temperature (2009) (60)
- A TNF-Regulated Recombinatorial Macrophage Immune Receptor Implicated in Granuloma Formation in Tuberculosis (2011) (60)
- Outcome after relapse of myelodysplastic syndrome and secondary acute myeloid leukemia following allogeneic stem cell transplantation: a retrospective registry analysis on 698 patients by the Chronic Malignancies Working Party of the European Society of Blood and Marrow Transplantation (2017) (59)
- Gemtuzumab Ozogamicin in NPM1-Mutated Acute Myeloid Leukemia: Early Results From the Prospective Randomized AMLSG 09-09 Phase III Study (2018) (59)
- Prognostic effect of calreticulin mutations in patients with myelofibrosis after allogeneic hematopoietic stem cell transplantation (2014) (59)
- Myelodysplastic syndromes: clinical features. (1996) (58)
- HLA-identical sibling allogeneic transplants versus chemotherapy in acute myelogenous leukemia with t(8;21) in first complete remission: collaborative study between the German AML Intergroup and CIBMTR. (2008) (57)
- The effect of recombinant human granulocyte-macrophage colony-stimulating factor on neutropenia and related morbidity in chronic severe neutropenia. (1989) (56)
- BLAST: A Confirmatory, Single-Arm, Phase 2 Study of Blinatumomab, a Bispecific T-Cell Engager (BiTE®) Antibody Construct, in Patients with Minimal Residual Disease B-Precursor Acute Lymphoblastic Leukemia (ALL) (2014) (56)
- Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients (2020) (56)
- Acute but not chronic graft-versus-host disease is associated with a reduction of circulating CD4+CD25highCD127low/− regulatory T cells (2011) (56)
- Internal tandem duplication of the FLT3 gene confers poor overall survival in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based chemotherapy: an International Consortium on Acute Promyelocytic Leukemia study (2014) (56)
- Risk-adapted induction and consolidation therapy in adults with de novo AML aged ≤ 60 years: results of a prospective multicenter trial (2004) (55)
- Hematopoietic growth factors in the treatment of acquired bone marrow failure states. (2007) (55)
- Haploidentical versus unrelated allogeneic stem cell transplantation for relapsed/refractory acute myeloid leukemia: a report on 1578 patients from the Acute Leukemia Working Party of the EBMT (2018) (55)
- Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemia (2004) (55)
- Clonal evolution of acute myeloid leukemia with FLT3-ITD mutation under treatment with midostaurin. (2021) (55)
- Differential expression of miR-17∼92 identifies BCL2 as a therapeutic target in BCR-ABL-positive B-lineage acute lymphoblastic leukemia (2013) (55)
- Study of the prothrombin gene 20201 GA variant in FV:Q506 carriers in relationship to the presence or absence of juvenile venous thromboembolism. (1999) (55)
- Reduction of catheter-related infections in neutropenic patients: a prospective controlled randomized trial using a chlorhexidine and silver sulfadiazine-impregnated central venous catheter (2005) (54)
- All-trans retinoic acid as adjunct to intensive treatment in younger adult patients with acute myeloid leukemia: results of the randomized AMLSG 07-04 study (2016) (54)
- Stem Cells, Multiorgan Failure in Radiation Emergency Medical Preparedness: A U.S./European Consultation Workshop (2009) (54)
- Acquired cyclic amegakaryocytic thrombocytopenia associated with an immunoglobulin blocking the action of granulocyte-macrophage colony-stimulating factor. (1989) (54)
- Solid Organ Transplantation After Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective, Multicenter Study of the EBMT (2010) (53)
- Synergistic antiproliferative effect of recombinant interferon-gamma with recombinant interferon-alpha on chronic myelogenous leukemia hematopoietic progenitor cells (CFU-GEMM, CFU-Mk, BFU-E, and CFU-GM). (1988) (52)
- Health-Related Quality of Life, Treatment Satisfaction, Adherence and Persistence in β-Thalassemia and Myelodysplastic Syndrome Patients with Iron Overload Receiving Deferasirox: Results from the EPIC Clinical Trial (2012) (52)
- Increased risk of complicated CMV infection with the use of mycophenolate mofetil in allogeneic stem cell transplantation (2002) (52)
- High-affinity neurotrophin receptors and ligands promote leukemogenesis. (2009) (51)
- Correction of respiratory burst activity in X-linked chronic granulomatous cells to therapeutically relevant levels after gene transfer into bone marrow CD34+ cells. (1998) (51)
- Efficacy of a Benzalkonium Chloride-Impregnated Central Venous Catheter to Prevent Catheter-Associated Infection in Cancer Patients (2000) (51)
- Prognostic importance of histone methyltransferase MLL5 expression in acute myeloid leukemia. (2011) (51)
- Altered miRNA and gene expression in acute myeloid leukemia with complex karyotype identify networks of prognostic relevance (2013) (50)
- Prevalence, clonal dynamics and clinical impact of TP53 mutations in patients with myelodysplastic syndrome with isolated deletion (5q) treated with lenalidomide: results from a prospective multicenter study of the german MDS study group (GMDS) (2016) (50)
- Legionnaires' disease in immunocompromised patients: a case report of Legionella longbeachae pneumonia and review of the literature. (2008) (48)
- FLT3-internal tandem duplication and age are the major prognostic factors in patients with relapsed acute myeloid leukemia with normal karyotype (2011) (48)
- Specific Hammerhead Ribozyme-mediated Cleavage of Mutant N-ras mRNA in Vitro and ex Vivo (1997) (48)
- Isolation strategies of regulatory T cells for clinical trials: phenotype, function, stability, and expansion capacity. (2011) (48)
- Genetic characterization of acquired aplastic anemia by targeted sequencing (2014) (48)
- Tetramer monitoring to assess risk factors for recurrent cytomegalovirus reactivation and reconstitution of antiviral immunity post allogeneic hematopoietic stem cell transplantation (2011) (47)
- Prognosis of acute myeloid leukemia patients up to 60 years of age exhibiting trisomy 8 within a non-complex karyotype: individual patient data-based meta-analysis of the German Acute Myeloid Leukemia Intergroup. (2007) (47)
- Weekly administration of bendamustine: a phase I study in patients with advanced progressive solid tumours. (2000) (47)
- Hematologic responses in patients with aplastic anemia treated with deferasirox: a post hoc analysis from the EPIC study (2013) (47)
- Dendritic Cell–Mediated Immune Humanization of Mice: Implications for Allogeneic and Xenogeneic Stem Cell Transplantation (2014) (47)
- DNMT3A mutant transcript levels persist in remission and do not predict outcome in patients with acute myeloid leukemia (2018) (46)
- Cytoreductive treatment with clofarabine/ara‐C combined with reduced‐intensity conditioning and allogeneic stem cell transplantation in patients with high‐risk, relapsed, or refractory acute myeloid leukemia and advanced myelodysplastic syndrome (2012) (46)
- Progression free survival of first line vascular endothelial growth factor-targeted therapy is an important prognostic parameter in patients with metastatic renal cell carcinoma. (2012) (46)
- Prognostic significance of expression levels of stem cell regulators MSI2 and NUMB in acute myeloid leukemia (2013) (46)
- Combining prenylation inhibitors causes synergistic cytotoxicity, apoptosis and disruption of RAS‐to‐MAP kinase signalling in multiple myeloma cells (2005) (46)
- Distinct splicing signatures affect converged pathways in myelodysplastic syndrome patients carrying mutations in different splicing regulators (2016) (45)
- Individual outcome prediction for myelodysplastic syndrome (MDS) and secondary acute myeloid leukemia from MDS after allogeneic hematopoietic cell transplantation (2017) (45)
- A Tagging-via-substrate Approach to Detect the Farnesylated Proteome Using Two-dimensional Electrophoresis Coupled with Western Blotting* (2010) (45)
- Long-term outcome of patients with newly diagnosed chronic myeloid leukemia: a randomized comparison of stem cell transplantation with drug treatment (2015) (45)
- Limited efficacy of imatinib in severe pulmonary chronic graft-versus-host disease. (2009) (45)
- Improved multilineage response of hematopoiesis in patients with myelodysplastic syndromes to a combination therapy with all-trans-retinoic acid, granulocyte colony-stimulating factor, erythropoietin and α-tocopherol (1996) (45)
- Angiopoietin-2 predicts disease-free survival after allogeneic stem cell transplantation in patients with high-risk myeloid malignancies. (2008) (45)
- Evidence for allelic evolution of C/EBPalpha mutations in acute myeloid leukaemia (2003) (45)
- Effects of recombinant human IL-7 on blast cell proliferation in acute lymphoblastic leukemia. (1990) (44)
- Chronic hepatitis E in hematopoietic stem cell transplant patients in a low‐endemic country? (2012) (44)
- Proteomic peptide profiling for preemptive diagnosis of acute graft-versus-host disease after allogeneic stem cell transplantation (2013) (44)
- Impact of pretreatment characteristics and salvage strategy on outcome in patients with relapsed acute myeloid leukemia (2017) (44)
- An Analysis of Maintenance Therapy and Post-Midostaurin Outcomes in the International Prospective Randomized, Placebo-Controlled, Double-Blind Trial (CALGB 10603/RATIFY [Alliance]) for Newly Diagnosed Acute Myeloid Leukemia (AML) Patients with FLT3 Mutations (2017) (44)
- Immune thyroiditis after transplantation of allogeneic CD34+ selected peripheral blood cells (1997) (44)
- Incidence of lineage promiscuity in acute myeloblastic leukemia: diagnostic implications of immunoglobulin and T-cell receptor gene rearrangement analysis and immunological phenotyping. (1988) (44)
- Candida kefyr as an emerging pathogen causing nosocomial bloodstream infections in neutropenic leukemia patients. (2005) (44)
- OUTCOME OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS OVER 69 YEARS OF AGE WITH ACUTE MYELOID LEUKEMIA: ON BEHALF OF THE ACUTE LEUKEMIA WORKING PARTY OF THE EBMT. (2019) (44)
- Inhibitory effect of azidothymidine, 2'-3'-dideoxyadenosine, and 2'-3'-dideoxycytidine on in vitro growth of hematopoietic progenitor cells from normal persons and from patients with AIDS. (1989) (43)
- Effects of recombinant human interleukin-3 in patients with normal hematopoiesis and in patients with bone marrow failure. (1990) (43)
- A low affinity chimeric human alpha/beta-granulocyte-macrophage colony-stimulating factor receptor induces ligand-dependent proliferation in a murine cell line. (1994) (43)
- In vitro culture of common acute lymphoblastic leukemia blasts: effects of interleukin-3, interleukin-7, and accessory cells. (1992) (43)
- Association of Human Development Index with rates and outcomes of hematopoietic stem cell transplantation for patients with acute leukemia. (2010) (43)
- Isotype controls in phenotyping and quantification of microparticles: a major source of error and how to evade it. (2008) (43)
- Acute myeloid leukemia derived from lympho-myeloid clonal hematopoiesis (2017) (43)
- Chromothripsis is linked to TP53 alteration, cell cycle impairment, and dismal outcome in acute myeloid leukemia with complex karyotype (2018) (43)
- Transplant Outcomes for Secondary Acute Myeloid Leukemia: Acute Leukemia Working Party of the European Society for Blood and Bone Marrow Transplantation Study. (2018) (42)
- Online coupling of capillary electrophoresis with mass spectrometry for the identification of biomarkers for clinical diagnosis (2005) (42)
- Favourable response to antithymocyte or antilymphocyte globulin in low‐risk myelodysplastic syndrome patients with a ‘non‐clonal’ pattern of X‐chromosome inactivation in bone marrow cells (2002) (42)
- Efficacy of Sunitinib Re-Exposure after Failure of an mTOR Inhibitor in Patients with Metastatic RCC (2011) (42)
- Effect of long-term treatment with recombinant human interleukin-3 in patients with myelodysplastic syndromes. (1993) (42)
- Enantiomer-specific and paracrine leukemogenicity of mutant IDH metabolite 2-hydroxyglutarate (2016) (42)
- "Atypical" leukemias: preleukemia, smoldering leukemia and hypoplastic leukemia. (1984) (41)
- Quantification and facilitated comparison of von Willebrand factor multimer patterns by densitometry. (2001) (41)
- Effect of combination therapy with all-trans-retinoic acid and recombinant human granulocyte colony-stimulating factor in patients with myelodysplastic syndromes. (1994) (41)
- Clinical Effects of Recombinant Human Interleukin‐3 (1991) (40)
- Morphology and quantitative composition of hematopoietic cells in murine bone marrow and spleen of healthy subjects (2013) (40)
- Treatment of myelodysplastic syndromes with hematopoietic growth factors. (1992) (40)
- Evolution of FLT3-ITD and D835 activating point mutations in relapsing acute myeloid leukemia and response to salvage therapy. (2004) (40)
- Allogeneic Stem Cell Transplantation for Patients Age ≥ 70 Years with Myelodysplastic Syndrome: A Retrospective Study of the MDS Subcommittee of the Chronic Malignancies Working Party of the EBMT. (2017) (40)
- Cutaneous side effects of new antitumor drugs: clinical features and management. (2012) (40)
- Peripheral blood stem cell graft compared to bone marrow after reduced intensity conditioning regimens for acute leukemia: a report from the ALWP of the EBMT (2016) (39)
- Analysis of NUP98/NSD1 translocations in adult AML and MDS patients (2013) (39)
- Detection and quantification of CBFB/MYH11 fusion transcripts in patients with inv(16)‐positive acute myeloblastic leukemia by real‐time RT‐PCR (2001) (39)
- Lipid nanoparticle-mediated siRNA delivery for safe targeting of human CML in vivo (2019) (39)
- Therapeutic efficacy of prenylation inhibitors in the treatment of myeloid leukemia (2003) (39)
- Efficacy, safety and tolerability of recombinant factor VIII (REFACTO®) in patients with haemophilia A: interim data from a postmarketing surveillance study in Germany and Austria (2007) (39)
- All-Trans Retinoic Acid Improves Outcome in Younger Adult Patients with Nucleophosmin-1 Mutated Acute Myeloid Leukemia – Results of the AMLSG 07-04 Randomized Treatment Trial (2011) (39)
- Synergistic cytotoxic effects in myeloid leukemia cells upon cotreatment with farnesyltransferase and geranylgeranyl transferase-I inhibitors (2003) (38)
- Midostaurin in Combination with Intensive Induction and As Single Agent Maintenance Therapy after Consolidation Therapy with Allogeneic Hematopoietic Stem Cell Transplantation or High-Dose Cytarabine (NCT01477606) (2015) (38)
- T cell receptor γ chain variable gene rearrangements in acute lymphoblastic leukemias of T and B lineage (1987) (38)
- Long-term results of all-trans retinoic acid and arsenic trioxide in non-high-risk acute promyelocytic leukemia: update of the APL0406 Italian-German randomized trial (2019) (38)
- Clinical phase II study and pharmacological evaluation of rubitecan in non-pretreated patients with metastatic colorectal cancer-significant effect of food intake on the bioavailability of the oral camptothecin analogue. (2002) (38)
- Azacitidine for treatment of patients with myelodysplastic syndromes (MDS): practical recommendations of the German MDS Study Group (2010) (38)
- The emergence of a C/EBPα mutation in the clonal evolution of MDS towards secondary AML (2003) (38)
- Inhibition of GM-CSF receptor function by stable RNA interference in a NOD/SCID mouse hematopoietic stem cell transplantation model. (2003) (38)
- Treatment of patients with low-risk myelodysplastic syndromes using a combination of all-trans retinoic acid, interferon alpha, and granulocyte colony-stimulating factor (1999) (38)
- Sequential Intensified Conditioning Regimen Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Intermediate- or High-Risk Acute Myeloid Leukemia in Complete Remission: A Study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. (2017) (37)
- Remarkable leukemogenic potency and quality of a constitutively active neurotrophin receptor, ΔTrkA (2007) (37)
- Recombinant factor VIII expression in hematopoietic cells following lentiviral transduction (2003) (37)
- IL‐3 in the Clinic (1997) (37)
- Induction of TNF‐α in patients with myelodysplastic syndromes undergoing treatment with interleukin‐3 (1993) (36)
- Early detection of chronic disseminated Candida infection in leukemia patients with febrile neutropenia: value of computer-assisted serial ultrasound documentation (1998) (36)
- Changes in the haematopoietic progenitor cell compartment in the acquired immunodeficiency syndrome. (1990) (36)
- Prognostic impact of in vivo soluble cell adhesion molecules in metastatic renal cell carcinoma (1999) (35)
- Effect of recombinant interferons alpha and gamma on human bone marrow-derived megakaryocytic progenitor cells (1987) (35)
- Detection of antisense and ribozyme accessible sites on native mRNAs: application to NCOA3 mRNA. (2001) (35)
- Functional role of BAALC in leukemogenesis (2010) (35)
- Comparison of matched sibling donors versus unrelated donors in allogeneic stem cell transplantation for primary refractory acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT (2017) (35)
- Condensed versus standard schedule of high-dose cytarabine consolidation therapy with pegfilgrastim growth factor support in acute myeloid leukemia (2016) (35)
- Clinical and prognostic role of plasma coagulation factor XIII activity for bleeding disorders and 6‐year survival in patients with chronic liver disease (2006) (35)
- Midostaurin reduces relapse in FLT3-mutant acute myeloid leukemia: the Alliance CALGB 10603/RATIFY trial (2021) (34)
- Prognostic implications and molecular associations of NADH dehydrogenase subunit 4 (ND4) mutations in acute myeloid leukemia (2012) (34)
- Valproate and Retinoic Acid in Combination With Decitabine in Elderly Nonfit Patients With Acute Myeloid Leukemia: Results of a Multicenter, Randomized, 2 × 2, Phase II Trial. (2019) (34)
- ATRA and Arsenic Trioxide (ATO) Versus ATRA and Idarubicin (AIDA) for Newly Diagnosed, Non High-Risk Acute Promyelocytic Leukemia (APL): Results of the Phase III, Prospective, Randomized, Intergroup APL0406 Study by the Italian-German Cooperative Groups Gimema-SAL-AMLSG (2012) (34)
- Prognostic significance of combined MN1, ERG, BAALC, and EVI1 (MEBE) expression in patients with myelodysplastic syndromes (2012) (34)
- Hepatosplenic candidiasis in patients with acute leukaemia (2000) (34)
- Impact of gemtuzumab ozogamicin on MRD and relapse risk in NPM1 mutated AML patients: results from the AMLSG 09-09 Trial. (2020) (34)
- The deletion polymorphism in the angiotensin-converting enzyme gene is a moderate risk factor for venous thromboembolism (2003) (34)
- Unrelated donor versus matched sibling donor in adults with acute myeloid leukemia in first relapse: an ALWP-EBMT study (2016) (33)
- Central Venous Catheter Infections in Patients with Acute Leukemia (2002) (33)
- Clinical use of hematopoietic growth factors. (1996) (33)
- Evaluating the prognosis of patients with myelodysplastic syndromes (2002) (33)
- A switch toward demethylation is associated with the expression of myeloperoxidase in acute myeloblastic and promyelocytic leukemias. (1992) (33)
- In vivo effects of recombinant human erythropoietin on circulating human hemopoietic progenitor cells. (1989) (33)
- Haploidentical transplantation and posttransplant cyclophosphamide for treating aplastic anemia patients: a report from the EBMT Severe Aplastic Anemia Working Party (2019) (32)
- Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia (2001) (32)
- Improved short- and long-term outcome of allogeneic stem cell recipients admitted to the intensive care unit: a retrospective longitudinal analysis of 942 patients (2018) (32)
- MYELOKATHEXIS TREATED WITH RECOMBINANT HUMAN GRANULOCYTE‐MACROPHAGE COLONY‐STIMULATING FACTOR (rhGM‐CSF) (1992) (32)
- Clinical impact of GATA2 mutations in acute myeloid leukemia patients harboring CEBPA mutations: a study of the AML study group (2016) (32)
- All-trans retinoic acid with daunorubicin or idarubicin for risk-adapted treatment of acute promyelocytic leukaemia: a matched-pair analysis of the PETHEMA LPA-2005 and IC-APL studies (2015) (32)
- Novel therapies in advanced renal cell carcinoma: management of adverse events from sorafenib and sunitinib. (2008) (32)
- Comparing transplant outcomes in ALL patients after haploidentical with PTCy or matched unrelated donor transplantation. (2020) (32)
- Metastatic malignant ameloblastoma responding to chemotherapy with paclitaxel and carboplatin. (2001) (32)
- Use of colony-stimulating factors for chemotherapy-associated neutropenia: review of current guidelines. (2007) (31)
- Improved Outcome in High Risk and Very High Risk ALL by Risk Adapted SCT and in Standard Risk ALL by Intensive Chemotherapy in 713 Adult ALL Patients Treated According to the Prospective GMALL Study 07/2003. (2007) (31)
- The neutrophil recombinatorial TCR-like immune receptor is expressed across the entire human life span but repertoire diversity declines in old age. (2012) (31)
- Pharmacokinetics of recombinant human interleukin-2 in advanced renal cell carcinoma patients following subcutaneous application. (1998) (31)
- Sequential Anti-Cytomegalovirus Response Monitoring May Allow Prediction of Cytomegalovirus Reactivation after Allogeneic Stem Cell Transplantation (2012) (31)
- Influence of molecular subgroups on outcome of acute myeloid leukemia with normal karyotype in 141 patients undergoing salvage allogeneic stem cell transplantation in primary induction failure or beyond first relapse (2013) (31)
- Thrombopoietin serum levels are elevated in patients with hepatitis B/C infection compared to other causes of chronic liver disease. (2002) (31)
- Complete haematological and cytogenetic response to interferon alpha-2a of a myeloproliferative disorder with eosinophilia associated with a unique t(4;7) aberration (2000) (31)
- Posttransplantation MRD monitoring in patients with AML by next-generation sequencing using DTA and non-DTA mutations. (2021) (31)
- Conditioning intensity in secondary AML with prior myelodysplastic syndrome/myeloproliferative disorders: an EBMT ALWP study. (2018) (30)
- High-dose therapy and autologous stem cell transplantation for extra-nodal NK/T lymphoma in patients from the Western hemisphere: a study from the European Society for Blood and Marrow Transplantation (2015) (30)
- Hepatitis E virus infection in a hematopoietic stem cell donor (2014) (30)
- Expression of the p14ARF tumor suppressor predicts survival in acute myeloid leukemia (2004) (30)
- Restoration of impaired cytokine secretion from monocytes of patients with myelodysplastic syndromes after in vivo treatment with GM-CSF or IL-3. (1993) (30)
- Myelodysplastic syndrome and acute myelogenous leukemia secondary to heart transplantation. (2000) (30)
- Treatment of everolimus-resistant metastatic renal cell carcinoma with VEGF-targeted therapies (2011) (30)
- ASXL 1 mutations in younger adult patients with acute myeloid leukemia : a study by the German-Austrian Acute Myeloid Leukemia Study Group (2015) (29)
- Elevated frequencies of leukemic myeloid and plasmacytoid dendritic cells in acute myeloid leukemia with the FLT3 internal tandem duplication (2011) (29)
- Tissue factor and thrombomodulin levels are correlated with stage of cirrhosis in patients with liver disease (2001) (29)
- Fluorescence in situ hybridization (FISH) is a reliable diagnostic tool for detection of the 9;22 translocation. (1996) (29)
- BCR-ABL Affects STAT5A and STAT5B Differentially (2014) (29)
- Repeated administration of short infusions of bendamustine: a phase I study in patients with advanced progressive solid tumours (2000) (29)
- Clinical use of hematopoietic growth factors in the myelodysplastic syndromes. (1996) (29)
- Outcomes in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with isolated deletion 5q treated with lenalidomide: a subset analysis from the MDS-004 study (2014) (29)
- Long-term survival data from a phase 3 study of Filgrastim as an adjunct to chemotherapy in adults with de novo acute myeloid leukemia (2006) (28)
- Platelet endothelial cell adhesion molecule-1 (PECAM-1): a potential prognostic marker involved in leukocyte infiltration of renal cell carcinoma. (1996) (28)
- Impact of MLL5 expression on decitabine efficacy and DNA methylation in acute myeloid leukemia (2014) (28)
- Establishment of two Epstein-Barr virus negative Burkitt cell lines from a patient with AIDS and B-cell lymphoma. (1988) (28)
- Surveillance with successful reduction of central line-associated bloodstream infections among neutropenic patients with hematologic or oncologic malignancies (2009) (28)
- Inferior outcome of allogeneic stem cell transplantation for secondary acute myeloid leukemia in first complete remission as compared to de novo acute myeloid leukemia (2020) (28)
- Pan-Mutant-IDH1 Inhibitor Bay-1436032 Is Highly Effective Against Human IDH1 Mutant Acute Myeloid Leukemia In Vivo (2016) (28)
- Molecular landscape and prognostic impact of FLT3-ITD insertion site in acute myeloid leukemia: RATIFY study results (2021) (28)
- Results of a multicenter prospective phase II trial investigating the safety and efficacy of lenalidomide in patients with myelodysplastic syndromes with isolated del(5q) (LE-MON 5) (2016) (27)
- Genetically modified donor leukocyte transfusion and graft-versus-leukemia effect after allogeneic stem cell transplantation. (2011) (27)
- Acquired haemophilia caused by non-haemophilic factor VIII gene variants (2010) (27)
- In vivo effects of granulocyte-macrophage colony-stimulating factor and interleukin-3 on clonal and non-clonal cell populations in patients with clonal hematopoietic disorders. (1991) (27)
- Midostaurin in patients with acute myeloid leukemia and FLT3-TKD mutations: a subanalysis from the RATIFY trial. (2020) (27)
- Clofarabine‐containing conditioning regimen for allo‐SCT in AML/ALL patients: a survey from the Acute Leukemia Working Party of EBMT (2012) (27)
- TET2 mutations in cytogenetically normal acute myeloid leukemia: Clinical implications and evolutionary patterns (2014) (27)
- Human Regulatory T Cells of G-CSF Mobilized Allogeneic Stem Cell Donors Qualify for Clinical Application (2012) (26)
- Diagnostic value of highly-sensitive chimerism analysis after allogeneic stem cell transplantation (2018) (26)
- Cytogenetic aberrations in myelodysplastic syndrome detected by comparative genomic hybridization and fluorescence in situ hybridization. (1999) (26)
- Decreased haematopoietic colony growth in long-term bone marrow cultures of HIV-positive patients. (1993) (26)
- RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico-pathologic and genetic features (2016) (26)
- In vitro improvement of bone marrow‐derived hematopoietic colony formation in HIV‐positive patients by alpha‐D‐tocopherol and erythropoietin (1994) (26)
- Reduced intensity allogeneic stem cell transplantation for follicular lymphoma relapsing after an autologous transplant achieves durable long term disease control. An analysis from the Lymphoma Working Party Of the EBMT. (2016) (26)
- Azidothymidine in the treatment of AIDS. (1988) (26)
- Renal side effects of VEGF-blocking therapy (2010) (26)
- Allogeneic transplantation in multiple myeloma: long-term follow-up and cytogenetic subgroup analysis (2019) (26)
- Interleukin 3 alone and in combination with GM-CSF in the treatment of patients with neoplastic disease. (1991) (26)
- Hepatic lesions of chronic disseminated systemic candidiasis in leukemia patients may become visible during neutropenia: value of serial ultrasound examinations. (1998) (26)
- Extracorporeal cytokine removal in severe CAR-T cell associated cytokine release syndrome. (2020) (26)
- Syngeneic transplantation in aplastic anemia: pre-transplant conditioning and peripheral blood are associated with improved engraftment: an observational study on behalf of the Severe Aplastic Anemia and Pediatric Diseases Working Parties of the European Group for Blood and Marrow Transplantation (2013) (25)
- Thrombelastographic monitoring of recombinant factor VIIa in acquired haemophilia (2008) (25)
- Differential quantitation of alternatively spliced messenger RNAs using isoform-specific real-time RT-PCR. (1999) (25)
- Sequential chemotherapy followed by reduced‐intensity conditioning and allogeneic haematopoietic stem cell transplantation in adult patients with relapse or refractory acute myeloid leukaemia: a survey from the Acute Leukaemia Working Party of EBMT (2017) (25)
- Lentivirus-induced dendritic cells for immunization against high-risk WT1(+) acute myeloid leukemia. (2013) (25)
- Teniposide (VM-26) and cytosine arabinoside as consolidation therapy in adult high-risk patients with acute lymphoblastic leukemia. (1987) (25)
- Weekly 24 h infusion of aviscumine (rViscumin): a phase I study in patients with solid tumours. (2005) (25)
- Constitutive IRF8 expression inhibits AML by activation of repressed immune response signaling (2014) (25)
- High ΔNp73/TAp73 ratio is associated with poor prognosis in acute promyelocytic leukemia. (2015) (25)
- Treatment of myelodysplastic syndrome with isolated del(5q) including bands q31–q33 with a combination of all-trans-retinoic acid and tocopherol-α: a phase II study (2005) (25)
- Bone marrow findings after treatment with recombinant human interleukin-3. (1991) (25)
- Radioimmunotherapy with [188Re]-labelled anti-CD66 antibody in the conditioning for allogeneic stem cell transplantation for high-risk acute myeloid leukemia (2008) (25)
- Genomic heterogeneity in core-binding factor acute myeloid leukemia and its clinical implication. (2020) (24)
- CAR-T Cells Targeting Epstein-Barr Virus gp350 Validated in a Humanized Mouse Model of EBV Infection and Lymphoproliferative Disease (2020) (24)
- Chemotherapy-induced mobilization of karyotypically normal PBSC for autografting in CML (1998) (24)
- Risk and outcome in metastatic malignant melanoma patients receiving DTIC, cisplatin, BCNU and tamoxifen followed by immunotherapy with interleukin 2 and interferon alpha2a. (1998) (24)
- Stem cell mobilization in normal donors. (1998) (24)
- Continued Low-Dose Decitabine (DAC) Is an Active First-Line Treatment in All Cytogenetic Subgroups of Older AML Patients: Results of the FR00331 Multicenter Phase II Study. (2007) (24)
- Safe administration of irinotecan, oxaliplatin and raltitrexed in a DPD-deficient patient with metastatic colon cancer. (2001) (24)
- Monitoring dendritic cell and cytokine biomarkers during remission prior to relapse in patients with FLT3-ITD acute myeloid leukemia (2013) (24)
- Paroxysmal nocturnal hemoglobinuria: Differential gene expression of EGR-1 and TAXREB107. (2002) (24)
- Effects of Flt3 ligand and interleukin-7 on in vitro growth of acute lymphoblastic leukemia cells. (1996) (24)
- Prior and concurrent administration of recombinant human megakaryocyte growth and development factor in patients receiving consolidation chemotherapy for de novo acute myeloid leukemia—a randomized, placebo-controlled, double-blind safety and efficacy study (2003) (24)
- Advanced head and neck cancer and clinical experience of an effective new agent: docetaxel. (1998) (23)
- Intensive chemotherapy with idarubicin, ara-C, etoposide, and m-AMSA followed by immunotherapy with interleukin-2 for myelodysplastic syndromes and high-risk Acute Myeloid Leukemia (AML) (2000) (23)
- Colony-stimulating factors in the management of neutropenia and its complications (2005) (23)
- Haploinsufficiency of ETV6 and CDKN1B in patients with acute myeloid leukemia and complex karyotype (2014) (23)
- Impact of gemtuzumab ozogamicin on MRD and relapse risk in patients with NPM1-mutated AML: results from the AMLSG 09-09 trial. (2020) (23)
- Impaired Functionality of Antiviral T Cells in G-CSF Mobilized Stem Cell Donors: Implications for the Selection of CTL Donor (2013) (23)
- Six versus eight doses of rituximab in patients with aggressive B cell lymphoma receiving six cycles of CHOP: results from the “Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas” (PETAL) trial (2019) (23)
- Analysis of lymphocyte subsets in patients with aplastic anemia before and during immunosuppressive therapy (1993) (23)
- Impact of Age and Midostaurin-Dose on Response and Outcome in Acute Myeloid Leukemia with FLT3-ITD: Interim-Analyses of the AMLSG 16-10 Trial (2016) (23)
- ITD‐ and FL‐induced FLT3 signal transduction leads to increased C/EBPβ‐LIP expression and LIP/LAP ratio by different signalling modules (2010) (22)
- Abnormalities of hematopoiesis in the acquired immunodeficiency syndrome. (1988) (22)
- Continued Low-Dose Decitabine (DAC) Is an Active First-Line Treatment of Older AML Patients: First Results of a Multicenter Phase II Study. (2005) (22)
- Lentiviral vectors for induction of self-differentiation and conditional ablation of dendritic cells (2011) (22)
- Recall pneumonitis during systemic treatment with sunitinib. (2010) (22)
- Effects of pharmacological intervention on coagulopathy and organ function in xenoperfused kidneys (2008) (22)
- Role of Consolidation Therapy in the Treatment of Patients up to 60 Years with High Risk AML. (2005) (22)
- A randomized clinical trial comparing SC interleukin-2, SC Alpha-2A-interferon, and IV bolus 5-fluorouracil against oral tamoxifen in progressive metastatic renal cell carcinoma patients (1997) (22)
- Engineered dendritic cells from cord blood and adult blood accelerate effector T cell immune reconstitution against HCMV (2015) (22)
- Human Effector Memory T Helper Cells Engage with Mouse Macrophages and Cause Graft-versus-Host-Like Pathology in Skin of Humanized Mice Used in a Nonclinical Immunization Study. (2017) (22)
- Prognostic factors in allo-SCT of elderly patients with AML (2011) (22)
- A one-mutation mathematical model can explain the age incidence of acute myeloid leukemia with mutated nucleophosmin (NPM1) (2008) (22)
- Integrase-defective lentiviral vectors encoding cytokines induce differentiation of human dendritic cells and stimulate multivalent immune responses in vitro and in vivo. (2012) (22)
- Analysis of factors contributing to higher erythropoietin levels in patients with chronic liver disease (2004) (22)
- Frequency and prognostic impact of casein kinase 1A1 mutations in MDS patients with deletion of chromosome 5q (2015) (22)
- Treatment of myelodysplastic syndromes with cytokines and cytotoxic drugs. (1992) (21)
- G-CSF and cyclosporin induce an increase of normal cells in hypoplastic paroxysmal nocturnal hemoglobinuria (1997) (21)
- Cytogenetic studies in chronic myeloproliferative disorders. (1983) (21)
- Treatment of AIDS-Related Kaposi’s Sarcoma with Recombinant γ-Interferon (1986) (21)
- Inflammatory pseudotumor of the lung following invasive aspergillosis in a patient with chronic graft‐vs.‐host disease (2005) (21)
- The Addition of Midostaurin to Standard Chemotherapy Decreases Cumulative Incidence of Relapse (CIR) in the International Prospective Randomized, Placebo-Controlled, Double-Blind Trial (CALGB 10603 / RATIFY [Alliance]) for Newly Diagnosed Acute Myeloid Leukemia (AML) Patients with FLT3 Mutations (2017) (21)
- Regulatory T-cells in the control of immunological diseases (2006) (21)
- Signatures of T and B Cell Development, Functional Responses and PD-1 Upregulation After HCMV Latent Infections and Reactivations in Nod.Rag.Gamma Mice Humanized With Cord Blood CD34+ Cells (2018) (21)
- The impact of HLA-matching on reduced intensity conditioning regimen unrelated donor allogeneic stem cell transplantation for acute myeloid leukemia in patients above 50 years—a report from the EBMT acute leukemia working party (2016) (21)
- Outcome of patients with Fanconi anemia developing myelodysplasia and acute leukemia who received allogeneic hematopoietic stem cell transplantation: A retrospective analysis on behalf of EBMT group (2020) (21)
- Prevalence of a 23bp Insertion in Exon 3 of the Endothelial Cell Protein C Receptor Gene in Venous Thrombophilia (2001) (20)
- Unified classification and risk-stratification in Acute Myeloid Leukemia (2022) (20)
- New Strategies in the Treatment of Infectious Complications in Haematology and Oncology:Is There a Role for Out-Patient Antibiotic Treatment of Febrile Neutropenia? (1998) (20)
- Histamine release from basophils after in vivo application of recombinant human interleukin-3 in man. (1990) (20)
- Synergistic activity of IDH1 inhibitor BAY1436032 with azacitidine in IDH1 mutant acute myeloid leukemia (2020) (20)
- Plasma P-selectin levels are elevated in patients with chronic liver disease (2003) (20)
- Late treatment-related mortality versus competing causes of death after allogeneic transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia (2018) (20)
- IDH1/2 mutations in acute myeloid leukemia patients and risk of coronary artery disease and cardiac dysfunction—a retrospective propensity score analysis (2020) (20)
- Rapid Prediction of Hematologic Acute Radiation Syndrome in Radiation Injury Patients Using Peripheral Blood Cell Counts (2017) (20)
- Changes in erythroid progenitor cell and accessory cell compartments in patients with myelodysplastic syndromes during treatment with all‐trans retinoic acid and haemopoietic growth factors (1995) (20)
- Ultrastructural demonstration of peroxidase expression in acute unclassified leukemias: correlation to immunophenotype and treatment outcome. (1991) (20)
- Inhibition of granulocyte-macrophage colony-stimulating factor receptor function by a splice variant of the common beta-receptor subunit. (2001) (19)
- Intensive Intravenous Amphotericin B for Prophylaxis of Systemic Fungal Infections (2000) (19)
- Megakaryocytic cells in mixed haemopoietic colonies (CFU‐GEMM) from the peripheral blood of normal individuals (1985) (19)
- FLA‐IDA salvage chemotherapy combined with a seven‐day course of venetoclax (FLAVIDA) in patients with relapsed/refractory acute leukaemia (2020) (19)
- Infection of granulocyte/monocyte progenitor cells with HIV1. (1991) (19)
- Identity, potency, in vivo viability, and scaling up production of lentiviral vector-induced dendritic cells for melanoma immunotherapy. (2012) (19)
- Activation of protein kinase A (PKA) by 8-Cl-cAMP as a novel approach for antileukaemic therapy (2004) (19)
- Recombinant human granulocyte-macrophage colony-stimulating factor and low-dose cytosine arabinoside in patients with myelodysplastic syndrome. A pilot study. (1989) (19)
- Influence of human recombinant interferon-alpha and interferon-gamma on bone marrow progenitor cells of HIV-positive individuals. (1992) (19)
- Possible Impact of Cytomegalovirus-Specific CD8+ T Cells on Immune Reconstitution and Conversion to Complete Donor Chimerism after Allogeneic Stem Cell Transplantation. (2017) (19)
- Invasive drug delivery. (2002) (18)
- Effective reversal of a transformed phenotype by retrovirus-mediated transfer of a ribozyme directed against mutant N-ras (1998) (18)
- Salvage therapy with high-dose cytarabine and mitoxantrone in combination with all-trans retinoic acid and gemtuzumab ozogamicin in acute myeloid leukemia refractory to first induction therapy (2016) (18)
- The AML1/MTG8 Fusion Transcript in t(8;21) Positive AML and its Implication for the Detection of Minimal Residual Disease (2000) (18)
- Combining gene mutation with gene expression analysis improves outcomes prediction in acute promyelocytic leukemia. (2019) (18)
- Leukemic colony-forming cells in acute myeloblastic leukemia: maturation hierarchy and growth conditions. (1987) (18)
- Sinusoidal Obstruction Syndrome of the Liver after Hematopoietic Stem Cell Transplantation: Decision Making for Orthotopic Liver Transplantation (2006) (18)
- Induction of myeloperoxidase in five cases of acute unclassified leukaemia (1988) (17)
- Corrigendum: Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemia (Leukemia (2016) 30 (1672-1681) DOI: 10.1038/leu.2016.69) (2016) (17)
- Prospective randomized trial to evaluate two delayed granulocyte colony stimulating factor administration schedules after high-dose cytarabine therapy in adult patients with acute lymphoblastic leukemia (2002) (17)
- Good manufacturing practice-compliant validation and preparation of BM cells for the therapy of acute myocardial infarction. (2007) (17)
- Targeting the RAS signaling pathway in malignant hematologic diseases. (2007) (17)
- Incidence and prognostic impact of ASXL2 mutations in adult acute myeloid leukemia patients with t(8;21)(q22;q22): a study of the German-Austrian AML Study Group (2017) (17)
- The proteome pattern cGvHD_MS14 allows early and accurate prediction of chronic GvHD after allogeneic stem cell transplantation (2017) (17)
- Quantification of hepatic thrombopoietin mRNA transcripts in patients with chronic liver diseases shows maintained gene expression in different etiologies of liver cirrhosis. (2002) (17)
- Allogeneic Hematopoietic Cell Transplantation for Chronic Lymphocytic Leukemia (CLL) with 17p Deletion: A Retrospective EBMT Analysis. (2007) (17)
- Carboplatin plus weekly docetaxel as salvage chemotherapy in docetaxel-resistant and castration-resistant prostate cancer (2010) (16)
- Gene Mutations as Predicitive Markers for Postremission Therapy in Younger Adults with Normal Karyotype AML. (2006) (16)
- Human acute unclassified leukemia with a unique t(4;17) chromosomal translocation expresses T lymphoid and myeloid surface antigens after in vitro culture. (1987) (16)
- Recombinant human granulocyte-macrophage colony-stimulating factor and low-dose cytosine-arabinoside in the treatment of patients with myelodysplastic syndromes. A phase II study. (1990) (16)
- Association between structural and numerical chromosomal aberrations in acute myeloblastic leukemia: a study by RT-PCR and FISH in 447 patients with de-novo AML (1999) (16)
- Results of the Randomized Phase II Study Decider (AMLSG 14-09) Comparing Decitabine (DAC) with or without Valproic Acid (VPA) and with or without All-Trans Retinoic Acid (ATRA) Add-on in Newly Diagnosed Elderly Non-Fit AML Patients (2016) (16)
- Generation of lentivirus-induced dendritic cells under GMP-compliant conditions for adaptive immune reconstitution against cytomegalovirus after stem cell transplantation (2015) (16)
- Long-term interleukin-3 and intensive immunosuppression in the treatment of aplastic anemia. (1996) (16)
- The Role of GM‐CSF, G‐CSF, Interleukin‐3, and Erythropoietin in Myelodysplastic Syndromes (1991) (16)
- γδ-T cell-receptor-positive lymphocytes inhibit human hematopoietic progenitor cell growth in HIV type 1-infected patients (1996) (16)
- Low-dose cytosine arabinoside in the treatment of acute nonlymphoblastic leukemia and myelodysplastic syndromes. (1985) (16)
- Initial chemotherapy with mitoxantrone, chlorambucil, prednisone impairs the collection of stem cells in patients with indolent lymphomas--results of a randomized comparison by the German Low-Grade Lymphoma Study Group. (2006) (16)
- Synthesis and properties of hammerhead ribozymes stabilized against nucleases by different 2′-modifications: methoxyethoxy-, fluoro- and amino groups (1997) (16)
- Targeted Inhibition of the NUP98-NSD1 Fusion Oncogene in Acute Myeloid Leukemia (2020) (16)
- Imatinib-induced liver cirrhosis in a patient with advanced gastrointestinal stroma tumor (GIST) (2012) (16)
- Identification of novel regulators in T-cell differentiation of aplastic anemia patients (2006) (16)
- Role of age and hematopoietic cell transplantation-specific comorbidity index in myelodysplastic patients undergoing an allotransplant. A retrospective study from the CMWP (Chronic Malignancies Working Party) of the EBMT. (2020) (15)
- Competitive cytokeratin 19 RT-PCR for quantification of breast cancer cells in blood cell suspensions. (2000) (15)
- In vitro and in vivo action of recombinant human GM-CSF (rhGM-CSF) in patients with myelodysplastic syndromes. (1988) (15)
- TRANSPLANTATION AND CELLULAR ENGINEERING: Prolonged isolated red blood cell transfusion requirement after allogeneic blood stem cell transplantation: identification of patients at risk (2009) (15)
- Comparison of FLAMSA-based reduced intensity conditioning with treosulfan/fludarabine conditioning for patients with acute myeloid leukemia: an ALWP/EBMT analysis (2018) (15)
- Therapy-related myeloid neoplasms (2017) (15)
- Successful use of extracorporeal membrane oxygenation during induction chemotherapy in a patient with mediastinal tumor mass of a T lymphoblastic lymphoma (2016) (15)
- NTAL is associated with treatment outcome, cell proliferation and differentiation in acute promyelocytic leukemia (2020) (15)
- Acute lymphoblastic leukemia with the (4;11) translocation: combined cytogenetic, immunological and molecular genetic analyses. (1992) (15)
- New Definition of Treatment Response in Adult Acute Lymphoblastic Leukemia (ALL): Use of Molecular Markers for Minimal Residual Disease (MRD). (2009) (15)
- SURAMIN TREATMENT FOR AIDS (1985) (15)
- Impact of Allogeneic Transplantation From Matched Related and Unrelated Donors on Clinical Outcome In Younger Adult AML Patients with FLT3 Internal Tandem Duplications (2010) (15)
- Minimal Residual Disease Monitoring in Acute Myeloid Leukemia (AML) with Translocation t(8;21)(q22;q22): Results of the AML Study Group (AMLSG) (2016) (15)
- Pyrimethamine as a Potent and Selective Inhibitor of Acute Myeloid Leukemia Identified by High-throughput Drug Screening. (2016) (14)
- Clinical use of hematopoietic growth factors in patients with myelodysplastic syndromes. (1997) (14)
- Monosomal karyotype and chromosome 17p loss or TP53 mutations in decitabine-treated patients with acute myeloid leukemia (2020) (14)
- Donor Vδ1+ γδ T cells expand after allogeneic hematopoietic stem cell transplantation and show reactivity against CMV-infected cells but not against progressing B-CLL (2013) (14)
- Explaining the connection between privilege and health. (1994) (14)
- Baseline and interim PET‐based outcome prediction in peripheral T‐cell lymphoma: A subgroup analysis of the PETAL trial (2019) (14)
- Use of hematopoietic growth factors in the treatment of acute myelogenous leukemia (1997) (14)
- Deferasirox (Exjade®, ICL670) Demonstrates Dose-Related Effects on Body Iron Levels Related to Transfusional Iron Intake in Transfusion-Dependent Anemia. (2005) (14)
- Sunitinib and Intensive Chemotherapy in Patients with Acute Myeloid Leukemia and Activating FLT3 Mutations: Results of the AMLSG 10-07 Study (ClinicalTrials.gov No. NCT00783653) (2012) (14)
- Shedding of the endothelial receptor tyrosine kinase Tie2 correlates with leukemic blast burden and outcome after allogeneic hematopoietic stem cell transplantation for AML (2010) (14)
- Preconditioning therapy with lentiviral vector-programmed dendritic cells accelerates the homeostatic expansion of antigen-reactive human T cells in NOD.Rag1-/-.IL-2rγc-/- mice. (2011) (14)
- Risks and benefits of erythropoiesis-stimulating agents in cancer management. (2007) (14)
- Improving Safety of Preemptive Therapy with Oral Valganciclovir for Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation (2012) (14)
- Value of proteomics applied to the follow-up in stem cell transplantation (2006) (14)
- Leukemogenic potency of the novel FLT3-N676K mutant (2016) (13)
- Modulation of anthracycline-induced cytotoxicity by targeting the prenylated proteome in myeloid leukemia cells (2012) (13)
- Myeloid growth factors in acute myeloid leukemia: systematic review of randomized controlled trials (2011) (13)
- Antitumor activity of sequential treatment with tyrosine kinase inhibitors (TKI) after failure of RAD001 in metastatic renal cell carcinoma (mRCC). (2010) (13)
- New strategies in the treatment and prophylaxis of chemo- and radiotherapy-induced oral mucositis. (2000) (13)
- Regulation of early hematopoiesis in serum-deprived cultures of mafosfamide-treated and untreated CD34-enriched bone marrow cells. (1991) (13)
- In vivo administration of recombinant human interleukin-3 elicits an acute phase response involving endogenous synthesis of interleukin-6. (1991) (13)
- Prognostic Impact of NPM1/FLT3-ITD genotypes from Randomized Patients with Acute Myeloid Leukemia (AML) Treated within the International Ratify Study (2017) (13)
- Optimized induction of mitochondrial apoptosis for chemotherapy-free treatment of BCR-ABL+acute lymphoblastic leukemia (2018) (13)
- Expression of the p75 neurotrophin receptor in acute leukaemia (2005) (13)
- Up-front randomization and common standard arm: a proposal for comparing AML treatment strategies between different studies. (2002) (13)
- Deletion of c-fms sequences in the 5q- syndrome. (1987) (13)
- Long term follow up of patients after allogeneic stem cell transplantation and transfusion of HSV-TK transduced T-cells (2015) (13)
- Altered expression of beta 1 integrins in renal carcinoma cell lines exposed to vinblastine. (1999) (12)
- Intramedullary spinal cord implantation of human CD34+ umbilical cord-derived cells in ALS (2011) (12)
- Oral 9-cis retinoic acid (Alitretinoin) in the treatment of myelodysplastic syndromes: results from a pilot study (2000) (12)
- miR-181a Expression in Donor T Cells Modulates Graft-versus-Host Disease after Allogeneic Bone Marrow Transplantation (2016) (12)
- Comparative outcomes of myeloablative and reduced‐intensity conditioning allogeneic hematopoietic cell transplantation for therapy‐related acute myeloid leukemia with prior solid tumor: A report from the acute leukemia working party of the European society for blood and bone marrow transplantation (2019) (12)
- Recombinant gamma-interferon induces in vitro monocytic differentiation of blast cells from patients with acute nonlymphocytic leukemia and myelodysplastic syndromes. (1988) (12)
- Sustained decrease of peripheral lymphocytes after allogeneic blood stem cell aphereses (1998) (12)
- Prognostic impact of KMT2E transcript levels on outcome of patients with acute promyelocytic leukaemia treated with all‐trans retinoic acid and anthracycline‐based chemotherapy: an International Consortium on Acute Promyelocytic Leukaemia study (2014) (12)
- Exposure to vinblastine modulates beta 1 integrin expression and in vitro binding to extracellular matrix molecules in a human renal carcinoma cell line. (1996) (12)
- HLA phenotype and cytokine-induced tumor control in advanced renal cell cancer. (2001) (12)
- Treatment of AIDS-related Kaposi's sarcoma with recombinant gamma-interferon. (1986) (12)
- Evolving treatment options of myelodysplastic syndromes (2001) (12)
- Cost-effectiveness of methods in personalized medicine. Results of a decision-analytic model in patients with acute myeloid leukemia with normal karyotype. (2017) (12)
- Treatment of Patients up to 60 Years with High Risk AML: Final Results of the AML SHG-Hannover 01/99 Trial. (2006) (12)
- Improved Outcome with ATRA-Arsenic Trioxide Compared to ATRA-Chemotherapy in Non-High Risk Acute Promyelocytic Leukemia – Updated Results of the Italian-German APL0406 Trial on the Extended Final Series (2014) (12)
- [Activated protein C resistance and venous thrombophilia: molecular genetic prevalence study in the German population]. (1999) (12)
- Characterization of High-Avidity Cytomegalovirus-Specific T Cells with Differential Tetramer Binding Coappearing after Allogeneic Stem Cell Transplantation (2017) (12)
- Expansion of recipient‐derived antiviral T cells may influence donor chimerism after allogeneic stem cell transplantation (2013) (12)
- Effect of intensified chemotherapy on the pluripotent haematopoietic progenitor cells CFU‐GEMM in adult acute lymphoblastic leukaemia (1986) (12)
- Clinical and functional implications of microRNA mutations in a cohort of 935 patients with myelodysplastic syndromes and acute myeloid leukemia (2015) (12)
- In vivo distribution of integrins in renal cell carcinoma: integrin-phenotype alteration in different degrees of tumor differentiation and VLA-2 involvement in tumor metastasis. (1995) (12)
- Rare Phenomenon of Extracranial Metastasis of Glioblastoma (2011) (11)
- Two years rituximab maintenance vs. observation after first line treatment with bendamustine plus rituximab (B-R) in patients with marginal zone lymphoma (MZL): Results of a prospective, randomized, multicenter phase 2 study (the StiL NHL7-2008 MAINTAIN trial). (2018) (11)
- Effect of treatment with rhGM-CSF and low-dose cytosine arabinoside on leukemic blast cells in patients with myelodysplastic syndromes. (1990) (11)
- In vivo efficacy of mutant IDH1 inhibitor HMS-101 and structural resolution of distinct binding site (2019) (11)
- Complete response of a gastric primary after a short but toxic course of 'S-1' EORTC Early Clinical Studies Group. (1999) (11)
- Second allogeneic haematopoietic cell transplantation using HLA‐matched unrelated versus T‐cell replete haploidentical donor and survival in relapsed acute myeloid leukaemia (2021) (11)
- RNA interference efficiently targets human leukemia driven by a fusion oncogene in vivo (2017) (11)
- Spatiotemporally Skewed Activation of Programmed Cell Death Receptor 1–Positive T Cells after Epstein-Barr Virus Infection and Tumor Development in Long-Term Fully Humanized Mice (2019) (11)
- Clinical and in vitro response to 13-cis-retinoic acid in interferon-alpha resistant renal cell carcinoma. (1997) (11)
- Long Term Follow-up of 121 Elderly Patients with Philadelphia-Positive Acute Lymphoblastic Leukaemia (Ph+ALL) Treated in Prospective GMALL Trials Supports a Greater Emphasis On Allogeneic SCT as Definitive Postremission Therapy. (2012) (11)
- Recent Advances in Myelodysplastic Syndromes (1998) (11)
- Who Is the Best Hematopoietic Stem-Cell Donor for a Male Patient With Acute Leukemia? (2014) (11)
- Measurable residual disease status and outcome of transplant in acute myeloid leukemia in second complete remission: a study by the acute leukemia working party of the EBMT (2021) (11)
- What is the outcome in patients with acute leukaemia who survive severe acute graft‐versus‐host disease? (2018) (11)
- Cytokines in the Treatment of Hematopoietic Failure (1998) (11)
- Detection of melanoma cells in peripheral blood stem cell harvests of patients with progressive metastatic malignant melanoma (1997) (11)
- Reconstitution and Phenotype of Tregs in CMV Reactivating Patients Following Allogeneic Hematopoietic Stem Cell Transplantation (2013) (11)
- Phase I/II study with GM-CSF in patients with myelodysplastic syndromes. (1988) (11)
- A Phase II study of selinexor plus cytarabine and idarubicin in patients with relapsed/refractory acute myeloid leukaemia (2020) (11)
- Satisfaction and Adherence Significantly Improves in Patients with β-Thalassemia and Myelodysplastic Syndromes Treated with Deferasirox (Exjade®) (2008) (10)
- Clinical impact of BAALC expression in high-risk acute promyelocytic leukemia. (2017) (10)
- Molecular pathogenesis of acute myeloid leukemia: A diverse disease with new perspectives (2010) (10)
- Possible Role of Minor H Antigens in the Persistence of Donor Chimerism after Stem Cell Transplantation; Relevance for Sustained Leukemia Remission (2015) (10)
- Effective drug treatment identified by in vivo screening in a transplantable patient-derived xenograft model of chronic myelomonocytic leukemia (2020) (10)
- ICSBP promoter methylation in myelodysplastic syndromes and acute myeloid leukaemia (2011) (10)
- Targeting vascular endothelial growth factor (VEGF)-receptor-signaling in renal cell carcinoma (2007) (10)
- FLAMSA-based reduced intensity conditioning versus myeloablative conditioning in younger patients with relapsed/refractory acute myeloid leukemia with active disease at the time of allogeneic stem cell transplantation: an ALWP/EBMT analysis. (2020) (10)
- Molecular detection of c-mpl thrombopoietin receptor gene expression in chronic myeloproliferative disorders. (1999) (10)
- Outcome of peripheral blood stem cell mobilization in advanced phases of CML is dependent on the type of chemotherapy applied (1998) (10)
- Stimulation of granulopoiesis in patients with malignancy by recombinant human granulocyte-macrophage colony-stimulating factor: assessment of two routes of administration. (1990) (10)
- DNA analysis from stool samples: a fast and reliable method avoiding invasive sampling methods in mouse models of bleeding disorders (2009) (10)
- Platelet glycoprotein expression in patients with myelodysplastic syndrome. (2000) (10)
- Treating acute promyelocytic leukaemia in Latin America: lessons from the International Consortium on Acute Leukaemia experience (2017) (10)
- Improved Health-Related Quality of Life in Patients with Hematological Disorders Receiving Deferasirox (Exjade®) (2008) (10)
- Treatment of Adult Patients with High Risk Acute Myeloblastic Leukemia up to 60 Years: Role of Consolidation Therapy within a Prospective Multicenter Trial. (2004) (10)
- 18F-FDG PET/CT of off-target lymphoid organs in CD19-targeting chimeric antigen receptor T-cell therapy for relapsed or refractory diffuse large B-cell lymphoma (2020) (10)
- Venetoclax and dexamethasone synergize with inotuzumab-ozogamicin induced DNA damage signaling in B-lineage ALL. (2020) (10)
- Regulatory T cells as therapeutic target in Hodgkin's lymphoma. (2008) (10)
- The AML1/MTG8 Fusion Transcript in t(8;21) Positive AML and its Implication for the Detection of Minimal Residual Disease; Malignancy. (2001) (10)
- Delayed Distant Spinal Metastasis in Thymomas (2013) (10)
- A phase II open-label study of cetuximab in unresectable hepatocellular carcinoma. (2006) (10)
- Publisher Correction: Human γδ T cells are quickly reconstituted after stem-cell transplantation and show adaptive clonal expansion in response to viral infection (2018) (10)
- Classical Hodgkin’s Lymphoma: Molecular Evidence for Specific Alterations in Circulating T Lymphocytes (2006) (9)
- Reduced SLIT2 is Associated with Increased Cell Proliferation and Arsenic Trioxide Resistance in Acute Promyelocytic Leukemia (2020) (9)
- Response to 13-cis-retinoic acid plus interferon alfa-2a in two patients with therapy-refractory advanced renal cell carcinoma. (1995) (9)
- Deletion or inhibition of Fc gamma receptor 2B (CD32) prevents FVIII-specific activation of memory B cells in vitro (2015) (9)
- Monocytes reprogrammed with lentiviral vectors co-expressing GM-CSF, IFN-α2 and antigens for personalized immune therapy of acute leukemia pre- or post-stem cell transplantation (2019) (9)
- Abstract 2670: Intracoronary Bone Marrow Cell Transfer After Myocardial Infarction: 5-Year Follow-up of the BOOST Trial (2008) (9)
- Comparable Long-Term Outcome after Allogeneic Stem-Cell Transplantation from Sibling and Matched Unrelated Donors in AML Patients Older than 50 years. A Report on Behalf of the ALWP of EBMT. (2019) (9)
- Allogeneic stem cell transplantation from related and unrelated donors for aplastic anaemia in adults—a single-centre experience (2008) (9)
- Synergistic Activity of IDH1 Inhibitor Bay-1436032 with Azacitidine in IDH1 Mutant Acute Myeloid Leukemia (2017) (9)
- Recombinant human erythropoietin in the treatment of nonrenal anemia (2006) (9)
- Hematopoietic growth factors in the treatment of the myelodysplastic syndromes (1995) (9)
- Erythropoietin in cancer-related anemia (2008) (9)
- [Myelodysplastic syndromes. Diagnosis and therapeutic strategies]. (2002) (9)
- Impaired formation of erythroblastic islands is associated with erythroid failure and poor prognosis in a significant proportion of patients with myelodysplastic syndromes (2016) (9)
- Regulatory T cells as therapeutic target in Hodgkin's lymphoma (2008) (9)
- Endogenous serum levels of thrombopoietic cytokines in healthy whole‐blood and platelet donors: implications for plateletpheresis (1999) (9)
- Functional Analysis of a Single Chain Chimeric α/β-Granulocyte-Macrophage Colony-stimulating Factor Receptor (1999) (9)
- Clinical importance of T-ALL subclassification according to thymic or prethymic maturation stage. (1990) (9)
- Long-term results of a prospective randomized trial evaluating G-CSF priming in intensive induction chemotherapy followed by autologous stem cell transplantation in elderly patients with acute myeloid leukemia (2014) (9)
- Clinical use of recombinant human hematopoietic growth factors (GM-CSF, IL-3, EPO) in patients with myelodysplastic syndrome. (1991) (9)
- Erratum: Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemia (2016) (8)
- VH1 Family Immunoglobulin Repertoire Sequencing after Allogeneic Hematopoietic Stem Cell Transplantation (2017) (8)
- Low-dose Ara-C in the treatment of acute leukemia cytotoxicity or differentiation induction? (1984) (8)
- Activation of TRKB receptor in murine hematopoietic stem/progenitor cells induced mastocytosis. (2014) (8)
- A Novel Inhibitor of Mutant IDH1 Induces Differentiation in Vivo and Prolongs Survival in a Mouse Model of Leukemia (2014) (8)
- Evaluation of Tissue Factor Bearing Microparticles as Biomarkers in Allogeneic Stem-Cell Transplantation (2011) (8)
- Interstitial lung disease during targeted therapy in metastatic renal cell carcinoma: a case series from three centres (2014) (8)
- The High Prevalence of FLT3-ITD Mutations Is Associated with the Poor Outcome in Adult Patients with t(6;9)(p23;q34) Positive AML - Results of an International Metaanalysis. (2007) (8)
- Seasonal human coronaviruses respiratory tract infection in recipients of allogeneic hematopoietic stem cell transplantation. (2020) (8)
- Simultaneous administration of granulocyte colony-stimulating factor (Filgrastim) and induction chemotherapy in acute lymphoblastic leukemia (1993) (8)
- Abnormalities of hematopoesis in the acquired immunodeficiency syndrome (1988) (8)
- Leukemias induced by altered TRK-signaling are sensitive to mTOR inhibitors in preclinical models (2011) (8)
- Constitutive expression of hematopoietic growth factor genes by acute myeloblastic leukemia cells. (1988) (8)
- miR-625-3p is upregulated in CD8+ T cells during early immune reconstitution after allogeneic stem cell transplantation (2017) (8)
- In vitro and in vivo effects of recombinant human erythropoietin on human hemopoietic progenitor cells. (1988) (8)
- ID1 expression associates with other molecular markers and is not an independent prognostic factor in cytogenetically normal acute myeloid leukaemia (2012) (8)
- The German competence network ‘Acute and chronic leukemias’ (2004) (8)
- Clinical Impact of WT1 Mutations in the Context of Other Molecular Markers in Cytogenetically Normal Acute Myeloid Leukemia (AML): A Study of the German-Austrian AML Study Group (AMLSG). (2007) (8)
- Clinical results with recombinant human interleukin-3. (1993) (8)
- Increased amounts of von Willebrand factor are bound to microparticles after infusion of desmopressin (2013) (8)
- Transplant outcomes for patients with therapy-related acute myeloid leukemia with prior lymphoid malignancy: an ALWP of EBMT study (2019) (8)
- Bendamustine Plus Rituximab Followed By Rituximab Maintenance for Patients with Untreated Advanced Follicular Lymphomas. Results from the StiL NHL 7-2008 Trial (MAINTAIN trial) (ClinicalTrials.gov Identifier: NCT00877214) (2014) (8)
- Cardiac surgery in a patient with paroxysmal nocturnal hemoglobinuria. (2002) (8)
- Clonal Evolution of FLT3 -ITD Positive AML in Patients Treated with Midostaurin in Combination with Chemotherapy within the Ratify (CALGB 10603) and AMLSG 16-10 Trials (2017) (8)
- The stem cell zinc finger 1 (SZF1)/ZNF589 protein has a human-specific evolutionary nucleotide DNA change and acts as a regulator of cell viability in the hematopoietic system. (2016) (8)
- Comparative evaluation of commonly used clones and fluorochrome conjugates of monoclonal antibodies for CD34 antigen detection. (1999) (7)
- Treatment with growth factors in myelodysplastic syndromes. (1997) (7)
- Cytomegalovirus-specific CD8+ T-cells are associated with a reduced incidence of early relapse after allogeneic stem cell transplantation (2019) (7)
- Effect of recombinant human transforming growth factor beta and tumor necrosis factor alpha on bone marrow progenitor cells of HIV-infected persons (1991) (7)
- Response of renal lesions during systemic treatment with sunitinib in patients with metastatic renal cell carcinoma: a single center experience with 14 patients (2011) (7)
- Event-Free Survival Is a Surrogate for Overall Survival in Patients Treated for Acute Myeloid Leukemia (2015) (7)
- Postremission Therapy with an Allogeneic Transplantation from an HLA-Matched Family Donor Seems To Overcome the Negative Prognostic Impact of FLT3 -ITD in Younger Patients with Acute Myeloid Leukemia Exhibiting a Normal Karyotype. (2005) (7)
- Low frequency of calreticulin mutations in MDS patients (2014) (7)
- Association of Serum Ferritin Levels Before Start of Conditioning With Mortality After alloSCT – A Prospective, Non-interventional Study of the EBMT Transplant Complications Working Party (2020) (7)
- [Rational therapy with G-CSF and GM-CSF]. (1994) (7)
- Remission of juvenile chronic myeloid leukemia following graft failure of an unrelated marrow transplant and autologous recovery of marrow function promoted by GM-CSF and IL-3. (1991) (7)
- Proteomics studies after hematopoietic stem cell transplantation. (2009) (7)
- Cytological characterization of murine bone marrow and spleen hematopoietic compartments for improved assessment of toxicity in preclinical gene marking models (2013) (7)
- A multicenter prospective, randomized, placebo-controlled phase II/III trial for preemptive acute graft-versus-host disease therapy (2020) (7)
- Peripheral blood cytogenetics allows treatment monitoring and early identification of treatment failure to lenalidomide in MDS patients: results of the LE-MON-5 trial (2017) (7)
- Improved Outcome for Patients with Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) with Poor Risk Cytogenetics – Result from An Analysis on 172 Patients Receiving FLAMSA-RIC Conditioning for Allogeneic Stem Cell Transplantatioin (SCT). (2008) (7)
- Midostaurin plus intensive chemotherapy for younger and older patients with AML and FLT3 internal tandem duplications (2022) (7)
- Lack of noncanonical RAS mutations in cytogenetically normal acute myeloid leukemia (2014) (7)
- Proteome analysis in hematology using capillary electrophoresis coupled on-line to mass spectrometry. (2009) (7)
- implications for transplantation and autoimmune diseases G-CSF as immune regulator in T cells expressing the G-CSF receptor: (2013) (7)
- Impact of sarcopenia in advanced and metastatic soft tissue sarcoma (2021) (7)
- Allogeneic stem cell transplantation using HLA-matched donors for acute myeloid leukemia with deletion 5q or monosomy 5: a study from the Acute Leukemia Working Party of the EBMT (2019) (7)
- Treatment intensity significantly influencing fibrosis in bone marrow independently of the cytogenetic response: meta-analysis of the long-term results from two prospective controlled trials on chronic myeloid leukemia (2004) (7)
- Autologous hematopoietic stem cell transplantation for relapsed/refractory systemic anaplastic large cell lymphoma. A retrospective analysis of the lymphoma working party (LWP) of the EBMT (2019) (6)
- Neurological management and work-up of neurotoxicity associated with CAR T cell therapy (2022) (6)
- Anticoagulant prophylaxis and therapy in patients with cancer. (2000) (6)
- The hypomorphic TERT A1062T variant is associated with increased treatment-related toxicity in acute myeloid leukemia (2017) (6)
- The impact of cytogenetic risk on the outcomes of allogeneic hematopoietic cell transplantation in patients with relapsed/refractory acute myeloid leukemia: On behalf of the acute leukemia working party (ALWP) of the European group for blood and marrow transplantation (EBMT) (2020) (6)
- Interleukin 3 and interleukin 3/gm‐csf combination therapy ‐ clinical implications (1993) (6)
- Severe allo-immune antibody-associated peripheral and central nervous system diseases after allogeneic hematopoietic stem cell transplantation (2021) (6)
- Birth order and transplantation outcome in HLA-identical sibling stem cell transplantation: an analysis on behalf of the Center for International Blood and Marrow Transplantation. (2013) (6)
- Molecular Predictors of Outcome in Patients with MDS and AML Following MDS after Allogeneic Hematopoietic Stem Cell Transplantation (2015) (6)
- Receptor-mediated endocytosis of CD34 on hematopoietic cells after stimulation with the monoclonal antibody anti-HPCA-1. (2001) (6)
- The fate of cells with chromosome aberrations after total-body irradiation and bone marrow transplantation. (1983) (6)
- P-selectin glycoprotein ligand-1 positive microparticles in allogeneic stem cell transplantation of hematologic malignancies. (2011) (6)
- Does the onset of bone metastasis in sunitinib-treated renal cell carcinoma patients impact the overall survival? (2016) (6)
- MN1 overexpression induces acute myeloid leukemia in mice and predicts ATRA resistance in AML patients (2007) (6)
- Cluster of differentiation 33 single nucleotide polymorphism rs12459419 is a predictive factor in patients with nucleophosmin1-mutated acute myeloid leukemia receiving gemtuzumab ozogamicin (2021) (6)
- Risk-adapted, treosulfan-based therapy with auto- and allo-SCT for relapsed/refractory aggressive NHL: a prospective phase-II trial (2014) (6)
- Prognostic Impact of Insertion Site in Acute Myeloid Leukemia (AML) with FLT3 Internal Tandem Duplication: Results from the Ratify Study (Alliance 10603) (2018) (6)
- Letter to the Editor: Production of Mature Healthy Hematopoietic Cells from Induced Pluripotent Stem Cells Derived from an AML Diagnostic Sample Containing the t(8;21) Translocation (2016) (6)
- Hepatic toxicity during regorafenib treatment in patients with metastatic gastrointestinal stromal tumors. (2020) (6)
- Acute abdomen due to endometriosis as a diagnostic and therapeutic challenge in the treatment of acute myelocytic leukemia (1997) (6)
- Application of Granulocyte-Macrophage Colony-Stimulating Factor in Patients with Malignant Hematological Diseases (1989) (6)
- Therapy of Treatment‐Related Hypertension in Metastatic Renal‐Cell Cancer Patients Receiving Sunitinib (2017) (6)
- Activation of TRKA receptor elicits mastocytosis in mice and is involved in the development of resistance to KIT-targeted therapy. (2017) (6)
- Iron Chelation in Regularly Transfused Patients with Aplastic Anemia: Efficacy and Safety Results from the Large Deferasirox EPIC Trial (2008) (5)
- Association of uric acid levels before start of conditioning with mortality after allogeneic hematopoietic stem cell transplantation – a prospective, non-interventional study of the EBMT Transplant Complication Working Party (2019) (5)
- Total body irradiation + fludarabine compared to busulfan + fludarabine as “reduced-toxicity conditioning” for patients with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation in first complete remission: a study by the Acute Leukemia Working Party of the EBMT (2020) (5)
- Tumor cell-based vaccination in renal cell carcinoma: rationale. approaches, and recent clinical development. (2002) (5)
- Mutations in the Fms-Related Tyrosine Kinase 3 (FLT3) Gene Independently Predict Poor Outcome in Acute Myeloid Leukemia (AML) with t(8;21): A Study of the German-Austrian AML Study Group (AMLSG). (2009) (5)
- Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome using treosulfan based compared to other reduced‐intensity or myeloablative conditioning regimens. A report of the chronic malignancies working party of the EBMT (2021) (5)
- Detection of RAS, KIT and FLT3 Gene Mutations in t(8;21)-Positive Acute Myeloid Leukemia (AML): Evaluation of the Clinical Relevance. (2006) (5)
- Monitoring of Minimal Residual Disease (MRD) of DNMT3A Mutations (DNMT3Amut) in Acute Myeloid Leukemia (AML): A Study of the AML Study Group (AMLSG) (2015) (5)
- Immunosuppression for Patients with Low and Intermediate Risk Myelodysplastic Syndrome: A Prospective Randomized Multicenter Trial Comparing Antithymocyte Globulin + Cyclosporine with Best Supportive Care: SAKK 33/99. (2007) (5)
- Treatment of relapsed acute lymphocytic leukemia in adults. (1990) (5)
- Case Report: Convalescent Plasma Therapy Induced Anti-SARS-CoV-2 T Cell Expansion, NK Cell Maturation and Virus Clearance in a B Cell Deficient Patient After CD19 CAR T Cell Therapy (2021) (5)
- Prognostic indicators and scoring systems for predicting outcome in patients with myelodysplastic syndromes. (2004) (5)
- Phosphoinositide phospholipase Cbeta1 (PI-PLCbeta1) gene in myelodysplastic syndromes and cytogenetically normal acute myeloid leukemia: not a deletion, but increased PI-PLCbeta1 expression is an independent prognostic factor. (2010) (5)
- Megakaryocytic differentiation capacity of human pluripotent bone marrow progenitor cells CFU-GEMM in vitro after cryopreservation. (2009) (5)
- No Elevated Rates of Treatment-Related Myelodysplastic Syndromes and Second Solid Tumors Following Therapy with Bendamustine Compared with Other Anti-Lymphoma Regimes for Low-Grade Non-Hodgkin's Lymphoma (2010) (5)
- Dissecting Genetic and Phenotypic Heterogeneity to Map Molecular Phylogenies and Deliver Personalized Outcome and Treatment Predictions in AML (2015) (5)
- Immunoaffinity Selection of CD34+ Blood Cells for Allogeneic Transplantation (1997) (5)
- [A case of symptomatic paroxysmal kinesigenic dsykinesia with primary central nervous system lymphoma]. (2003) (5)
- An Intergroup Randomised Trial of Standard Intensity Versus Reduced Intensity TBI-Based Conditioning In Patients with Acute Myeloid Leukemia in First Complete Remission (2011) (5)
- Induced dendritic cells co-expressing GM-CSF/IFN-α/tWT1 priming T and B cells and automated manufacturing to boost GvL (2021) (5)
- Prognostic Effect of Mutations in the Splicing Gene Machinery in 339 Patients with MDS or Secondary AML Following MDS After Allogeneic Hematopoietic Stem Cell Transplantation (2012) (5)
- The impact of concomitant cytogenetic abnormalities on acute myeloid leukemia with monosomy 7 or deletion 7q after HLA‐matched allogeneic stem cell transplantation (2019) (5)
- Expression of the ETS transcription factor GABPα is positively correlated to the BCR-ABL1/ABL1 ratio in CML patients and affects imatinib sensitivity in vitro. (2015) (5)
- Measurable residual disease (MRD) status before allogeneic hematopoietic cell transplantation impact on secondary acute myeloid leukemia outcome. A Study from the Acute Leukemia Working Party (ALWP) of the European society for Blood and Marrow Transplantation (EBMT) (2022) (5)
- Focusing of the regulatory T-cell repertoire after allogeneic stem cell transplantation indicates protection from graft-versus-host disease (2019) (5)
- Clinical use of hematopoietic growth factors in the myelodysplastic syndromes. (1997) (5)
- Type and Number of Secondary Molecular Lesions Improve Outcome Prediction in Acute Myeloid Leukemia (AML) with inv(16) or t(16;16): A Study of the German-Austrian AML Study Group (AMLSG). (2009) (5)
- Expression of the c-fes proto-oncogene in granulocyte-macrophage colony-stimulating factor-dependent acute myelogenous leukemia cells grown autonomously. (1991) (5)
- AML1/ETO inhibits AML1/CCAAT-enhancer binding protein-alpha mediated activation of the CD11c promoter and represses CD11c expression in HL60 cells. (2003) (5)
- Randomized phase-II trial evaluating induction therapy with idarubicin and etoposide plus sequential or concurrent azacitidine and maintenance therapy with azacitidine (2019) (5)
- Prospective Evaluation of An Agvhd-Specific Proteomic Pattern in More Than 340 Patients. (2009) (5)
- Differential Effects of Gut-Homing Molecules CC Chemokine Receptor 9 and Integrin-β7 during Acute Graft-versus-Host Disease of the Liver. (2015) (5)
- Routes of Clonal Evolution into Complex Karyotypes in Myelodysplastic Syndrome Patients with 5q Deletion (2018) (5)
- Pre T-Cell Receptor Alpha (pTα) Expression Patterns and Functional Analysis in Human T-Cell Lymphoblastic Leukemia (2010) (5)
- Effect of human recombinant erythropoietin on human hemopoietic progenitor cells in vitro (1988) (5)
- Meningioma 1 is indispensable for mixed lineage leukemia-rearranged acute myeloid leukemia (2019) (5)
- Clonal expansion of CD8+ T cells reflects graft-versus-leukemia activity and precedes durable remission following DLI (2021) (5)
- In vitro response of myelodysplastic megakaryocytopoiesis to megakaryocyte growth and development factor (MGDF) (2002) (5)
- Shuttle system allowing simplified cloning of expression cassettes into advanced generation lentiviral vectors. (2005) (5)
- [Patient education--support--help with decisions: ethical aspects in treatment of amyotrophic lateral sclerosis]. (1996) (4)
- The hematopoietic growth factors in acute leukemia: a European perspective. (2011) (4)
- Longitudinal outcome over two decades of unrelated allogeneic stem cell transplantation for relapsed/refractory acute myeloid leukemia: an ALWP/EBMT analysis. (2022) (4)
- Presentation assessment of minor histocompatibility antigens by predictive proteasomal cleavage analysis (2004) (4)
- High cut-off dialysis as a salvage therapy option in high-dose methotrexate chemotherapy? (2014) (4)
- Factor VIII Inhibitor–Tests Could Be Less Sensitive Than Supposed (1999) (4)
- Retrospective Analyses of Patient Characteristics Having Predictive Impact on Survival under Everolimus (2011) (4)
- Valproic Acid as Adjunct to Induction Therapy in Patients with Acute Myeloid Leukemia: First Results of Two Randomized Studies of the AMLSG. (2005) (4)
- Azacitidine-Containing Induction Regimens Followed by Azacitidine Maintenance Therapy in High Risk Acute Myeloid Leukemia: First Results of the Randomized Phase-II AMLSG 12-09 Study (ClinicalTrials.gov No. NCT01180322) (2012) (4)
- Cutaneous Side Effects of New Antitumor Drugs (2012) (4)
- [Possibilities and limits of ambulatory supportive measures in oncology exemplified by antibiotic therapy of febrile neutropenia]. (1998) (4)
- Mixed megakaryocytic-granulocytic differentiation during diffusion chamber culture of peripheral blast cells from the blast crisis of chronic myelocytic leukemia. (1985) (4)
- Impact of Molecular Genetics on Disease-Free Survival in Myelofibrosis Patients Following Allogeneic Stem Cell Transplantation (2015) (4)
- Flow cytometric characterization of acute leukemia reveals a distinctive “blast gate” of murine T-lymphoblastic leukemia/lymphoma (2017) (4)
- Reappearance of Effector T Cells Predicts Successful Recovery from COVID-19 (2020) (4)
- Distribution of major lymphocyte subsets and memory T-cell subpopulations in healthy adults employing GLP-conforming multicolor flow cytometry (2021) (4)
- Interleukin-2 in hematology and oncology : state of the art (1995) (4)
- A Comparative Review of Methods for T Cell Depletion in the Prophylaxis of Graft-versus-Host Disease (1998) (4)
- CFU‐GM:CFU‐MIX RATION INTHE PERIPHERAL BLOOD AND BONE MARROW AND ITS IMPORTANCE IN AUTOLOGOUS TRANSPLANTATION OF CIRCULATING STEAM CELLS (1986) (4)
- Transient increase of leukocytes after transplantation of expanded and nonexpanded allogeneic CD34+ blood cells is of host origin. (1997) (4)
- Growth kinetics of CFU-GEMM, BFU-E, and CFU-C in diffusion-chamber cultures of normal human bone marrow cells. (1984) (4)
- Long-Term Outcomes after Vaccine-Induced Thrombotic Thrombocytopenia (2022) (4)
- Validation of a Frailty Score Predicting Survival of Elderly, Non-Fit AML Patients Receiving Hypomethylating Therapy: Results of the Decider Trial (2018) (4)
- RUNX1 Mutations in Acute Myeloid Leukemia (AML): Correlation with Distinct Cytogenetic Subgroups and Clinical Outcome. Results of the AML Study Group (AMLSG) (2008) (4)
- Treatment of renal cell carcinoma (2006) (4)
- Persistent aplasia after chemotherapy for acute myeloid leukaemia treated with stem cell transplantation from a matched unrelated donor after dose‐reduced conditioning (2002) (4)
- Key Data Elements in Myeloid Leukemia (2016) (4)
- Successful stimulation of autologous bone marrow recovery by GM-CSF and IL-3 after an unrelated donor BMT for juvenile CML complicated by graft failure. (1991) (4)
- miR-125b regulates chemotaxis and survival of bone marrow derived granulocytes in vitro and in vivo (2018) (4)
- [Hematopoietic stem cell transplantation. Indications, foundations and perspective]. (2009) (4)
- Late Consolidation for Patients with Standard Risk AML up to 60 Years: Results of a Prospective Randomized Comparison of High Dose AraC and Autologous PBSCT. (2004) (4)
- Explaining survival differences between two consecutive studies with allogeneic stem cell transplantation in patients with chronic myeloid leukemia (2014) (4)
- 1255 CHRONIC HEPATITIS E IN IMMUNOSUPPRESSED PATIENTS BEYOND LIVER- AND KIDNEY TRANSPLANTATION (2011) (4)
- Monitoring of FLT3 Phosphorylation and FLT3 Ligand Levels in Patients with FLT3-ITD Mutated Acute Myeloid Leukemia (AML) Treated with Midostaurin within the AMLSG 16-10 Trial of the German-Austrian Study Group (2018) (3)
- MN1 is indispensable for MLL-rearranged acute myeloid leukemia. (2019) (3)
- ZRSR2 Mutations Cause Dysregulated RNA Splicing in MDS (2014) (3)
- Post Transplantation Measurable Residual Disease (MRD) Monitoring Using Next-Generation Sequencing Is Highly Predictive for Relapseafter Allogeneic Stem Cell Transplantation (2019) (3)
- Genitourinary tumors, prostate (2012) (3)
- Personally Tailored Risk Prediction of AML Based on Comprehensive Genomic and Clinical Data (2015) (3)
- [Effect of tumor necrosis factor on human hematopoietic precursor cells]. (1989) (3)
- Continued Treatment with An Outpatient Maintenance Schedule of Decitabine in Older AML Patients Ineligible for Induction Chemotherapy: Results of the 00331 Phase II Multicenter Trial (2008) (3)
- Pharmacodynamic Monitoring of the Efficacy of a Targeted Therapy with Midostaurin By Plasma Inhibitor Activity (PIA) Analysis in FLT3 -ITD Positive AML Patients within the AMLSG 16-10 Trial: A Study of the AML Study Group (AMLSG) (2015) (3)
- Aggressive chemotherapy combined with G-CSF and maintenance therapy with interleukin-2 for patients with advanced myelodysplastic syndrome, subacute or secondary acute myeloid leukemia — initial results (1993) (3)
- CD19-Targeted Immunotherapy Attenuates Vessel Wall Inflammation. (2021) (3)
- Genomic landscape of patients with FLT3-mutated acute myeloid leukemia (AML) treated within the CALGB 10603/RATIFY trial (2022) (3)
- Frequency and Prognostic Impact of NUP98/NSD1 Translocations in Adult AML and MDS Patients (2012) (3)
- Prognostic Impact of Mutant to Wild-Type Ratio and Insertion Site in Acute Myeloid Leukemia with FLT3 Internal Tandem Duplication (2012) (3)
- Prioritisation in Haemophilia A: A Qualitative Study of Stakeholder Attitudes and Preferences (2012) (3)
- Case report Immune thyroiditis after transplantation of allogeneic CD34 1 selected peripheral blood cells (1997) (3)
- The Polycistronic miRNA Cluster miR-17-92 Is Over-Expressed in Early Phase Chronic Myeloid Leukemia (CML) CD34+ Cells. (2006) (3)
- Comparison between molecularly defined and conventional therapeutics in a conditional BCR-ABL cell culture model. (2007) (3)
- Monitoring of Minimal Residual Disease in NPM1 Mutated Acute Myeloid Leukemia (AML): Results of the AML Study Group (AMLSG) (2008) (3)
- The transplant cohort of the German center for infection research (DZIF Tx-Cohort): study design and baseline characteristics (2021) (3)
- Myelodysplastic Syndromes (1998) (3)
- Evaluation of six different types of sequential conditioning regimens for allogeneic stem cell transplantation in relapsed/refractory acute myelogenous leukemia – a study of the Acute Leukemia Working Party of the EBMT (2020) (3)
- Analysis of the nuclear distribution of the translocation t(8;21)-derived fusion protein AML1/ETO by confocal laser scanning microscopy. (2002) (3)
- Extramedullary Acute Leukemias prior to and after Allogeneic Hematopoietic Stem Cell Transplantation: a Single Center Study. (2008) (3)
- Effect of recombinant human granulocyte-macrophage colony-stimulating factor on the hemopoietic progenitor cells from patients with AIDS. (1988) (3)
- [47-year-old patient with pulmonary hypertension, anemia and thrombocytopenia]. (1995) (3)
- Adaptive NK cells undergo a dynamic modulation in response to human cytomegalovirus and recruit T cells in in vitro migration assays (2022) (3)
- Stable depletion of RUNX1-ETO in Kasumi-1 cells induces expression and enhanced proteolytic activity of Cathepsin G and Neutrophil Elastase (2019) (3)
- Low-Dose Decitabine Vs Best Supportive Care In Older Patients With AML and Low Blast Counts: Results Of a Subgroup Analysis Of The Randomized Phase III Study 06011 Of The EORTC Leukemia Cooperative Group and German MDS Study Group (2013) (3)
- A unique role of p53 haploinsufficiency or loss in the development of acute myeloid leukemia with FLT3-ITD mutation (2021) (3)
- Pharmacodynamic Analysis Of The Inhibitory Potency Of The Tyrosine Kinase Inhibitor Midostaurin In Combination With Intensive Chemotherapy Including Allogeneic Hematopoietic Stem Cell Transplantation Followed By Maintenance Therapy In FLT3-ITD Positive Acute Myeloid Leukemia In The Ongoing AMLSG 16- (2013) (3)
- Hemostatic Alterations in Patients Undergoing Hematopoietic Stem Cell Transplantation. (2004) (3)
- Detection of chronic systemic candida infection in leukaemia patients with febrile neutropenia: value of computer‐assisted serial ultrasound documentation (1998) (3)
- Antigen-recognition sites of micromanipulated T cells in patients with acquired aplastic anemia. (2005) (3)
- Low-Dose Decitabine (DAC), Alone or in Combination with All-Trans Retinoic Acid (ATRA), Is An Active First-Line Treatment in Older AML Patients of All Cytogenetic Risk Groups: Final Results of the FR00331 Multicenter Phase II Study. (2009) (3)
- Myelodysplastic syndromes: a guide to treatment with epoetin and colony-stimulating factors. (1998) (3)
- Retrospective Comparison between 12-Gray and 8-Gray Total Body Irradiation (TBI) before Allogeneic Hematopoietic Cell Transplantation in Patients with Acute Lymphoblastic Leukemia in First Complete Remission (2021) (3)
- Higher Dose of CPX-351 Is Associated with Prolonged Hematologic Recovery: Results from an Interim Safety Analysis of the Randomized, Phase III AMLSG 30-18 Trial (2020) (3)
- Long-Term Effects of Deferasirox (Exjade®, ICL670) on Serum Ferritin: Outcome of Dose Adjustments in Achieving Maintenance or Reduction in Body Iron Stores. (2006) (3)
- Ratify (Alliance 10603): Prognostic Impact of FLT3 tyrosine Kinase Domain (TKD) and NPM1 Mutation Status in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) Treated with Midostaurin or Placebo Plus Standard Chemotherapy (2018) (3)
- Effect of sequential treatment with interleukin 3 (rhIL‐3) and granulocyte‐macrophage colony stimulating factor (rhGM‐CSF) on circulating CFU‐GM (1992) (3)
- Quantification of transforming capacity and cooperation of defined genetic alterations in myeloid malignancies. (2010) (3)
- Identification of Clinically Relevant Predictive MRD Checkpoints in AML Patients with NPM1 Mutations: A Study of the AML Study Group (AMLSG). (2009) (3)
- ASXL1 Mutations Predict for Resistance to Chemotherapy and Inferior Outcome in Younger Adult Patients with Acute Myeloid Leukemia (AML): A Study of the German-Austrian AMLSG (2011) (3)
- Cytokine control of human megakaryocytopoiesis. (1990) (3)
- Risk groups in adult acute lymphoblastic leukemia. (1987) (3)
- Amplified EPOR/JAK2 Genes Define a Unique Subtype of Acute Erythroid Leukemia (2022) (3)
- Impact of patient: donor HLA disparity on reduced-intensity-conditioned allogeneic stem cell transplants from HLA mismatched unrelated donors for AML: from the ALWP of the EBMT (2020) (3)
- Impact of complete surgical resection on outcome in aggressive non‐Hodgkin lymphoma treated with immunochemotherapy (2020) (3)
- The EBMT Score Predicts Transplant Related Mortality and Overall Survival after Allogeneic Stem Cell Transplantation for Myelodysplastic Syndromes (2015) (3)
- Acute Myeloid Leukemia (AML) with 9q Aberrations Occuring within a Non-Complex Karyotype Is Highly Associated with CEBPA and NPM1 Mutations - A Joint Analysis of the German-Austrian AML Study Group (AMLSG) and Cancer and Leukemia Group B (CALGB). (2007) (3)
- Deregulated Expression of EVI1 Defines a Poor Prognostic Subset of MLL-Rearranged Acute Myeloid Leukemias (2011) (3)
- Improving survival in metastatic renal cell carcinoma (mRCC) patients: do elderly patients benefit from expanded targeted therapeutic options? (2022) (2)
- Correction: Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients (2020) (2)
- Long Term Remission in Follicular Lymphoma (FL) and Mantle Cell Lymphoma (MCL) with Rituximab Consolidation after High-Dose Chemotherapy and Autologous Stem Cell Transplantation: Extended Follow-Up of a Multicenter Phase II Study. (2005) (2)
- Gamma delta-T cell-receptor-positive lymphocytes inhibit human hematopoietic progenitor cell growth in HIV type 1-infected patients. (1996) (2)
- Analysis of the ETS Family Member Genes ERG, ETS2, ETS1 and FLI1 in Acute Myeloid Leukemia (AML) Patients with Normal Cytogenetics: Expression Levels and Impact On Clinical Outcome. A Study of the AMLSG. (2009) (2)
- Novel Molecular Pathogenesis and Therapeutic Target in Acute Erythroid Leukemia (2019) (2)
- Outcomes and toxicity of allogeneic hematopoietic cell transplantation in chronic myeloid leukemia patients previously treated with second-generation tyrosine kinase inhibitors: a prospective non-interventional study from the Chronic Malignancy Working Party of the EBMT (2021) (2)
- Long-term complete remissions in patients with low-risk myelodysplastic syndromes during combination treatment using all-trans retinoic acid (1998) (2)
- Fluorescence in situ Hybridization and Surface Markers of Fine Needle Aspiration Specimen Confirm Extramedullary Myelobastoma in a Patient with Chronic Myeloid Leukemia (1998) (2)
- Specific MiRNA Silencing by Lentivirus Mediated Antagomir Expression in Chronic Myeloid Leukemia (CML) Cells. (2007) (2)
- Reply to I.H.I.M. Hollink et al (2010) (2)
- P-211 Splicing gene mutations in MDS and secondary AML: Clinical implications in the setting of allogeneic hematopoietic stem cell transplantation (2013) (2)
- Haploidentical Transplantation Using High Dose Post-Transplant Cyclophosphamide for Patients with Aplastic Anemia : The European Group for Blood and Marrow Transplantation Experience (2018) (2)
- High-Dose Therapy and Autologous Stem Cell Transplantation for Extra-Nodal NK/T Lymphoma in Western Patients; A Study From the European Group for Blood and Marrow Transplantation (EBMT). (2012) (2)
- Randomized Phase II Study of All-Trans Retinoic Acid and Valproic Acid Added to Decitabine in Newly Diagnosed Elderly AML Patients (DECIDER trial): Predictive Impact of TP53 Status (2021) (2)
- Comparable Outcome after Allogeneic Hematopoietic Cell Transplantation from Matched Unrelated and Sibling Donors in Elderly Patients with Acute Myeloid Leukemia - Results of a Retrospective Analysis in 368 Patients. (2007) (2)
- [Multilocular Castleman's Disease of the mixed type. An rare differential diagnosis in lymphadenopathy with weakness, weight loss and night-sweats]. (2001) (2)
- Treatment with tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma is associated with drug-induced hyperparathyroidism: a single center experience in 59 patients (2010) (2)
- TCR Diversity Is a Predictive Marker for Donor Lymphocyte Infusion Response (2016) (2)
- The Multicentre, Double-Blinded, Placebo-Controlled Clinical-Trial (Pre-GvHD) for Prediction and Pre-Emptive Treatment of Acute GvHD (2017) (2)
- Secondary AML After a History of Myelodysplastic Syndrome Is An Independent Adverse Prognostic Factor for Achievement of Complete Remission, Relapse-Free and Overall Survival. An Analysis of 2,819 Adult Patients with Newly Diagnosed AML Enrolled On Seven AMLSG Treatment Trials. (2009) (2)
- DNMT3A mutations Predict for Inferior Outcome in NPM1-Wildtype and Molecular Unfavorable Cytogenetically-Normal Acute Myeloid Leukemia: A Study of the German-Austrian AMLSG (2011) (2)
- Histopathologie der Graft-versus-Host-Erkrankung (2011) (2)
- T helper Type 2 Differentiation is Associated with Induction of Antibacterial Defense Mechanisms in Blood Lymphocytes of Patients with Sarcoidosis (2009) (2)
- `Personalised Medicine': Multidisciplinary Perspectives and Interdisciplinary Recommendations on a Framework for Future Research and Practice (2015) (2)
- Outcomes In RBC Transfusion-Dependent Patients (Pts) With Low-/Intermediate (Int)-1-Risk Myelodysplastic Syndromes (MDS) With Isolated Deletion 5q Treated With Lenalidomide (LEN): A Subset Analysis From The MDS-004 Study (2013) (2)
- Therapeutic value of interleukin-3 given alone or in combination with other cytokines. (1993) (2)
- Lineage-Specific Regulation of miRNA-Expression by the BCR-ABL Oncogene. (2008) (2)
- Finally progress in the understanding of myelodysplastic syndromes? (1999) (2)
- Midostaurin Plus Intensive Chemotherapy for Younger and Older Patients with Acute Myeloid Leukemia and FLT3 Internal Tandem Duplications (2021) (2)
- Impact of Pegfilgrastim on Hematological Reconstitution and Incidence of Neutropenic Fever after Consolidation Therapy with High-Dose Cytarabine in Acute Myeloid Leukemia: Comparative Analysis between AMLSG 07-04 and the German AML Intergroup Trial. (2006) (2)
- Comparison of long-term outcome for AML patients alive free of disease 2 years after allogeneic hematopoietic cell transplantation with umbilical cord blood versus unrelated donor: a study from the ALWP of the EBMT (2021) (2)
- Prognostic significance of free testosterone levels during chemotherapy with carboplatin plus docetaxel (CD) in metastatic castration- and docetaxel-resistant prostate cancer (mDRPC). (2016) (2)
- Genotype-Phenotype Relationships and Therapeutic Targets in Acute Erythroid Leukemia (2020) (2)
- Prognostic Impact Of a Newly Defined Structurally Complex Karyotype In Patients With AML and MDS After Allogeneic Stem Cell Transplantation (2013) (2)
- The E3 Ligase Itch Is a Regulator of Bone Marrow Mesenchymal Stem Cells and the Hematopoietic Stem Cell Niche (2017) (2)
- All-Trans Retinoic Acid and Gemtuzumab Ozogamicin as Adjunct To Salvage Therapy in Primary Refractory Acute Myeloid Leukemia: Results of Consecutive Phase II Studies of the AMLSG. (2005) (2)
- Lower Relapse Incidence and Relapse Mortality in Patients Transplanted from a Younger Sibling in HLA-Identical Stem Cell Transplantation: Does Microchimerism Matter? (2008) (2)
- Reply to S. Masuda (2011) (2)
- FLT3-ITD and Age Are the Major Prognostic Factors In Relapsed AML with Normal Karyotype (2010) (2)
- Gemtuzumab Ozogamicin Plus Intensive Chemotherapy for Patients with NPM1-Mutated Acute Myeloid Leukemia (2022) (2)
- Interleukin-3 and granulocyte-macrophage colony-stimulating factor in combination: clinical implication. (1992) (2)
- Deletion or Inhibition of Fc Gamma Receptor IIb (CD32) Prevents the Memory B Cell Response to Factor VIII in a Hemophilia A Mouse Model (2011) (2)
- Phase I/II study on cytarabine and idarubicin combined with escalating doses of clofarabine in newly diagnosed patients with acute myeloid leukaemia and high risk for induction failure (AMLSG 17‐10 CIARA trial) (2018) (2)
- Next-Generation Sequencing (NGS)-Based Measurable Residual Disease (MRD) Monitoring in Acute Myeloid Leukemia with FLT3 Internal Tandem Duplication (FLT3-ITD+ AML) Treated with Additional Midostaurin (2020) (2)
- [Acute lymphatic leukemia in the adult. Diagnosis, risk groups and therapy]. (2002) (2)
- gene rearrangement clonality suggested by analysis of surface markers and immunoglobulin Acute undifferentiated leukemia: implications for cellular origin and (2011) (2)
- Evolution of severe (transfusion‐dependent) anaemia in myelodysplastic syndromes with 5q deletion is characterized by a macrophage‐associated failure of the eythropoietic niche (2022) (2)
- [Bone marrow transplantation. Indications, chances and perspectives]. (2004) (2)
- Carboplatin plus weekly docetaxel as salvage chemotherapy in docetaxel-resistant and castration-resistant prostate cancer (DRPC). (2010) (2)
- Elevated plasma levels of interleukin-1 receptor antagonist are associated with decreased cellular BCL-2 oncoprotein expression in B-chronic lymphocytic leukemia. (1998) (2)
- Outcome of Third Salvage Autologous Stem Cell Transplantation in Multiple Myeloma (2016) (2)
- Complete cytogenetic remission after decitabine treatment in a patient with secondary AML harbouring high p15INK4b gene methylation and high global DNA methylation (2009) (2)
- Clinical Impact of TERT A1062T Mutations in Younger Patients with Acute Myeloblastic Leukemia (2012) (2)
- Supportive care in cancer patients : recent developments (1999) (2)
- All-Trans Retinoic Acid and Gemtuzumab Ozogamicin as Adjunct to High-Dose Cytarabine-Based Salvage Therapy in Primary Refractory Acute Myeloid Leukemia: Results of AMLSG 05-04 Trial. (2007) (2)
- Erythropoietin plasma levels are elevated in chronic liver disease and correlate with anemia, liver dysfunction, bleeding episodes and interleukin-6 (2002) (2)
- Cross-trial networking in AML: a step forward rather than corner cutting. (2004) (2)
- Targeted Inhibition of the NUP98-NSD1 Fusion Oncogene in AML (2019) (2)
- Prognostic Effect of ASXL1 Mutations in Patients with MDS and Secondary AML Following MDS After Allogeneic Hematopoietic Stem Cell Transplantation (2011) (2)
- Interleukin-3 in the treatment of myelodysplastic syndromes (1992) (2)
- Clinical Relevance of Minimal Residual Disease Monitoring in NPM1 Mutated AML: A Study of the AML Study Group (AMLSG) (2015) (2)
- Clinical significance of mitochondrial DNA content in acute promyelocytic leukaemia (2021) (2)
- Haploinsufficiency of ETV6 and CDKN1B in patients with acute myeloid leukemia and complex karyotype (2014) (2)
- A new technical approach for the ultrastructural analysis of hematopoietic cells using cell monolayers adherent to electron-transparent melamine resins. (1993) (2)
- Shift to a New Donor Does Not Improve the Outcome After Second Allogeneic Stem Cell Transplantation (alloSCT) in Acute Leukemia Relapse After a First Allosct – a Risk Factor Analysis by the German Stem Cell Registry (DRST). (2009) (2)
- The Metabolite R-2-Hydroxyglutarate (R2HG) Collaborates with HoxA9 to Induce Monocytic Leukemia (2014) (2)
- Priming with Granulocyte-Colony Stimulating Factor Did Not Improve Outcome in a Randomized Study of Elderly Acute Myeloid Leukemia but Increased Induction Mortality. (2006) (2)
- Inferior Outcome of Allogeneic Stem Cell Transplantation in First Complete Remission for Secondary AML As Compared to De Novo Disease: Results from a Retrospective, Registry-Based Analysis on Behalf of the Acute Leukemia Working Party of the EBMT (2018) (2)
- Going from genes to proteins in myelodysplastic syndromes (2007) (2)
- Loss of hematopoietic progenitor cells CFU-GEMM, BFU-E, CFU-Mk, and CFU-GM in the acquired immunodeficiency syndrome (AIDS)? (1987) (2)
- S1616 MEASURABLE RESIDUAL DISEASE MONITORING IN ACUTE MYELOID LEUKEMIA (AML) WITH T(8;21)(Q22;Q22.1); RUNX1-RUNX1T1: RESULTS OF THE AML STUDY GROUP (AMLSG) (2019) (2)
- Adenosine stress perfusion cardiac magnetic resonance imaging in patients undergoing intracoronary bone marrow cell transfer after ST-elevation myocardial infarction: the BOOST-2 perfusion substudy (2019) (2)
- [Therapy of multiple myeloma: indications and options]. (2007) (2)
- Effect of stimulation by interferonγ and tumor necrosis factorα on CD54 expression and homotypic aggregation of blasts of acute lymphoblastic leukemias (1998) (2)
- Progression-free survival (PFS) of first-line VEGF-targeted therapy as a prognostic parameter for overall survival (OS) in patients with metastatic renal cell carcinoma (mRCC). (2011) (2)
- Gvhd and Relapse Free Survival (GRFS) after Allogeneic Transplantation for Idiopathic Severe Aplastic Anemia: An Analysis from the Saawp Data Quality Initiative Program of EBMT (2020) (1)
- Acral Necrosis after Inadequate Excessive Administration of Bleomycin in a Testicular Cancer Patient (2004) (1)
- Prognostic Impact of Clonal Hierarchy of Myelodysplasia-Related Gene Mutations in AML Patients (2022) (1)
- TIBO R82913, a new HIV-1 inhibiting agent, does not inhibit hematopoietic progenitor cells. (1991) (1)
- Endothelial Microparticles Improve Primary and Secondary Hemostasis in Patients with Von-Willebrand Disease (2011) (1)
- Immunosuppressive treatment strategies in low-risk MDS (2007) (1)
- The Impact of Therapy-Related and Secondary AML in Relation to Karyotype and Molecular Markers: A Study of the AMLSG. (2007) (1)
- Prognosis of Adult Patients ≤60 Years with AML and Aberrations of Chromosome 11q23: Pooled Data Analysis of the German AML-Intergroup. (2006) (1)
- In CML, Marrow Fibrosis Relapses or Emerges in 5 - 6 % of Patients Per Year Independently Indicating Imatinib Failure and Shortened Survival Time of Patients. (2006) (1)
- Cumulative dosages of chemotherapy and radiotherapy exposure, and risk of secondary malignancies after allogeneic hematopoietic stem cell transplantation (2018) (1)
- Prognosis of Adult Patients ≤60 Years with AML and Aberrations of Chromosome 11q23: Pooled Data Analysis of the AML-SG and SHG-Dresden Study Groups. (2005) (1)
- Virus-Associated Hemophagocytic Syndrome Contributes to Fatal Outcome In Critical Ill Patients with 2009 Influenza A (H1N1) Infection. (2010) (1)
- Molecular Characterization of Relapsed Core-Binding Factor (CBF) Acute Myeloid Leukemia (AML) (2015) (1)
- Clinical Use of Interleukin-3 in Hematology (1999) (1)
- Proteomics for hematopoietic stem cell transplantation (2020) (1)
- Post-transplant complications Increased risk of complicated CMV infection with the use of mycophenolate mofetil in allogeneic stem cell transplantation (2002) (1)
- Assessment of Clonal Evolution in 42 AML with NPM1 Mutations by Molecular Characterization of Paired Diagnosis and Relapse Samples (2011) (1)
- RT-PCR for the Diagnosis of Acute Myeloblastic Leukemia with Inv(16) and Detection of Minimal Residual Disease (1998) (1)
- Priming with Granulocyte Colony-Stimulating Factor (G-CSF) Has No Impact on Treatment Outcome but Impairs Mobilization of Peripheral Blood Stem Cells (PBSC) in Elderly Patients with Acute Myeloid Leukemia: Results of a Randomized Oligocenter Trial. (2004) (1)
- [Transplantation of hematopoietic stem cells]. (1996) (1)
- Effective Treatment of Human CML By RNAi In Vivo in a Xenotransplantation Mouse Model (2015) (1)
- Allogeneic, CD34 +, Umbilical Cordblood-Derived NK Cell Adoptive Immunotherapy for the Treatment of Acute Myeloid Leukemia Patients with Measurable Residual Disease (2021) (1)
- Updated definition of cure in adult patients with non-APL acute myeloid leukemia (2015) (1)
- Impact of PPM1D mutations in patients with myelodysplastic syndrome and deletion of chromosome 5q (2021) (1)
- Plateletpheresis does not lead to a lasting increase in serum thrombopoiesis growth factor levels (1999) (1)
- Frequency and Clinical Characteristics Associated with Putative CAR Targets ADGRE2, CCR1, CD70, and LILRB2 in Acute Myeloid Leukemia (2018) (1)
- Predicting death in patients with acute graft-versus-host disease after reduced-intensity conditioning. (2017) (1)
- Plateletpheresis does not lead to a lasting increase in serum thrombopoiesis growth factor levels (1999) (1)
- Navigating preemptive and therapeutic donor lymphocyte infusions in advanced myeloid malignancies by high-sensitivity chimerism analysis (2022) (1)
- Fluorescence in situ hybridization and surface markers of fine needle aspiration specimen confirm extramedullary myeloblastoma in a patient with chronic myeloid leukemia. (1998) (1)
- Treatment of Minimal Residual Disease in Adult ALL: The German National Study (1986) (1)
- 174 Intensive chemotherapy (idarubicin, ARA-C, VP-16) combined with G-CSF-priming yields high remission rates in patients with advanced MDS and high-risk AML (1997) (1)
- Immunosuppressive therapy for myelodysplastic syndromes. (2012) (1)
- Anti-BK Virus Activity of Ciprofloxacin and Related Antibiotics (2005) (1)
- 358 Inhibitors of the Ras/Raf/MAPK signaling pathway sensitize pancreatic cancer cells resistant to EGFR inhibitors (2004) (1)
- Effect of stimulation by interferon gamma and tumor necrosis factor alpha on CD54 expression and homotypic aggregation of blasts of acute lymphoblastic leukemias. (1998) (1)
- Evaluation of a Device for Negative Selection of CD34+ Cells Alone or in Combination with Breast Cancer Tumor Cell Purging (2001) (1)
- Impact of ASXL1 Mutations On Outcome After Reduced Intensity Allograft in Patients with Myelofibrosis (2012) (1)
- [Clinical research within the German competence net "acute and chronic leukemias"]. (2006) (1)
- An EBMT Prospective Non-Interventional Study of Outcomes and Toxicity of Allogeneic Stem Cell Transplantation in Chronic Myeloid Leukemia Patients Previously Treated with Second Generation Tyrosine Kinase Inhibitors (2016) (1)
- EPOR/JAK/STAT Signaling Pathway As Therapeutic Target of Acute Erythroid Leukemia (2021) (1)
- Allogeneic hematopoietic cell transplantation (allo-HCT) outcomes in myeloma patients on renal replacement therapy: a report from the Chronic Malignancy Working Party (CMWP) of the European Society of Blood and Marrow Transplantation (EBMT) (2020) (1)
- Histiocytic sarcoma progressing from follicular lymphoma and mimicking acquired hemophagocytic lymphohistiocytosis (2020) (1)
- Safety, feasibility and therapeutic activity of intrapleural autologous lymphocyte conditioned medium followed by systemic recombinant interleukin-2 and interferon-alpha in a patient with malignant pleural mesothelioma. (1997) (1)
- Prospective Evaluation of Graft-Versus-Host Disease-Specific Proteomics Pattern in Patients after Allogeneic Stem Cell Transplantation. (2005) (1)
- Myeloablative Versus Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation for Secondary Acute Myeloid Leukemia in Patients with Prior Myelodysplastic Syndrome/ Myeloproliferative Disorders: An ALWP of EBMT Study (2017) (1)
- Outcome of second-line chemotherapy with a combination of docetaxel and carboplatin (DC) in docetaxel-resistant (DR) hormone refractory prostate cancer (HRPC) patients (2008) (1)
- Function of STAT5 Isoforms in Bcr-Abl Positive Cells (2011) (1)
- Treatment of myelodysplastic syndromes. (2005) (1)
- Effectiveness of abiraterone as salvage therapy in patients with docetaxel- and castration-resistant prostate cancer (mDCPC) that progressed during second-line chemotherapy with carboplatin plus weekly docetaxel (DC). (2013) (1)
- Important aspects of cost-effectiveness analysis in febrile neutropenia. (1999) (1)
- Paroxysmal nocturnal hemoglobinuria (2002) (1)
- [Intravascular lymphoma: two case reports demonstrating the heterogeneity of the disease]. (2009) (1)
- Urinary proteomic peptide profiling allows preemptive diagnosis of acute graft-versus-host-disease after allogeneic stem cell transplantation (2013) (1)
- In Acute Myeloid Leukemia with Complex Karyotype TP53 Alterations Are Associated with Specific Genomic Aberrations and Predict Inferior Survival. (2009) (1)
- Recombinant human interleukin-3 in patients with hematopoietic failure. (1991) (1)
- Accurate quantification of chromosomal lesions via short tandem repeat analysis using minimal amounts of DNA (2017) (1)
- Acquired long QT syndrome during conditioning for allogeneic stem cell transplantation—are we aware of this side effect? (2018) (1)
- Prospective Randomized Comparison of High Dose AraC and Autologous Peripheral Blood Stem Cell Transplantation as Late Consolidation for Patients ≤60 Years with Standard Risk AML. (2005) (1)
- Effect of Interleukin-3 on Human Hematopoietic Progenitor and Precursor Cells in Patients with Myelodysplastic Syndromes (1992) (1)
- Prognostic Factors in Patients Receiving An Allogeneic Stem Cell Transplantation for Relapsed AML. Results of the Prospective AML 295 and 01/99 Studies (2008) (1)
- The Farnesyltransferase Inhibitor (FTI) L-778,123 Displays Promising Anti-Leukemia Activity (2008) (1)
- Phase I/II trial of lenalidomide, methotrexate, leucovorin, cytarabine, and rituximab (LeMLAR) in relapsed or refractory diffuse large B cell lymphoma (2021) (1)
- Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34 (cid:1) cells (2007) (1)
- THE EFFICACY OF IBRUTINIB IN PATIENTS WITH RELAPSED MANTLE CELL LYMPHOMA AFTER FIRST LINE INTENSIVE CHEMO‐IMMUNOTHERAPY AND ASCT – A RETROSPECTIVE STUDY FROM THE LWP‐EBMT (2019) (1)
- MN1 Inhibits Myeloid Differentiation by Transcriptional Repression of EGR2 (2010) (1)
- High-Throughput Drug Screening Identifies Pyrimethamine As a Potent and Selective Inhibitor of Acute Myeloid Leukemia (2014) (1)
- A multicenter phase II trial of Decitabine as first-line treatment of older patients with acute myeloid leukemia judged unfit for induction chemotherapy Running head: First-line DAC for older AML patients unfit for induction (2011) (1)
- Priming reloaded? (2009) (1)
- Functional analysis of a single chain chimeric alpha/beta-granulocyte-macrophage colony-stimulating factor receptor. Importance of a glutamate residue in the transmembrane region. (1999) (1)
- Acquired Hemophilia Caused by Non-Hemophilic Factor VIII Gene Variants. (2004) (1)
- Author Correction: Cdkn1a deletion improves stem cell function and lifespan of mice with dysfunctional telomeres without accelerating cancer formation (2020) (1)
- YNK01, an Oral Cytosine Arabinoside Derivative in Acute Myeloid Leukemia and Chronic Myeloid Leukemia (1997) (1)
- Casein Kinase 1A1 (CSNK1A1) Is Recurrently Mutated in MDS Patients with Deletion of Chromosome 5q (2014) (1)
- Matched Pair Analysis of Cryopreserved Versus Fresh Allogeneic Peripheral Blood Stem Cell Transplantation (2011) (1)
- Valproic Acid Induces Cell Cycle Arrest and Differentiation of t(15;17) Positive Leukemic Cells Independent from ATRA Sensitivity and Has No Effect on CD34 pos Cells. (2005) (1)
- [Evaluation of 196 patients with chronic myeloid leukemia based on a standard prognosis model]. (1990) (1)
- Allogeneic Hematopoietic Stem Cell Transplantation for Secondary Acute Myeloid Leukemia- a Report from the Acute Leukemia Working Party of the EBMT (2015) (1)
- Comprehensive Molecular Profiling of FLT3-Mutated Acute Myeloid Leukemia (AML) Patients Treated within the Ratify Trial (Alliance C10603) (2018) (1)
- Induction Therapy with Idarubicin, Ara-C, and VP-16, Followed by G-CSF and Maintenance Immunotherapy with Interleukin-2 for High-Risk AML (1996) (1)
- Genetic Heterogeneity of t(8;21)(q22;q22.1) Acute Myeloid Leukemia Revealed By High-Throughput Targeted Sequencing (2017) (1)
- Active surveillance (AS) in the management of patients (pts) with metastatic renal cell carcinoma (mRCC). (2016) (1)
- Modified Hammerhead Ribozymes as Potential Therapeutics (1998) (1)
- P448: PROGNOSTIC IMPACT OF SOMATIC CEBPA BZIP DOMAIN MUTATIONS IN ACUTE MYELOID LEUKEMIA (2022) (1)
- Atypical Presentations of EBV Reactivation and EBV-Associated PTLD Post-HSCT: Implication for Routine EBV Surveillance after Allogeneic HSCT?. (2005) (1)
- Genetic changes of miR-182 G106A: rather a polymorphism than a somatic mutation (2011) (1)
- [The competence network "acute and chronic leukemias"]. (2004) (1)
- [Clinical research in the "acute and chronic leukemias"competence network ]. (2004) (1)
- Prospective Evaluation of Immunophenotype In Correlation to Genotype In Previously Untreated Adult Patients with Acute Myeloid Leukemia In the Context of the WHO Classification (2010) (1)
- Survival in metastatic renal cell carcinoma (mRCC) patients over two decades: Does age mater? (2020) (1)
- Immunoelectron microscopic analysis of CD 54 surface distribution and its role in homotypic interaction on normal monocytes and blasts of acute myeloid leukemia (2000) (1)
- In vitro differentiation of a null-acute leukemia: T-lymphoid surface antigen expression associated with rearrangement in T-cell receptor beta chain variable genes. (1987) (1)
- Expression of CD7 and CD15 on Leukemic Blasts Are Prognostic Parameters in Patients with Acute Myelocytic Leukemia — Irrelevance of CD34 (1996) (1)
- RAS, KIT and FLT3 Gene Mutations in inv(16)/t(16;16)-Positive Acute Myeloid Leukemia (AML): Incidence and Relevance on Clinical Outcome. (2006) (1)
- The Role of PPM1D Mutations in Lenalidomide Resistance and Progression in Patients with MDS and Deletion of Chromosome 5q (2018) (1)
- Prognostic Factors Identified Via a Cox Proportional Hazard Cure Model Explain Survival Differences After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Chronic Myeloid Leukemia (CML) Between Two Consecutive Patient Cohorts (2012) (1)
- Ibrutinib for Relapsed Mantle Cell Lymphoma after Standard First Line Therapy and ASCT Is Efficacious but Does Not Overcome the Impact of POD24 - a Retrospective Study from the LWP-EBMT (2019) (1)
- Induction of early myeloperoxidase in acute unclassified leukemia. (1987) (1)
- Functional and clinical characterization of the alternatively spliced isoform AML1-ETO9a in adult patients with translocation t(8;21)(q22;q22.1) acute myeloid leukemia (AML) (2019) (1)
- Prognostic Implication of Insertion of FLT3 Internal Tandem Duplication in the BETA-1-Sheet of the Tyrosine Kinase Domain-1 (2008) (1)
- An Alternative Multicolor Compensation Method for the Sample-Directed Immune Phenotyping of CD34+Cells via Flow Cytometry: A Technical Note (1998) (1)
- Incidence and Prognostic Relevance of ASXL2 Mutations in Adult CBF-AML with t(8;21)(q22;q22): A Study of the German-Austrian AML Study Group (AMLSG) (2015) (1)
- Modern trends in human leukemia V (1982) (1)
- Suramin treatment for AIDS [letter] (1985) (1)
- Activation of TRKA receptor elicits mastocytosis in mice and is involved in the development of resistance to KIT-targeted therapy (2017) (1)
- Allogeneic hematopoietic cell transplantation in patients with therapy-related myeloid neoplasm after breast cancer: a study of the Chronic Malignancies Working Party of the EBMT (2020) (1)
- Impact of in vivo T-cell depletion in patients with myelodysplastic syndromes undergoing allogeneic hematopoietic stem cell transplant: a registry study from the Chronic Malignancies Working Party of the EBMT (2022) (1)
- Prognostic Factors in Adult Patients up to 60 Years with AML and Translocations of Chromosome 11q23: Individual Patient Data Based Analysis of the German AML-Intergroup. (2007) (1)
- [Gastrointestinal complications in stem cell transplantation]. (1997) (1)
- Treatment of Patients with Myelodysplastic Syndromes with Recombinant Human Granulocyte/Macrophage Colony-Stimulating Factor: A Phase I/II Trial (1992) (1)
- Cytogenetic Studies in Acute Leukemia and in the Blast Phase of the Chronic Myelocytic Leukemia (1985) (1)
- Comparison of Matched-Sibling Donors Versus Unrelated Donors in Allogeneic Stem Cell Transplantation (allo-SCT) for Primary Refractory Acute Myeloid Leukemia (PRF AML): A Report of 1041 Patients from the Acute Leukemia Working Party of the EBMT (2015) (1)
- Application of a Short Tandem Repeat Based PCR Assay for Chronological Monitoring of Myelodysplastic Syndrome (MDS) Patients with Deletion of Chromosome 5q Following Lenalidomide Treatment (2015) (1)
- Prognostic Impact of Splicing Factor Mutations in Patients with Myelofibrosis Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (2014) (1)
- Healthy-like CD4+ Regulatory and CD4+ Conventional T-Cell Receptor Repertoires Predict Protection from GVHD Following Donor Lymphocyte Infusion (2022) (1)
- Isocitrate Dehydrogenase (IDH) 1 and 2 Mutation Is an Independent Predictor of Better Outcome in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Study of the ALWP of EBMT (2021) (1)
- Secondary AML Is an Independent Risk Factor for Outcome after SCT in First Complete Remission - a Registry-Based Comparison to De Novo AML on Behalf of the EBMT Acute Leukemia Working Party (2019) (1)
- Clonal Evolution in NPM1 Mutated Acute Myeloid Leukemia (AML) (2015) (1)
- Genetic Characterization Of Aplastic Anemia Patients By Targeted Sequencing (2013) (1)
- Presence of more than two rearranged immunoglobulin heavy-chain genes in adult precursor B-cell acute lymphoblastic leukemia (1992) (1)
- HSCT in severe congenital neutropenia. (2015) (0)
- NOD/SCID-repopulating cells derived CD34+ - Lentiviral gene transfer into peripheral blood (2013) (0)
- Proliferation-Inducing Effects of Recombinant Human Interleukin-7 and Interleukin-3 in B-Lineage Acute Lymphoblastic Leukemia (1992) (0)
- An Ex Vivo Perfusion Model To Study the Treatment of Thrombotic Microangiopathy during Pig-to-Human Xenogenic Kidney Transplantation. (2007) (0)
- High response to docetaxel (D)/carboplatin (C) based chemotherapy as salvage therapy in patients with docetaxel-resistant metastastic hormone-refractory prostate cancer (HRPC). (2009) (0)
- Drug-Response Signature Predicts Outcome in Adult Acute Myeloid Leukemia and Associates Poor Response with Molecular Characteristics of Hematopoietic Stem Cells. (2004) (0)
- Proteomic screening applied to the diagnosis of chronic graft-versus-host disease (2010) (0)
- Improvement in the Management of Cancer Patients: Digital Ultrasound Documentation (1998) (0)
- Salvage chemotherapy with carboplatin plus weekly docetaxel in patients (pts) with castration- and docetaxel-resistant prostate cancer (DRPC): Associations of patient and disease characteristics with overall survival (OS). (2014) (0)
- MN1 Expression Predicts Prognosis of Acute Myeloid Leukemia with Normal Cytogenetics. (2005) (0)
- Evaluation of Trends in Outcome over 2 Decades of Patients with Relapsed/Refractory Acute Myelogenous Leukemia Undergoing Allogeneic Stem Cell Transplantation from Unrelated Donors: An ALWP/EBMT Analysis (2022) (0)
- 119 UPDATE ON THE MULTICENTER MDS BIOREGISTRY PROJECT OF THE “KREBSHILFE-VERBUNDFORSCHUNGSPROJEKT MDS” OF THE GERMAN MDS STUDY GROUP (2015) (0)
- “Human Development Index” Correlates with Rates and Influences Outcome of Hematopoietic Stem Cell Transplantation for Patients with Acute Leukemia. (2009) (0)
- Age-related changes in serum concentrations of SHBG , testosterone , estrogens and IGF-I in men : results from cross-sectional investigation on healthy subjects and calculations from previously reported studies (2019) (0)
- Targeted anti-BCR-ABL+ ALL therapy may benefit the heart (2021) (0)
- DEK-NUP214 Acute Myeloid Leukemia Depends on CRM1 In Vivo (2022) (0)
- Stable Silencing of RUNX1/ETO Induces Expression of a Shortened PU.1 Variant in t(8;21) Kasumi Cells (2016) (0)
- P157 FLAMSA-RIC allogeneic transplantation yields superior results in myelodysplastic syndromes and secondary acute myelogenous leukemia (2007) (0)
- MRD Status Impact on Secondary Acute Myeloid Leukemia Outcomes after Allogeneic Hematopoietic Cell Transplantation. A Study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT) (2021) (0)
- Hematologic Recovery from Venetoclax-Containing Regimens in Relapsed/Refractory Acute Myeloid Leukemia Patients Depending on Prior Allogeneic Hematopoietic Cell Transplantation (2019) (0)
- hematopoietic progenitor cells (CFU-GEMM, CFU-Mk, BFU-E, and CFU-GM) recombinant interferon-alpha on chronic myelogenous leukemia Synergistic antiproliferative effect of recombinant interferon-gamma with (2013) (0)
- Treatment-Related AML Is An Independent Adverse Prognostic Factor for Relapse-Free and Overall Survival. An Analysis of 2,868 Adult Patients with Newly Diagnosed AML Enrolled On Seven AMLSG Treatment Trials. (2009) (0)
- 524. Immune-Monitoring of Mature Human T Cell Reconstitution in Humanized NRG Mice After Cord Blood Stem Cell Transplantation and Engineered Dendritic Cell Prime/Boost: TCR Polyclonality and No GvHD (2015) (0)
- vitro culture translocation expresses T lymphoid and myeloid surface antigens after in Human acute unclassified leukemia with a unique t(4;17) chromosomal (2011) (0)
- Isolation of Cytomegalovirus (CMV) Specific T-Cells from Sersopositve Donors: A Possible Tool for CMV-Prophylaxis. (2005) (0)
- Pembrolizumab Therapy Exacerbates EBV-Induced Infections and Tumors in a Long-Term Fully Humanized Mouse Model (2018) (0)
- patient with AIDS and B-cell lymphoma Establishment of two Epstein-Barr virus negative Burkitt cell lines from a (2011) (0)
- FLT3-ITD-Associated Accumulation of Dendritic Cell Precursors, Depletion of Mature Dendritic Cells and Abnormal Cytokine Production in Acute Myeloid Leukemia: Analyses At Diagnosis, Remission and Relapse (2011) (0)
- Investigation of Urine/Plasma Biomarkers to Predict Tolerance and Graft-Versus-Host Disease Post Allogeneic Stem Cell Transplantation. (2012) (0)
- Rapid and Reproducible Karyotyping with Nanopore Sequencing in AML Patients (2022) (0)
- Prognostic value of free testosterone (FT) levels during salvage chemotherapy with carboplatin plus weekly docetaxel in metastatic castration- and docetaxel-resistant prostate cancer (mDRPC). (2012) (0)
- Monocytes Induced to Differentiate Into Dendritic Cells After Overnight Transduction with Lentiviral Vectors Co-Expressing GM-CSF/ IL-4 and a Truncated Form of WT1: Preclinical Validation for Immunotherapy of High Risk Leukemia Patients After Allo-SCT (2011) (0)
- 737 Haemolysis or Activation of Coagulation: Differences in Patients with HeartMate II and HeartWare HVAD System (2012) (0)
- [Leukemia research in Germany: the Competence Network Acute and Chronic Leukemias]. (2016) (0)
- Gene Expression Analysis of Independent Data Sets Identifies HBG1 to Be Associated with Outcome in Cytogenetically Normal AML. (2009) (0)
- Effect of remobinant granulocyte-macrophage colony stimulating factor (GM-CSF) on leukopenia in AIDS (1991) (0)
- Thromboelastometry in Patients Receiving Platelet Transfusion after Chemotherapy. (2004) (0)
- Development of SMART-DC co-expressing truncated WT1 for stimulation and expansion of T cells against leukemia relapse (2009) (0)
- [Suramin therapy in patients with LAS/AIDS]. (1985) (0)
- Modulation of anthracycline-induced cytotoxicity by targeting the prenylated proteome in myeloid leukemia cells (2011) (0)
- Functional Screening for Pathways Regulating Chemoresistance and Sensitivity in Leukemia Stem Cells (2018) (0)
- P-313 Response and progression rate of patients with primary MDS and isolated del(5q), IPSS low/int1 under treatment with lenalidomide (2013) (0)
- Acknowledgement to Referees (2005) (0)
- Monocytes transduced with tricistronic lentiviral vectors in a closed bag system induce differentiation of loaded "SMART-DCs" for melanoma immunotherapy (2010) (0)
- A process for producing lentiviral particles (1999) (0)
- Increased late non-cardiac non-relapse mortality in patients with atrial fibrillation diagnosed during hospital stay for allogeneic stem cell transplantation. (2022) (0)
- Acute Myeloid Leukemia (AML): Prospective Comparison of Different Treatments with a Common Standard Treatment - A Study by the German AML Intergroup (2010) (0)
- Phase I-study of bendamustine-HCI in patients with solid tumors (1999) (0)
- German AML Intergroup (2004) (0)
- The Clinical and Prognostic Influence Of Mutations In The Cohesin Complex In Acute Myeloid Leukemia (2013) (0)
- In Vivo Kinetics of Early, Hypomethylating Agent-Induced Methylome and Transcriptome Changes in Primary AML Blasts: Random or Specific? (2018) (0)
- Mutated IDH1 Has 2-Hydroxyglutarate-Independent Functions in Leukemogenesis (2012) (0)
- Late onset of bone metastases as a prognostic parameter in metastatic renal cell cancer (mRCC): A single-center experience in 82 mRCC patients treated with sunitinib. (2014) (0)
- Axl, a therapeutic target in AML mediates stroma-induced chemoresistance (2013) (0)
- Prediction of response to RAD001 (everolimus) in patients with metastatic renal cell carcinoma. (2010) (0)
- Prolyl Hydroxylase 3 (Phd3) Is a Therapeutic Target in Isocitrate Dehydrogenase 1 (IDH1) Mutated Acute Myeloid Leukemia (2018) (0)
- P-175: Outcomes of autologous-allogeneic vs autologous tandem approach followed by thalidomide maintenance for transplant-eligible patients with newly diagnosed multiple myeloma: a prospective phase II-study (2021) (0)
- Acute Myelogenous Leukemia (Contemporary Hematology) (2008) (0)
- Cost-Effectiveness Analysis of Arsenic Trioxide in Combination with All-Trans Retinoic Acid in Acute Promyelocytic Leukemia with Pretreatment White Blood Counts <10G/L (2014) (0)
- Impact Of The Pretreatment Characteristics As Well As Cyto- and Molecular-Genetic Profile On Outcome After Relapse In Acute Myeloid Leukemia (2013) (0)
- Crystal structure of IDH1 R132H in complex with HMS101 (2019) (0)
- The Therapeutic Effect of Recombinant Human Cytokines (GM-CSF, Interleukin-3, Erythropoietin) in Patients with Myelodysplastic Syndromes (1992) (0)
- P956 Surveillance of nosocomial sepsis and identifcation of relevant risk factors in neutropenic haematology-oncology patients (2007) (0)
- Acute promyelocytic leukemia. (1994) (0)
- 15th Annual Meetings: Association for Oncology of the Upper Rhine (AOR) (1998) (0)
- NADH Dehydrogenase Subunit 4 (ND4) Mutations in Pediatric Acute Myeloid Leukemia (2012) (0)
- Graft Versus Leukemia With Little Graft Versus Host Disease? Long Term Follow-Up Of a Study Using Transduced Donor T-Cells For Donor Leukocyte Transfusion (2013) (0)
- 7053 POSTER Hormonal Impact of Second-line Salvage Chemotherapy With Carboplatin Plus Weekly Docetaxel in Patients With Castration and Docetaxel-resistant Prostate Cancer (2011) (0)
- Assessment of Treatment Effects By Measurable Residual Disease Monitoring in NPM1-Mutated AML Patients Randomized for Gemtuzumab-Ozogamicin (GO) within the AMLSG 09-09 Trial of the German-Austrian AML Study Group (AMLSG) (2018) (0)
- 9-cis-retinoic acid treatment for myelodysplasia [Abstract] (1998) (0)
- Overall Outcome of Relapsed Acute Lymphoblastic Leukemia Can Be Improved by Stem Cell Transplantation and Early Treatment in Stage of Molecular Relapse (2011) (0)
- [Erosion hemorrhage in a pancreatic pseudocyst as a cause of intermittent gastrointestinal hemorrhage]. (1981) (0)
- Prognostic Value Of Plasma Biomarkers Compared To Urinary Proteome Patterns (2013) (0)
- Marrow Fibrosis in Myelodysplastic Syndromes - Its Significance in the Context of the WHO Classification of Disease and the International Prognostic Scoring System. (2004) (0)
- Analysis of the Fibrinogen Genes of 40 Patients with Suspicion of Dys-, Hypo- or Afibrinogenemia (2002) (0)
- Assessment of the Genomic Landscape of Intermediate Risk Acute Myeloid Leukemia As Defined By 2010 ELN Risk Classification (2018) (0)
- [Current status of clinical indications for hematopoietic growth factors after chemo-/radiotherapy in gynecology]. (1997) (0)
- Chemotherapy with Idarubicin, Ara-C,VP-16, Amsacrine, Followed by G-CSF and Maintenance Immunotherapy with Interleukin-2 for Patients with High-Risk Acute Myeloid leukemia: a 3-Years Follow-Up (1998) (0)
- A database of naturally occurring human urinary peptides and proteins for use in clinical applications (2007) (0)
- The application of an integrated clinical, cytogenetic, and molecular risk stratification for acute myeloid leukemia patients using a central laboratory in a Brazilian multicentric study (2017) (0)
- Arsenic Trioxide Abrogate MN1 Mediated RA-Resistance in Acute Promyelocytic Leukemia (2019) (0)
- Acute leukemia. (1994) (0)
- Prognostic role of docetaxel-induced suppression of free testosterone serum levels in metastatic prostate cancer patients (2021) (0)
- Treatment of relapsed acute lymphoblastic leukemia (ALL): Improved results in GMALL studies but optimisation is an ongoing challenge (2011) (0)
- in 2853 adult patients with newly diagnosed AML The impact of therapy-related acute myeloid leukemia (AML) on outcome (2011) (0)
- Amsa/ARA-C Followed By TBI 4 Gy or High Dose Chemotherapy Conditioning Regimens in Primary Refractory AML - Significantly Worse Outcomes in Younger Patients Conditioned with 4 Gy TBI (2022) (0)
- Results of phase I/II trials with recombinant human interleukin-3. (1991) (0)
- Contents, Vol. 92, 1990 (1990) (0)
- Similar outcome of different treatment strategies in patients 16 to 60 years of age with acute myeloid leukemia (AML) (2008) (0)
- [Myeloproliferative syndromes]. (1996) (0)
- Hormonal impact of salvage chemotherapy with carboplatin plus weekly docetaxel in patients with castration- and docetaxel-resistant prostate cancer (DRPC). (2012) (0)
- 38: Prediction of acute graft versus host disease after allogeneic hematopoietic stem cell transplantation by a proteomic aGvHD-specific pattern (2007) (0)
- Prospective Randomized Comparison of High Dose AraC and AutoPBSCT as Late Consolidation for Patients ≤60 Years with Standard Risk AML: Final Results of the AML SHG-Hannover 01/99 Trial. (2006) (0)
- RT-PCR for the Detection of Minimal Residual Disease in Acute Myeloblastic Leukemia with t(8;21) and t(15;17) (1998) (0)
- Effect of PEG-rHu MGDF in the induction treatment of acute myeloid leukemia (1997) (0)
- Induction of soluble IL-2 receptor in patients with myelodysplastic syndromes undergoing high-dose interleukin-3 treatment (1994) (0)
- Organ Complications after CD19 CAR T-Cell Therapy for Large B Cell Lymphoma. a Retrospective Study from the EBMT Transplant Complications and Lymphoma Working Partys (2022) (0)
- [Current status of the clinical application of hematopoietic growth factors in oncology]. (1996) (0)
- Correction: Trends in outcome of transplantation in patients with secondary acute myeloid leukemia: an analysis from the Acute Leukemia Working Party (ALWP) of the EBMT (2022) (0)
- High rate of recurrent thromboembolic complications in patients with inflammatory bowel disease (2001) (0)
- A STUDY ON THE CLINICAL SIGNIFICANCE OF THE WHO AML SUBTYPE INV(3)(Q21Q26.2)/T(3;3)(Q21;Q26.2) AND VARIOUS OTHER 3Q CHROMOSOMAL ABNORMALITIES IN 6,819 AML CASES (2010) (0)
- Clonal Relapse Dynamics in Acute Myeloid Leukemia Following Allogeneic Hematopoietic Cell Transplantation (2021) (0)
- Slit-Robo Pathway Is Clinically Relevant and May Represent a Potential Target in Acute Promyelocytic Leukemia (2018) (0)
- Next Generation Sequencing for Minimal Residual Disease Monitoring in AML Patients with FLT3-ITD, (2011) (0)
- Long Term Results of Allogeneic Hematopoietic Cell Transplantation in Elderly Patients. (2009) (0)
- Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia with Hyperdiploid Complex Karyotype: A Study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT) (2021) (0)
- In Vitro and In Vivo Regulation of Erythropoiesis (1989) (0)
- Inhibition of spontaneous apoptotic cell death of B-chronlc lymphocytic leukemia (B-CLL) cells by interleukin-12 in vitro (1997) (0)
- Comparison of Transplant Outcomes in Patients with Acute Lymphoblastic Leukemia after Haploidentical Transplant with Post-Transplant Cyclophosphamide or Matched Unrelated Donor Transplant (2020) (0)
- Reduced 8-Gray Compared to Standard 12-Gray Total Body Irradiation for Allogeneic Transplantation in First Remission Acute Lymphoblastic Leukemia: A Study of the Acute Leukemia Working Party of the EBMT (2023) (0)
- Measurable Residual Disease (MRD) Monitoring in Acute Myeloid Leukemia (AML) with t(8;21)(q22;q22.1) RUNX1-RUNX1T1 Identifies Patients at High Risk of Relapse: Results of the AML Study Group (AMLSG) (2019) (0)
- REDUCED INTENSITY ALLOGENEIC SCT ACHIEVES LONG TERM DISEASE CONTROL IN PATIENTS WITH FOLLICULAR LYMPHOMA RELAPSING AFTER A PRIOR AUTOLOGOUS SCT AND MAY OVERCOME THE ADVERSE IMPACT OF EARLY RELAPSE POST AUTOSCT. AN EBMT LYMPHOMA WORKING PARTY ANALYSIS (2014) (0)
- Impact of a salvage chemotherapy with carboplatin plus docetaxel on testosterone levels in metastatic castration - and docetaxel-resistant prostate cancer (mDRPC) (2016) (0)
- Activity of decitabine combined with all-trans retinoic acid in oligoblastic AML: Results from a randomized 2x2 phase II trial (DECIDER). (2023) (0)
- Incidence and sonographic features of hepatosplenic candidiaisis in patients with febrile neutropenia (1997) (0)
- Correction: Sequential Anti-Cytomegalovirus Response Monitoring May Allow Prediction of Cytomegalovirus Reactivation after Allogeneic Stem Cell Transplantation (2013) (0)
- Macrophages express a TCR{alpha}{beta}-based variable immunoreceptor (2009) (0)
- P-glycoprotein and multidrug resistance. (1996) (0)
- p21 deletion rescues stem cell senescence and premature ageing of telomere dysfunctional mice without accelerating cancer formation (2006) (0)
- transplantation in patients with high-risk myeloid malignancies Angiopoietin-2 predicts disease-free survival after allogeneic stem-cell (2013) (0)
- 328 - The challenge of informed consent (1997) (0)
- Effective treatment of refractory and relapsed AML with the triple combination of mitoxantrone, topotecan and cytosin-arabinoside (MTC) (2005) (0)
- 6. Donor Issues (2002) (0)
- University of Groningen Reduced SLIT2 is Associated with Increased Cell Proliferation and Arsenic Trioxide Resistance in Acute Promyelocytic Leukemia Weinhäuser, (2020) (0)
- Differential Expression of Mirna Species in Cancer and the Contribution of MiR-223 to the Development of Acute Myeloid Leukemia. (2009) (0)
- Metformintreatment Overcomes ATRA-Resistance in Acute Promyelocytic Leukemia and Increases FOXO3A Expression (2018) (0)
- O-003 ASXL1 frameshift mutations in patients with MDS and AML following MDS after allogeneic SCT: Update on 206 patients (2013) (0)
- Sarcopenia (SMI(+)) in patients (pts) with advanced or metastatic soft tissue sarcoma (a/mSTS): Potential parameter for risk prediction during multimodal therapy (MT)? (2019) (0)
- Activity of Decitabine (DAC) Combined with All-Trans Retinoic Acid (ATRA) in Oligoblastic AML: Subgroup Analysis of a Randomized 2x2 Phase II Trial (2020) (0)
- Transplant Outcomes in Patients with Ph+ Chronic Myeloid Leukemia: Haploidentical Donors Compared to Matched Sibling Donors and Matched/Mismatched Unrelated Donors: A Retrospective Analysis from the EBMT Chronic Malignancies Working Party (EBMT-CMWP) (2021) (0)
- Experimental Approaches to Hemophilia Gene Therapy: Gene Transfer into Hematopoietic Stem Cells (2004) (0)
- 8th Annual Meeting of the German Working Group for Gene Therapy (DAG-GT e.V.) (2014) (0)
- 6th International Meeting on Progress in Radio-Oncology, ICRO/ÖGRO 6 (1998) (0)
- Chaturvedi et al. Blood 2013 supplementary table (2016) (0)
- 368. Differential Sensitivity of Normal and CML-Derived CD34+Cells to Inhibition of SHP2, Gab2 and Stat5 Gene Expression by RNA Interference (RNAi) (2005) (0)
- Thrombopoietin serum levels are elevated in patients with chronic virus hepatitis and controlled on a post-transcriptional level (2002) (0)
- FLAMSA Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation in High Risk Myeloid Malignancies Is Also Feasible with Partially Mismatched Donors. (2007) (0)
- The 48th Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians Award Winners (O001-O007) (2022) (0)
- Comparison of haplo-identical versus unrelated allogeneic stem cell transplantation for acute myeloid leukemia with active disease: A report of 1578 patients from Acute Leukemia Working Party of EBMT (2016) (0)
- Risk groups in a multicenter pilot study for treatment of acute lymphoblastic and acute undifferentiated leukemia in adults. (1985) (0)
- Subject Index Vol. 24,1997 (1997) (0)
- Unrelated Hematopoietic Blood Stem Cell Transplantation in Patients with Acute Myelogenous Leukemia (AML) in First Remission. (2006) (0)
- Spectral flow cytometry cluster analysis of therapeutic donor lymphocyte infusions identifies T cell subsets associated with outcome in patients with AML relapse (2022) (0)
- Decitabine (DAC) Vs. Best Supportive Care in Elderly Patients with Intermediate- and High-Risk MDS with or without Monosomal Karyotypes: Results of the EORTC-LG/German MDS-SG Randomized Phase III Trial 06011 (2012) (0)
- Hemopoietic growth factors: Current status (1988) (0)
- Outcome of Transformed Fanconi Anaemia Patients after Hematopoietic Stem Cell Transplantation: Analysis on Behalf of European Group for Blood and Marrow Transplantation (2018) (0)
- Circulating Angiopoietin-2 Predicts Time to Relapse after Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. (2008) (0)
- P-277 Decitabine vs. best supportive care in elderly higher-risk MDS patients with or without monosomal karyotypes: EORTC-LG/GMDS-SG phase III trial 06011 (2013) (0)
- High EVI1 Expression Predicts Outcome in Younger Adult (15 to 60 years) Patients with Acute Myeloid Leukemia and Is Associated with Distinctive Cytogenetic Subgroups (2009) (0)
- Cytogenetic studies using HPCM-stimulated short-term liquid cultures of circulating hemopoietic precursor cells in patients with myelofibrosis (1982) (0)
- Real-Time RT-PCR for the Detection and Quantification of AML1/MTG8 Fusion Transcripts in Patients with t(8;21) Positive AML (2001) (0)
- Imatinib-induced liver cirrhosis in a patient with advanced gastrointestinal stroma tumor (GIST) (2012) (0)
- Treatment of minimal residual disease in adult acute lymphoblastic leukemia: The German national study (1986) (0)
- 633. Dose-Dependent Gene Silencing by Lentivirus-Mediated RNA Interference (RNAi) in bcr-abl Positive Cells (2004) (0)
- Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Acute Myeloid Leukemia over 70 Years of Age: On Behalf of the Acute Leukemia Working Party of the EBMT (2018) (0)
- Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation from Different Donor Types in Primary Refractory Acute Myeloid Leukemia: A Report from the ALWP of the EBMT (2022) (0)
- NTAL is associated with treatment outcome, cell proliferation and differentiation in acute promyelocytic leukemia (2020) (0)
- PF260 PROGNOSTIC AND PREDICTIVE IMPACT OF NPM1/FLT3-ITD GENOTYPES AS DEFINED BY 2017 EUROPEAN LEUKEMIANET RISK CATEGORIZATION FROM AML PATIENTS TREATED WITHIN THE INTERNATIONAL RATIFY STUDY (2019) (0)
- Persistence of Recipient-Derived Antiviral T cells Severely Influence Donor Chimerism Post Allogeneic HSCT, (2011) (0)
- Reduced Binding of C/EBPα to Myeloid Specific Promoters with Altered Gene Expression in the Presence of PML/RARα. (2005) (0)
- Therapeutic use of erythropoietin in dermatooncology (2007) (0)
- Effect of Recombinant Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) on Leukopenia in AIDS: A Study of Seven Cases (1991) (0)
- Prognostic Significance and Target Potential of Axl in Acute Myeloid Leukemia (2011) (0)
- Recombinant human interleukin 3: Effect on thrombopoiesis in patients with primary and secondary hemopoietic failure (1991) (0)
- Proteomic Screening Applied To Early The Diagnosis Of Chronic Graft-Versus-Host-Disease (2010) (0)
- 7150 Response of renal lesions in patients with metastatic renal cell carcinoma (mRCC) treated with sunitinib – a single center retrospective analysis (2009) (0)
- P-114 SETBP1 mutations in MDS and sAML (2013) (0)
- P-252 Routes of clonal evolution into complex karyotypes in myelodysplastic syndrome patients with del(5q) (2013) (0)
- Prognostic Impact of BAALC Expression in the Context of Other Molecular Markers in Cytogenetically Normal Acute Myeloid Leukemia. (2007) (0)
- NKG2C+CD57+ Natural Killer Cells May Play an Important Role in Maintaining Virus-Specific Immune Reconstitution Post-Allogeneic HSCT (2018) (0)
- Synergy between FLT3-ITD and p53 Haploinsufficiency or Loss in the Development of Acute Myeloid Leukemia (2018) (0)
- Post-Transplant Cyclophosphamide Versus Antithymocyte Globulin in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation from One Antigen HLA-Mismatched Donors: A Retrospective Analysis from the Acute Leukemia Working Party of the EBMT (2018) (0)
- Prospective Evaluation of Proteomic Screening with An Agvhd-Specific Proteomic Pattern MS-17. (2009) (0)
- Soluble VCAM-1 as predictor of survival in patients with advanced malignant melanoma (1997) (0)
- Response to Interleukin-3 Treatment in Graft Failure After Bone Marrow Transplantation (1992) (0)
- Impact of carboplatin plus weekly docetaxel as salvage chemotherapy in docetaxel-resistant and castration-resistant prostate cancer (DRPC) on free testosterone levels. (2011) (0)
- Efficacy of Chemotherapy, Phd-Inhibitor Molidustat or BRD4 Inhibitor JQ1 in Combination with Targeted Inhibition of Mutated IDH1 in Human AML In Vivo (2019) (0)
- P394: INSIGHTS INTO PATIENT-DERIVED XENOGRAFT MODELS FOR DEK-NUP214 LEUKEMIA (2022) (0)
- Low-dose human recombinant interferon-α-2c ARG (Hu-rIFN-α) in hairy cell-leukemia (HCL): design, recruitment and first observations in a prospective randomized multicenter trial (1986) (0)
- Allogeneic Hematopoietic Cell Transplantation in Patients with Therapy-Related Myeloid Neoplasm Following Treatment for Lymphoma: A Study of the Chronic Malignancies Working Party of the EBMT (2022) (0)
- TP53 Mutations Detected By Next-Generation Deep-Sequencing In Patients With Myelodysplastic Syndrome and Isolated Deletion (5q): Results From a German Multicenter Trial (2013) (0)
- Thrombin enhances migration of intestinal epithelial cells (2001) (0)
- Aberrant expression of the MLL5, BAALC, ID1, and WT1 genes is associated with higher induction mortality and poorer overall survival in acute promyelocytic leukemia patients treated with atra and anthracycline-based chemotherapy: an international consortium on acute promyelocytic leukemia study (2012) (0)
- [Molecular mechanisms of hematopoietic stem cell differentiation]. (1995) (0)
- An Adapted Gating Strategy Integrating a Myelomonocytic Window Is Necessary For Correct Flow Cytometric Diagnosis In a Large Proportion Of AML With Mutated NPM1 (2013) (0)
- Diagnostic and prognostic significance of individualized medicine for acute myeloid leukemia with normal karyotype in patients younger than 65 years: a systematic review and meta-analysis with regard to FLT3-ITD (2013) (0)
- 68 ASXL1 is frequently mutated and associated with a negative prognosis in MDS (2011) (0)
- [Liver complications in stem-cell transplantation]. (1997) (0)
- Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia with Normal Karyotype: A Risk Factor Analysis in 247 Patients, Based On Molecular Markers and Stage at Transplantation. (2009) (0)
- PS968 GENETIC LANDSCAPE OF FLT3-MUTATED ACUTE MYELOID LEUKEMIA (AML) PATIENTS TREATED WITHIN THE RATIFY TRIAL: CALGB 10603 (ALLIANCE) (2019) (0)
- Characteristics and Prognosis of AML Patients with or without a History of Clonal Hematopoiesis (2015) (0)
- Research Report Analysis of the Nuclear Distribution of the Translocation t(8;21)-Derived Fusion Protein AML1/ETO by Confocal Laser Scanning Microscopy (2002) (0)
- Trends in outcome of transplantation in patients with secondary acute myeloid leukemia: an analysis from the Acute Leukemia Working Party (ALWP) of the EBMT (2022) (0)
- acute myeloid leukemia reveals new recurrent genomic alterations High-resolution genomic profiling of adult and pediatric core-binding-factor (2013) (0)
- 119 2011-update and overview of data in the German-Austrian-Suisse MDS registry (D-A-CH MDS registry) (2011) (0)
- Cytogenetic monitoring from peripheral blood in patients with myelodysplastic syndrome: First results from the German LEMON-5 trial (2016) (0)
- Regulation of the Expression of ICAM-1 on Pre-B Cell Lines by TNF-α and IFN-γ (1994) (0)
- PPM1D Mutations in MDS Patients with Deletion of Chromosome 5q (2017) (0)
- P59 High efficacy of carboplatin (C) plus weekly docetaxel (D) as second-line treatment for docetaxel-resistant, hormone-refractory prostate cancer (HRPC) (2009) (0)
- O-68 The role of chemotherapy in the treatment of myelodysplastic syndromes (2005) (0)
- Differential effects of gut-homing molecules CC chemokine receptor 9 and integrin-beta7 during acute GvHD of the liver (2015) (0)
- Prognostic Value Of Five-Group Cytogenetic Risk Classification In Patients With MDS After Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Multicenter Study Of The Chronic Malignancies Working Party Of The EBMT (2013) (0)
- progenitor and precursor cells in vivo Effects of recombinant human interleukin-3 on human hematopoietic (2003) (0)
- Inferior outcome of allogeneic stem cell transplantation for secondary acute myeloid leukemia in first complete remission as compared to de novo acute myeloid leukemia (2020) (0)
- Graft-versus-host disease and relapse/rejection-free survival after allogeneic transplantation for idiopathic severe aplastic anemia: a comprehensive analysis from the SAAWP of the EBMT. (2023) (0)
- What can Heraclitus tell us about AML? (2021) (0)
- NF1 Alterations Are Common In AML with Complex Karyotype and Correlate with Specific Genomic Imbalances (2010) (0)
- PF256 RATIFY: PROGNOSTIC IMPACT OF FLT3 TYROSINE KINASE DOMAIN (TKD) AND NPM1 MUTATION STATUS IN PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA (AML) TREATED WITH MIDOSTAURIN + STANDARD CHEMOTHERAPY (2019) (0)
- Decitabine alone or in combination with ATRA: results of a phase II trial in 227 older medically non-fit AML patients, and a randomized, 4-arm follow-up study (DECIDER trial) (2012) (0)
- Lack of c-kit proto-oncogene rearrangement in patients with acute lymphoblastic leukemia (ALL) and the t(4;11)(q21;q23) translocation. (1992) (0)
- Emerging Marrow Fibrosis Is an Early Indicator of Imatinib Failure and Shortened Survival Time in CML Independent of Hematologic, Cytogenetic and Molecular Response. (2005) (0)
- CT patterns of organizing pneumonia in patients treated with VEGF/mTOR inhibitors for metastatic renal cell cancer: an observational study (2017) (0)
- Clinical research in the competence network "acute and chronic leukemias" (2004) (0)
- Is Longer MDS Duration Prior to Non-Intensive AML Treatment a Favorable Prognostic Factor? Results of the 00331 Multicenter Phase II Decitabine Trial (2010) (0)
- Expression of Protease-activated Receptors in Neuroblastoma Cells (2003) (0)
- ALLOANTIGEN-SPECIFIC DE NOVO INDUCED FOXP3(+) REGULATORY T CELLS FAIL TO PREVENT GVHD DUE TO IN VIVO INSTABILITY (2009) (0)
- Leukemogenic Cascade Induced by a Constitutively Active Neurotrophin Receptor, ΔTrkA. (2006) (0)
- Integration project as a path into the future (2010) (0)
- Therapy of Advanced MDS, AML Evolving from MDS, or Secondary AML with Idarubicin Ara-C, VP-16, Followed by G-CSF-Priming Exhibits High Remission Rate (1998) (0)
- P046 Characterization of the T-cell receptor repertoire in patients with myelodysplastic syndromes (2007) (0)
- Genetic Profile of Acute Erythroid Leukemia (2016) (0)
- Regulatory T Cells of G-CSF Mobilized Stem Cell Donors Qualify for Clinical Applications, (2011) (0)
- Reagent and method for inhibiting the expression of n-ras. (1997) (0)
- Active surveillance and deferred medical treatment (ASDT) in metastatic renal cell carcinoma (mRCC): Update of a single center experience and efficacy of medical treatment. (2018) (0)
- Allogeneic Stem Cell Transplantation in Myelodysplastic Syndrome; A More Favorable Outcome after Fludarabine and Treosulfan Conditioning. a Survey on Behalf of the Chronic Malignancies Working Party of the EBMT (2014) (0)
- Treatment Results In Acute Myeloid Leukemia Over a Time Period Of 20 Years: Analysis Of The German-Austrian Acute Myeloid Leukemia Study Group (AMLSG) (2013) (0)
- Hyperfibrinolysis in Hemophagocytic Lymphohistiocytosis (2004) (0)
- 456. Pharmacodynamics and GMP Development of a Lentivirus-Induced DC Vaccine for Accelerated Adaptive Immune Reconstitution Against Cytomegalovirus after Stem Cell Transplantation (2015) (0)
- MP475OXALIPLATIN PHARMACOKINETICS ON HEMODIALYSIS IN A PATIENT WITH DIFFUSE LARGE B-CELL LYMPHOMA (2016) (0)
- Prenylation Inhibitors Block IL-6 and IGF-1 Dependent Activation of RAS Signaling in Multiple Myeloma Cells. (2005) (0)
- Role of allotransplantation in older patients with AML. (2023) (0)
- Prognostic value of a new clinically-based classification system in patients with CMML undergoing allogeneic HCT: a retrospective analysis of the EBMT-CMWP (2022) (0)
- P1456: EARLY SAFETY AND CLINICAL COURSE OF PATIENTS WITH ACUTE MYELOID LEUKEMIA AND MEASURABLE RESIDUAL DISEASE RECEIVING GTA002, AN OFF-THE-SHELF, EX VIVO-CULTURED ALLOGENEIC NK CELL PREPARATION (2022) (0)
- Diagnostic Workup of Patients with Acquired Von Willebrand’s Syndrome. (2006) (0)
- Prognostic Importance of Duration of MDS Prior to Randomization Between Decitabine (DAC) Vs. Best Supportive Care (BSC) In Elderly IPSS Intermediate-2 and High Risk MDS Patients: Results of the 06011 EORTC-GMDSSG Phase III Trial (2010) (0)
- 150 Treatment of low-risk MDS: Combination of hematopoietic growth factors and biological response modifiers (1997) (0)
- Modified antisense oligodeoxynucleotides against the splice acceptor site of tat do not inhibit in vitro hematopoietic colony growth in HIV-positive patients (1995) (0)
- Poster: AML-440 Prognosis of Molecularly-Defined Secondary Acute Myeloid Leukemia Patients (2022) (0)
- Neurotrophin Receptors and Ligands Are Highly Expressed in Acute Leukemia and Promote Leukemogenesis. (2007) (0)
- Personally tailored cancer management based on knowledge banks of genomic and clinical data (2016) (0)
- Hematologic Responses in Patients with Aplastic Anemia Treated with Deferasirox: A Post-Hoc Analysis From the EPIC Study (2011) (0)
- Enforced Expression of Mir-125b Blocks Granulocytic Differentiation by Simultaneous Repression of Multiple Targets. (2010) (0)
- Clofarabine Containing Conditioning Regimen for Allo-SCT in AML/ALL Patients: A Survey From the Acute Leukemia Working Party of EBMT (2011) (0)
- Macrophages express a TCRαβ-based variable immunoreceptor (134.34) (2009) (0)
- [Intensive combined therapy for high-risk ALL patients]. (1988) (0)
- 7046 Effectiveness of Carboplatin (C) plus weekly docetaxel (D) as second-line treatment for docetaxel-resistant, hormone-refractory prostate cancer (HRPC) (2009) (0)
- Salvage Therapy of Adult ALL (1996) (0)
- Improvement of ultrasound with digital documentation in cancer patients (1999) (0)
- Validation of the Transplant Conditioning Intensity (TCI) Score for Allogeneic Hematopoietic Cell Transplantation (2022) (0)
- Favorable Prognostic Impact of WT1 SNP rs16754 in Cytogenetically Normal AML Independent of MN1, BAALC, and ERG Expression. (2009) (0)
- Decrease of Malignant Potential of t(8;21) Positive Cells after Stable Expression of RUNX-CBFA2T1-Specific Small Interfering RNA. (2004) (0)
- Myelodysplastic Syndromes: Treatment Indication and Choice of Therapy (1994) (0)
- graft-versus-host disease Limited efficacy of imatinib in severe pulmonary chronic (2011) (0)
- Signaling Pathways of Mutant IDH1 Independent of R-2-Hydroxyglutarate (2018) (0)
- Serially Transplantable Patient-Derived Xenograft Model of Chronic Myelomonocytic Leukemia (CMML) (2017) (0)
- Prospective Evaluation Of Proteomic Pattern Specific For aGvHD In More Than 300 Patients (2010) (0)
- Fla-IDA Chemotherapy with or without Venetoclax in Patients with Relapsed/Refractory Acute Myeloid Leukemia (2022) (0)
- [Therapy of multiple myeloma. What is confirmed?]. (2013) (0)
- Megakaryocytic differentiation of human circulating pluripotent hemopoietic progenitor cells in vitro (1984) (0)
- Prognostic Impact Of MLL5 transcript Levels On Outcome Of Patients With Acute Promyelocytic Leukemia Treated With All-Trans Retinoic Acid and Anthracycline-Based Chemotherapy: An International Consortium On Acute Promyelocytic Leukemia Study (2013) (0)
- Hormonal impact of salvage chemotherapy with carboplatin plus weekly docetaxel in patients with castration- and docetaxel-resistant prostate cancer (DRPC). (2012) (0)
- Association between Nuclear SET Domain (NSD) Protein Lysine Methyltransferases (KMT) Expression and Poor Prognosis in Acute Promyelocytic Leukemia (APL) Patients Treated with ATRA and Anthracycline Protocol (2017) (0)
- A prospective phase I/IIa trial to evaluate the safety and efficacy of GTA002, an off-the-shelf, ex vivo-cultured allogeneic NK cell preparation in patients with acute myeloid leukemia in complete morphological remission who have measurable residual disease. (2021) (0)
- Fluorescence In Situ Hybridization for the Diagnosis and Follow-up of BCR-ABL Positive ALL (1996) (0)
- Optimized Induction of Mitochondrial Apoptosis By Combination Therapies with Venetoclax for Chemotherapy-Free Treatment of BCR-ABL+ Acute Lymphoblastic Leukemia in Preclinical Models (2018) (0)
- Chemotherapy-Free Targeted Anti-BCR-ABL+ Acute Lymphoblastic Leukemia Therapy May Benefit the Heart (2022) (0)
- Proteomic Pattern-Based Risk Stratification of Outcome Shows Significant Higher Accuracy Compared to HCT-CI in Patients with AML and MDS, (2011) (0)
- Routes of Clonal Evolution Into Complex Karyotypes in Myelodysplastic Syndrome Patients with Del(5q) (2012) (0)
- Prognostic Value of a New Clinically-Based Classification System in Patients with CMML Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Analysis of the EBMT Chronic Malignancies Working Party (2018) (0)
- P468: MRD AS A BIOMARKER FOR RESPONSE TO DONOR LYMPHOCYTE INFUSION AFTER AL-LOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (2022) (0)
- A polymorphism in the coding sequence of WT1 is an independent prognostic marker in 1,101 patients with lobular breast cancer. (2011) (0)
- Use of Axl, a therapeutic target in AML, to mediate stroma-induced chemoresistance. (2013) (0)
- Prospective evaluation of a GvHD-specific proteomics pattern after allogeneic stem cell transplantation (2006) (0)
- Bendamustime: A Viewpoint by Patrick Sch??ffski and Arnold Ganser (2001) (0)
- Partial remission and severe adverse effect caused by metenolone acetate in a male patient with aplastic anemia (1995) (0)
- 120 RESULTS OF THE MULTICENTER, PHASE II STUDY OF THE SAFETY OF LENALIDOMIDE MONOTHERAPY IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS) ASSOCIATED WITH AN ISOLATED DEL(5Q) (2015) (0)
- Correction for Jiang et al., Proteins induced by telomere dysfunction and DNA damage represent biomarkers of human aging and disease (2018) (0)
- Allogeneic Hematopoietic Stem Cell Transplantation in Elderly Patients - A Single Center Study. (2006) (0)
- Addition of in-vitro generated endothelial microparticles to von-Willebrand plasma improves primary and secondary hemostasis. (2014) (0)
- patients with myelodysplastic syndromes--a phase I/II trial Recombinant human granulocyte-macrophage colony-stimulating factor in (2011) (0)
- TP53 and Complex Karyotype Represent a Very High-Risk Group in Myelofibrosis Undergoing Hematopoietic Stem Cell Transplantation: An International Collaborative Analysis (2022) (0)
- Prospective Validation of a Chronic GvHD-Specific Proteome Pattern (cGvHD-MS14) Post Allogeneic Hematopoietic Stem Cell Transplantation (2011) (0)
- Long-term bone marrow culture data is the most powerful predictor for peripheral blood progenitor cell mobilization in healthy donors. (2005) (0)
- 160. All-trans retinoic acid (ATRA) and granulocyte colony-stimulating factor (G-CSF) in the treatment of myelodysplastic syndromes (MDS): a pilot study (1992) (0)
- Allogeneic : Adult Allogeneic Stem Cell Transplantation for Patients Age ≥ 70 Years with Myelodysplastic Syndrome : A Retrospective Study of the MDS Subcommittee of the Chronic Malignancies Working Party of the EBMT (2016) (0)
- P045 T-cell receptor repertoire in patients with myelodysplastic syndromes (MDS) receiving lenalidomide treatment (2007) (0)
- Primary Cancer Matters in Therapy-related Myeloid Neoplasm Patients Receiving Allogeneic Hematopoietic Cell Transplantation: A Study From the Chronic Malignancies Working Party of the EBMT (2023) (0)
- Elevated Fibrinogen is a Risk Factor for Arterial Thrombosis in Children (2004) (0)
- 257 Inactivation of ICSBP by promoter methylation is likely involved in progressive leukemogenesis (2011) (0)
- PF208 MN1 IS INDISPENSABLE FOR MLL-REARRANGED ACUTE MYELOID LEUKEMIA (2019) (0)
- Treatment of Del(5q) Myelodysplastic Syndrome with All-Trans-Retinoic Acid and Tocopherol-α. (2004) (0)
- Hemopoietic growth factors in the treatment of acute leukemias and myelodysplastic syndromes. (1991) (0)
- 476. No GVHD, but Human Inflammatory “Cytokine Storm” and Mouse Macrophage Activation Upon Accelerated Development of Human CD4+ Effector Memory T Cells in Long-Term Humanized Mice (2016) (0)
- Effect of Biological Response Modifiers on Human Bone Marrow Progenitor Cells in Human Immunodeficiency Virus Infection (1992) (0)
- New Editor-in-Chief (2003) (0)
- PS983 NOVEL MOLECULAR PATHOGENESIS AND THERAPEUTIC TARGET IN ACUTE ERYTHROID LEUKEMIA (2019) (0)
- Allogeneic Stem Cell Transplantation in Patients with Myelodysplastic Syndrome (MDS) Using Treosulfan Based Compared to Standard Reduced-Intensity or Myeloablative Conditioning Regimens. a Report of the Chronic Malignancies Working Party of EBMT (2020) (0)
- Potentiation of Topoisomerase II Inhibitor-Mediated Myeloid Leukemia Cell Kill by Farnesyltransferase Inhibitor L-744,832. (2007) (0)
- Impact of Pegfilgrastim and Dosing Schedule of Cytarabine on Hematological Reconstitution Times, Incidences of Severe Infection and Duration of Hospitalization after Consolidation Therapy with High-Dose Cytarabine in Acute Myeloid Leukaemia - Interim Results from AMLSG 07-04 Trial. (2007) (0)
- AML-440 Prognosis of Molecularly-Defined Secondary Acute Myeloid Leukemia Patients. (2022) (0)
- Role of consolidation therapy in adults with high-risk acute myeloid leukemia aged ≤ 60 years: Results of a prospective multicenter trial. (2004) (0)
- Influence of Stem Cell Source (Bone Marrow versus Peripheral Blood) on Outcome after Reduced-Intensity Conditioning Regimens for Acute Leukemia—a Report from the Acute Leukemia Working Party of the EBMT (2015) (0)
- 61 POSTER Contrast enhanced perfusion CT (CEPCT) predicts early response of sunitinib in renal cell carcinoma (RCC) patients (2008) (0)
- The Impact of Cytogenetics on the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed/Refractory Acute Myeloid Leukemia: A Survey from the Acute Leukemia Working Party (ALWP) of EBMT (2018) (0)
- Preclinical and clinical evaluation of interleukin 3. (1991) (0)
- Association of therapy with sunitinib and treatment-related hyperparathyroidism in renal cell carcinoma. (2009) (0)
- [In vitro and in vivo effects of recombinant human interleukin-3 on hematopoietic progenitor cells]. (1990) (0)
- Targeting RAS Signaling in Multiple Myeloma (MM): Synergistic Inhibition by Co-Treatment with the MEK Inhibitor U0126 and Prenylation Inhibitors. (2004) (0)
- Outcome of Older AML Patients with Adverse Cytogenetics, Including Single or Multiple Monosomies, Treated with the DNA Hypomethylating Agent Decitabine (2011) (0)
- Expression of the ETS Transcription Factor GABPα Is Correlated to BCR-ABL/ABL ratio in Human CML and Mediates Imatinib Sensitivity (2014) (0)
- What Is the Outcome of Patients with Acute Leukemia Who Survive Severe Acute Graft-Versus-Host Disease? (2017) (0)
- in chronic myeloid leukemia (CML) Enhanced sensitivity to inhibition of SHP2, STAT5, and Gab2 expression (2012) (0)
- RT-PCR detection of melanoma cells in peripheral blood stem cell harvests of patients with metastatic malignant melanoma (1997) (0)
- 1012. Immortalization of Murine Hematopoietic Stem and Progenitor Cells by AML1-ETO and HoxB4 (2006) (0)
- Comparison of four categorized risk scoring systems for analyzing outcome in advanced MDS (1994) (0)
- Pooled Data Analysis of Acute Myeloid Leukemia Patients <= 60 Years with Trisomy 8 Treated within the Studies of the German Acute Myeloid Leukemia Intergroup. (2005) (0)
- Focused Regulatory T Cell Repertoires Are Indicative of Successful GvHD Control in Experimental and Clinical Stem Cell Transplantation (2018) (0)
- Gastrointestinal disturbances in iron-overloaded myelodysplastic syndromes patients receiving concomitant medications during deferasirox treatment (2013) (0)
- MO343: Deep Analysis of The AKI—CKD in Allogeneic Stem Cell Transplantation—A Big Data Approach (2022) (0)
- Trans-Atlantic Consensus on the Medical Management of Radiation Accident Victims (2008) (0)
- Clinical Impact of TP53 Mutations in Patients with MDS and Isolated Deletion 5(q) Treated with Lenalidomid: Results from the German Prospective Le-Mon-5 Trial (2014) (0)
- Prognostic V alue o f M inimal R esidual D isease Q uantification by R eal-Time R everse T ranscriptase P olymerase C hain Reaction i n P atients W ith C ore B inding F actor L eukemias (2003) (0)
- ID1 Expression Correlates with CEBPA Mutational Status and Is Not An Independent Risk Factor in Cytogenetically Normal AML (2011) (0)
- Minimal Residual Disease (MRD) Monitoring in NPM1 Mutated Acute Myeloid Leukemia (AML): Impact of Concurrent FLT3-ITD and DNMT3A Mutations on MRD Kinetics and Clinical Outcome (2013) (0)
- Mutational and immunogenetic landscape of HCV-associated B-cell lymphoproliferative disorders (2021) (0)
- P-316 TP53 mutations in patients with myelodysplastic syndrome and isolated deletion (5q) treated with lenalidomide: Results from the German Le-Mon-5 trial (2013) (0)
- Molecular response patterns in relapsed/refractory AML patients treated with selinexor and chemotherapy (2021) (0)
- Changes of the Niche of Erythropoiesis Appear to Contribute to Severe Transfusion-Dependent Anemia in a Significant Proportion of Patients with Myelodysplastic Syndromes (2015) (0)
- Identification of baseline characteristics that predict good outcome of alloSCT in young Cll patients - a retrospective analysis from the CMWP of EBMT (2016) (0)
- Altered Immunomodulatory Responses in the CX3CL1/CX3CR1 Axis Mediated by hMSCs in an Early In Vitro SOD1G93A Model of ALS (2022) (0)
- Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Patients with Therapy-Related Myeloid Neoplasm: A Study from the Chronic Malignancies Working Party of the EBMT. (2019) (0)
- Subject Index Vol. 27, 2006 (2006) (0)
- Sequential Chemotherapy Followed by Reduced Intensity Conditioning and Allogeneic Stem Cell Transplantation (allo-SCT) in Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML): A Survey From the Acute Leukemia Working Party of EBMT (2012) (0)
- Prospective Evaluation of a GvHD-Specific Proteom Pattern. (2004) (0)
- Identification of Baseline Characteristics That Predict Good Outcome of Allogeneic Hematopoietic Cell Transplantation in Young Chronic Lymphocytic Leukemia Patients - a Retrospective Analysis from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation. (2016) (0)
- Long-term survival of patients with MDS after allogeneic transplantation : a report from the Chronic Malignancies Working Party of EBMT (2017) (0)
- TKI discontinuation after allogeneic stem cell transplantation in patients with chronic myeloid leukemia (CML): A retrospective study from the chronic malignances working party (CMWP) (2019) (0)
- Prospective analysis of hereditary and acquired risk factors of thromboembolism in patients with inflammatory bowel disease (2000) (0)
- Severe cytopenia after CD19 CAR T-cell therapy: a retrospective study from the EBMT Transplant Complications Working Party (2022) (0)
- Impact of Different Postremission Strategies in Younger Adults with Acute Myeloid Leukemia and Normal Karyotype Exhibiting a CEBPA Mutation. (2005) (0)
- Comparison of HLA-Identical Sibling Hematopoietic Stem Cell Transplant (HCT) Versus Chemotherapy as Postremission Therapy in t(8;21) Acute Myeloid Leukemia (AML). (2005) (0)
- Generation of lentivirus-induced dendritic cells under GMP-compliant conditions for adaptive immune reconstitution against cytomegalovirus after stem cell transplantation (2015) (0)
- SUPPLEMENT (1966) (0)
- Targeting the mismatched minor antigen HA-1 may boost the conversion to complete donor chimerism by eradicating host hematopoietic stem/progenitor cells (2012) (0)
- Is allogeneic transplantation the preferred therapy for older patients with acute myeloid leukemia? (2021) (0)
- Patient Derived Xenotransplantation Model of Atypical Chronic Myeloid Leukemia (aCML) (2015) (0)
- IDH Mutations Are Associated with an Increased Risk of Coronary Artery Disease and Cardiotoxicity in Patients with Established AML (2020) (0)
- Differential Sensitivity of Normal and CML-Derived CD34+ Cells to Inhibition of SHP-2 Gene Expression by RNA Interference (RNAi). (2004) (0)
- Various Other 3 q Abnormalities in Acute Myeloid Leukemia (2010) (0)
- Regulation of T Cell Homeostasis and Cell Cycling in Patients with Acute Myeloid Leukemia. (2005) (0)
- Incidence of Central Venous Catheter (CVC)-lnfections in Patients with Acute Leukemia (2001) (0)
- Proteomic Screening Applied to the Diagnosis of Chronic Graft-Versus-Host-Disease. (2009) (0)
- Interferon-Gamma Production by Allogeneic Foxp3+ Regulatory T Cells Promotes Survival in Experimental GvHD (2011) (0)
- 199 Impaired pulmonary function in liver cirrhosis is a relevant factor for elevated erythropoietin levels in patients with chronic liver disease (2004) (0)
- Genome Wide DNA Methylation Analysis of Patients with Myelodysplastic Syndrome and Isolated Deletion (5q) Reveals Characteristic Methylation Profiles in Low and Intermediate-1 Risk Groups (2012) (0)
- Association of multimodality treatment (MT) with improved overall survival (OS) in patients (pts) with advanced/metastastic soft tissue sarcoma (a/m STS). (2018) (0)
- Stereotactic biopsy of a brain lesion caused by hormographiella aspergillata (2022) (0)
- Outpatient Treatment with Radiosynoviorthesis in Hemophiliac Arthropathy (2002) (0)
- Regulation of Hematopoietic Differentiation and Its Disruption Group Report (1985) (0)
- T Regulatory Cell Receptor Repertoire Focusing and Clonal Expansion Indicates Control of Acute GvHD after Donor Lymphocyte Infusion (2018) (0)
- CAR-T Cells Targeting gp350 Recognize Immortalized Cells Latently Infected with EBV (2018) (0)
- [Effects on bone marrow during stimulation of hematopoietic stem cells with recombinant human interleukin-3]. (1990) (0)
- Who Is the Best Haematopoietic Stem Cell Donor for a Male Patient with Acute Leukaemia (2014) (0)
- A Novel Proteomic Approach to Define Leukemia Cell Resistance to Farnesyltransferase Inhibitors. (2009) (0)
- Acute Myeloid Leukemia with Deletion 9q Is Associated with CEBPA Loss-of-Function Mutations. (2004) (0)
- MN1 Expression Is an Indepedent Prognostic Marker in FLT3-Mutated Acute Myeloid Leukemia and Is Involved in the Resistance to FLT3 Inhibitors (2019) (0)
- Phase I/II Study on Cytarabine and Idarubicin Combined with Escalating Doses of Clofarabine in Untreated Patients with Acute Myeloid Leukemia and High Risk for Induction Failure (AMLSG 17-10 CIARA) (2016) (0)
- Correction: Effective drug treatment identified by in vivo screening in a transplantable patient-derived xenograft model of chronic myelomonocytic leukemia (2021) (0)
- Impact of Donor Type on Outcome after Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia Patients: Analysis of the German-Austrian Acute Myeloid Leukemia Study Group (AMLSG) (2014) (0)
- (F1) GM-CSF and IL-3 in the treatment of MDS (1991) (0)
- Analysis of Vector Integration with LM-PCR after Retroviral HSV-Tk/ΔLNGFR Gene Transfer. (2004) (0)
- Autoimmunity induced by interleukin-2 and interferon-α is associated with long-term survival in patients with metastatic renal cell carcinoma (1997) (0)
- Andrea factor acute myeloid leukemia Gene expression profiling identifies distinct subclasses of core binding (2007) (0)
- effects of interleukin-3, interleukin-7, and accessory cells In vitro culture of common acute lymphoblastic leukemia blasts: (2011) (0)
- Clinical Impact of TET2 Mutations in Acute Myeloid Leukemia Patients Harboring CEBPA Mutations: A Study of the AML Study Group (AMLSG) (2013) (0)
- Palbociclib in Acute Leukemias With KMT2A-rearrangement: Results of AMLSG 23-14 Trial (2023) (0)
- S880 A PHASE II STUDY OF SELINEXOR PLUS CYTARABINE AND IDARUBICIN IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA (AML) (2019) (0)
- Prognostic Impact of Recipient and Donor CMV Serostatus in Acute Leukemia Patients After Allogeneic Stem Cell Transplantation At the Era of Preemptive Therapy. (2012) (0)
- Combined Treatment Modality with Recombinant Human Granulocyte/Macrophage Colony-Stimulating Factor and Low-Dose Cytosine Arabinoside in Patients with Myelodysplastic Syndromes (1992) (0)
- Major Route Additional Chromosomal Aberrations (ACA) Precede Increase of Blasts in CML: An Analysis of the German CML-Studies III and IIIA (2015) (0)
- Clinical Evaluation of Interleukin-3 (1992) (0)
- HAEMATOPOIETIC STEM CELL TRANSPLANTATION IN SEVERE CONGENITAL NEUTROPENIA: DATA FROM THE EUROPEAN GROUP FOR BLOOD AND MARROW TRANSPLANTATION (2014) (0)
- P-198 SPARC and TNF-α contribute significantly to erythroid failure in MDS with 5q deletion and influence considerably the efficacy of lenalidomide (2013) (0)
- Role of IL-15 in the Stimulation of Human CD8+ CMV-Reactive Human T Cells in a Hu-PBL Mouse Model Preconditioned with Self-Differentiated Human Dendritic Cells Programmed with Lentiviral Vectors (2011) (0)
- Sequential Intensified Conditioning Regimen Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with High-Risk AML in Complete Remission: A Survey from the ALWP of the EBMT (2015) (0)
- Contents Vol. 27, 2006 (2006) (0)
- Analysis Of Micro-RNA-142 Mutations In a Cohort Of 944 Patients With MDS and AML (2013) (0)
- ATRA resistance in AML patients MN1 overexpression induces acute myeloid leukemia in mice and predicts (2013) (0)
- Correction: Corrigendum: Myeloid-derived growth factor (C19orf10) mediates cardiac repair following myocardial infarction (2016) (0)
- Gvhd Prophylaxis Incorporating Methotrexate in Allo-HCT for Chronic Myeloid Malignancies and sAML: A Retrospective Analysis from the Cmwp of the EBMT (2022) (0)
- Mutational Landscape of Relapsed Core-Binding Factor Acute Myeloid Leukemia (CBF-AML) (2020) (0)
- Tissue-Factor- and PSGL-1-Bearing Microparticles Are Strong Outcome Predictors in Allogeneic Stem Cell Transplantation. (2009) (0)
- Characterization of a Novel R-RAS Mutation Cloned from Primary AML Cells. (2006) (0)
- Clonal evolution patterns in acute myeloid leukemia with NPM1 mutation (2019) (0)
- 2628 Decision making in metastatic renal cell cancer - A retrospective analysis of predictive factors for application of 2nd line therapy (2015) (0)
- Prevalence and Clinical Effect of TET2 Mutations in Cytogenetically Normal Acute Myeloid Leukemia (CN-AML) (2011) (0)
- Prognostic role of docetaxel-induced suppression of free testosterone serum levels in metastatic prostate cancer patients (2021) (0)
- Mechanisms of tolerance, rejection (2001) (0)
- Mir∼17-92 Identifies BCL2 As a Therapeutic Target In BCR-ABL Positive B-Lineage Acute Lymphoblastic Leukemia (2013) (0)
- Anti-EGFR-Based Therapy in Recurrent or Metastatic HNSCC – What Difference Does it Make? (2022) (0)
- Life-Threatening Bleeding after Vaccination as a First Manifestation of Hemophilia A (2004) (0)
- Role of consolidation therapy in adults with high-risk acute myeloid leukemia aged ≤ 60 years: Results of a prospective multicenter trial (2004) (0)
- The Novel FLT3-N676K Mutant Induces Acute Leukemia Independently of the Inv(16) Chimeric Gene CBFB-MYH11 (2015) (0)
- Early Hepatotoxicity in Patients with Myelofibrosis after Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) (2022) (0)
- - mutated acute myeloid leukemia NPM 1 Clonal evolution in relapsed (2013) (0)
- Cytostatic Anticancer Drug Development: Preclinical Studies and Early Clinical Trials (1990) (0)
- [Enhanced lymphocyte proliferation in the presence of epidermal cells of HIV-infected patients in vitro]. (1992) (0)
- [Current treatment options in acute myeloid leukemia]. (2011) (0)
- The Role of MSI2 Expression Levels on Outcome of MDS and AML Patients (2011) (0)
- Chaturvedi et al. Blood 2013 Supplementary figures (2016) (0)
- Publisher Correction: Human γδ T cells are quickly reconstituted after stem-cell transplantation and show adaptive clonal expansion in response to viral infection (2018) (0)
- Hematopoietic growth factors--present status and future development. (2007) (0)
- Clinical and Functional Studies Reveal That TP73 Isoforms Levels Are Associated with Prognosis and RA-Resistance in Acute Promyelocytic Leukemia (2019) (0)
- on APL countries through networking, results of the International Consortium Improving acute promyelocytic leukemia (APL) outcome in developing (2013) (0)
- Donor-derived IL-17A and IL-17F deficiency triggers Th1 allo-responses and increases gut leakage during acute GVHD (2020) (0)
- Cost-effectiveness of methods in personalized medicine. Results of a decision-analytic model in patients with AML (2015) (0)
- Prognostic value of CPSS cytogenetic risk classification in patients with CMML after allogeneic hematopoietic cell transplantation: a retrospective multicenter study of the Chronic Malignancies Working Party of the EBMT (2018) (0)
- that cytogenetic and molecular subgroups be carefully character- ized in current and future trials using CXCR4 antagonists. (2016) (0)
- Differentiation capacity of null-AL(L) cells in culture. (1985) (0)
- Tregs In Graft-Versus-Host Disease: A Task Force In Trouble?. (2010) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Arnold Ganser?
Arnold Ganser is affiliated with the following schools:
